Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,28187,0.0782822844107801,0.00290773769389182,0.0725831185307522,0.0839814502908081,1.20085472184982e-157
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,28091,0.154818659883572,0.00599620213266008,0.143066103703559,0.166571216063586,2.66880459512877e-145
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,28500,-0.208736020843102,0.00813633247921412,-0.224683232502361,-0.192788809183842,1.59795981283832e-143
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,27562,0.195987026873244,0.00826879004383842,0.179780198387321,0.212193855359168,5.85807086418787e-123
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,23198,0.0795161173147649,0.00340544822819174,0.072841438787509,0.0861907958420207,3.29790293021496e-119
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,23872,-0.081086693452104,0.00356397349807371,-0.0880720815083284,-0.0741013053958795,2.21859809789752e-113
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),23428,-0.266787075750438,0.0119184686635796,-0.290147274331054,-0.243426877169822,7.94417765251084e-110
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,23071,0.139741230983424,0.00648956236166076,0.127021688754569,0.152460773212279,7.66373495252816e-102
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,28452,0.0503850346652474,0.0024690068428806,0.0455457812532014,0.0552242880772933,6.60609791796586e-92
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,23872,-0.032939635294384,0.00165992758797805,-0.036193093366821,-0.029686177221947,6.24348283902453e-87
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,28336,-0.0474011674068341,0.00255089364110044,-0.052400918943391,-0.0424014158702773,1.28004908816859e-76
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,27791,-0.0667587089998954,0.0036000100279636,-0.0738147286547041,-0.0597026893450867,2.63477230125002e-76
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,23862,0.0488623108050044,0.00272067968338699,0.0435297786255659,0.0541948429844428,1.19791211070328e-71
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,28239,0.0961864090769675,0.00543991990252959,0.0855241660680095,0.106848652085925,1.38065078623794e-69
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,23846,0.0978600908911827,0.00556360710696193,0.0869554209615373,0.108764760820828,8.09983489668287e-69
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,23872,-0.0564186059335255,0.00323553266109449,-0.0627602499492707,-0.0500769619177803,1.13271860154408e-67
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,23738,0.0840141148134411,0.0048265339130505,0.0745541083438622,0.0934741212830201,1.92701159230885e-67
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,28148,0.115390857815774,0.00682139164107271,0.102020930199271,0.128760785432276,7.09707676023501e-64
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,23188,0.135193314375063,0.00823702543020374,0.119048744531864,0.151337884218262,3.3832911036192e-60
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,28182,-0.194962204513528,0.0118878074101113,-0.218262307037346,-0.17166210198971,3.62590232109685e-60
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,28091,0.039093223052018,0.00241652733858184,0.0343568294683976,0.0438296166356385,1.34004488525015e-58
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,28224,0.0668357985026119,0.00415505333970475,0.0586918939567906,0.0749797030484333,5.84857766882519e-58
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,28521,0.0299869588907177,0.00190543885193595,0.0262522987409232,0.0337216190405122,1.433479529929e-55
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,28307,-0.0345136972686838,0.00220471041832812,-0.0388349296886069,-0.0301924648487607,5.2667645438652e-55
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,28292,0.0339865517673212,0.00219134225046131,0.029691520956417,0.0382815825782253,4.99944966403458e-54
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,28253,-0.0202623660279055,0.00132612735402776,-0.0228615756418,-0.0176631564140111,1.70332209285922e-52
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,28321,0.0340699747656438,0.00229824701074877,0.0295654106245762,0.0385745389067114,1.56502533859429e-49
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,28494,-0.0617893612642533,0.00418349274870875,-0.0699890070517224,-0.0535897154767841,3.48911476176309e-49
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,23337,0.0511488401215334,0.00349956292006171,0.0442896967982124,0.0580079834448543,3.63930095211208e-48
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,23872,-0.0500668490833299,0.00345679333159955,-0.056842164013265,-0.0432915341533948,2.44315349484153e-47
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,27529,0.0575721783381173,0.00400002544457644,0.0497321284667475,0.0654122282094871,8.47703866206206e-47
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,28187,0.0514235617878736,0.0035766987271743,0.044413232282612,0.0584338912931353,1.05032882715725e-46
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,28320,-0.0266019507082281,0.00187712424305659,-0.0302811142246191,-0.0229227871918372,1.96327217491688e-45
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,27682,0.049441699247521,0.00349131086353441,0.0425987299549935,0.0562846685400484,2.28950004264092e-45
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,23775,-0.034284672077768,0.00246356740723352,-0.0391132641959457,-0.0294560799595903,7.45875293273622e-44
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,23198,0.0557368213216215,0.00402476254295547,0.0478482867374288,0.0636253559058142,1.93568847449204e-43
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,27418,0.0511972540721749,0.00370345887153553,0.0439384746839652,0.0584560334603845,2.54726206205417e-43
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,28176,0.0360832694976276,0.00263778084275073,0.0309132190458362,0.041253319949419,1.84291793556245e-42
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,28307,0.0227510001990682,0.00166628287754622,0.0194850857590776,0.0260169146390588,2.61204605813625e-42
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,23862,0.0294936490156573,0.00220907933806576,0.0251638535130484,0.0338234445182662,1.63171844144258e-40
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,27795,0.0260663358508064,0.00196177488875263,0.0222212570688513,0.0299114146327616,3.64710632285702e-40
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,28187,-0.0253487125703609,0.00192573604552542,-0.0291231552195907,-0.0215742699211311,1.87068793883385e-39
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,23893,-0.0227673042875283,0.00173250189353085,-0.0261630079988488,-0.0193716005762079,2.61476970332806e-39
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,23846,0.0231285840820038,0.00176417360365916,0.0196708038188318,0.0265863643451757,3.93478030274771e-39
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,23893,-0.0228740665308959,0.00174698344701946,-0.026298154087054,-0.0194499789747378,4.89181792476831e-39
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,28224,0.0294703365631062,0.00228776212356222,0.0249863228009242,0.0339543503252881,7.29501740596264e-38
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,23337,0.0286936470163253,0.00222837625978235,0.0243260295471519,0.0330612644854987,8.21547448590153e-38
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,28452,0.0214963578533905,0.0016733972251478,0.0182164992921008,0.0247762164146802,1.15389382848506e-37
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,28404,0.102240167385976,0.00797661834537951,0.086605995429032,0.11787433934292,1.66322580854216e-37
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,27918,0.0450645583233222,0.00351666831657357,0.0381718884228381,0.0519572282238064,1.73390134966474e-37
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,27682,0.0714652144569198,0.00561988114704456,0.0604502474087125,0.0824801815051272,6.07669222749522e-37
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,28187,0.032021564701649,0.00252352790277014,0.0270754500122195,0.0369676793910785,8.55954983643116e-37
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,23862,-0.0501389467392577,0.00396756867526076,-0.0579153813427688,-0.0423625121357466,1.72389044554655e-36
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,26272,0.0345549008783362,0.00274199111383418,0.0291805982952212,0.0399292034614512,2.61867525354521e-36
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,28091,0.0346645703903662,0.0027618385174102,0.0292513668962422,0.0400777738844902,4.88905014217924e-36
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,27338,0.0848814513166077,0.00676441076627064,0.0716232062147172,0.0981396964184981,5.10955598477361e-36
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,27910,0.060839977467586,0.00486853536466115,0.0512976481528501,0.0703823067823219,9.71769487530415e-36
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,23737,0.0708827695985197,0.00572245846620457,0.0596667510047588,0.0820987881922807,3.95847414381042e-35
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,27554,0.0410265958257736,0.00332514952890737,0.0345093027491151,0.047543888902432,6.96851284570403e-35
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,27544,0.0425914425852091,0.00345619825501991,0.03581729400537,0.0493655911650481,8.39319695389482e-35
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,28373,0.0477414790391129,0.00391366977100588,0.0400706862879414,0.0554122717902844,3.84893923401425e-34
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,28091,-0.0333267178903187,0.002752369570296,-0.0387213622480988,-0.0279320735325385,1.15706734458888e-33
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,27965,0.0473812741878528,0.00395931483043374,0.0396210171202027,0.055141531255503,6.3652126531124e-33
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,28091,0.0281697799501057,0.00238501981977258,0.0234951411033515,0.03284441879686,4.07400166852211e-32
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,28276,-0.0357124750098863,0.00302768806322848,-0.0416467436138141,-0.0297782064059585,4.90760372933366e-32
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,23893,0.0563207452466014,0.00484232617737571,0.0468297859389451,0.0658117045542578,3.48290891794177e-31
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,27965,0.0556031578949186,0.00478258166623329,0.0462292978291014,0.0649770179607359,3.57897812381106e-31
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23198,0.044578704357378,0.00384089904129085,0.037050542236448,0.0521068664783081,4.66447658847179e-31
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,28553,0.0390653072442472,0.00337818035823728,0.0324440737421022,0.0456865407463923,7.34815855445421e-31
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,28313,0.0506754022586268,0.0043829408009954,0.0420848382886759,0.0592659662285778,7.53455237971171e-31
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,28553,-0.022282226246919,0.0019387244066118,-0.0260821260838781,-0.0184823264099598,1.66522803037592e-30
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,28336,-0.0443666880662456,0.00391914317173607,-0.0520482086828483,-0.0366851674496429,1.20291444112634e-29
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,28176,0.0250253277077133,0.00221436581990195,0.0206851707007054,0.0293654847147211,1.49618799834301e-29
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,23725,0.041853379445534,0.00371670131971374,0.0345686448588951,0.0491381140321729,2.42986649583387e-29
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,28521,-0.019168302654372,0.00170588224776019,-0.0225118318599819,-0.015824773448762,3.10597973452274e-29
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,23846,0.068773649490996,0.00614342806466836,0.056732530484246,0.080814768497746,5.11604502838685e-29
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,28367,-0.0207259301648664,0.00186998362834006,-0.0243910980764129,-0.0170607622533199,1.72667187847951e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,23337,0.0563741449977077,0.00508770879376913,0.0464022357619202,0.0663460542334952,1.83817822128056e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,23725,0.0282017532081634,0.00254776807140593,0.0232081277882078,0.0331953786281191,2.07746558787536e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23198,0.0271555304186884,0.00247284613324684,0.0223087519975246,0.0320023088398522,5.49903731283826e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,28307,0.0245854000098873,0.00224750857488586,0.020180283203111,0.0289905168166636,8.5330573010948e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,23775,0.0518299925983732,0.00474272049382884,0.0425342604304687,0.0611257247662777,9.82515064007242e-28
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,28521,0.0381305634256604,0.00349234411307709,0.0312855689640293,0.0449755578872915,1.06902223799154e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,28428,0.0175733294465042,0.00161543882478823,0.0144070693499192,0.0207395895430891,1.65616952360274e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,28091,0.0586701285752525,0.00540212435911578,0.0480819648313855,0.0692582923191194,2.01422766265881e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,28236,0.0230557195944989,0.0021273062001242,0.0188861994422555,0.0272252397467424,2.57427109745107e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,27562,0.0557496221714329,0.00515790460734988,0.0456401291410271,0.0658591152018386,3.55445852461347e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,28145,0.0144693486638493,0.00133914739069933,0.0118446197780787,0.01709407754962,3.68982758174925e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,28452,-0.0334743484267167,0.00309914293805871,-0.0395486685853117,-0.0274000282681216,3.83726590042814e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,27840,0.0276222336226412,0.00255889727334722,0.0226067949668807,0.0326376722784018,4.13196942666168e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,28091,0.0503113197467779,0.00468287758583319,0.0411328796785448,0.0594897598150109,7.15827141683116e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,23846,0.021502822887443,0.0020025634556878,0.0175777985142949,0.025427847260591,7.80380870061567e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,28174,0.0608748852106132,0.00567480229483637,0.0497522727127339,0.0719974977084925,8.54457899187825e-27
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,28452,0.0467274944728517,0.00437040057066963,0.0381615093543392,0.0552934795913641,1.24925149837155e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,23862,0.0389571401628696,0.00364764986054958,0.0318077464361924,0.0461065338895468,1.44902470525225e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,28224,-0.0332672178184067,0.00311822086517023,-0.0393789307141403,-0.027155504922673,1.60309029429928e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,23561,-0.0300027110158847,0.00281227062123264,-0.0355147614335007,-0.0244906605982688,1.64307133489458e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",28187,-0.0173730342662141,0.00163215539929883,-0.0205720588488398,-0.0141740096835884,2.08250825419043e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,28091,0.0310823358801272,0.00292455320890436,0.0253502115906746,0.0368144601695797,2.47613410071868e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,23322,0.0338125636161643,0.00318779458993398,0.0275644862198937,0.0400606410124349,3.17708555528149e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,28097,0.0219718963372774,0.00207707184223978,0.0179008355264875,0.0260429571480674,4.20710131661998e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,28224,-0.0265884927971871,0.00251944512173204,-0.0315266052357819,-0.0216503803585923,5.48263493891467e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,28176,-0.0332012001021335,0.00314982143207793,-0.0393748501090062,-0.0270275500952607,6.27054918999925e-26
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,28176,0.0281563670781461,0.00269834530308077,0.0228676102841078,0.0334451238721844,1.91621046101346e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,27562,0.0441871814102834,0.00424047084416438,0.0358758585557212,0.0524985042648456,2.2320510234208e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,28452,0.03204838832018,0.0030944459769332,0.0259832742053909,0.038113502434969,4.32218549769746e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,28404,0.0293065374771789,0.00283384183288888,0.0237522074847167,0.0348608674696411,5.05929810616039e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,27705,0.0548016092597713,0.00530267306655497,0.0444083700493235,0.065194848470219,5.45024555318297e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,28187,-0.0235854822191136,0.00228680915555029,-0.0280676281639922,-0.0191033362742351,6.76604113648969e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,28320,-0.0142190218642732,0.00137906070990637,-0.0169219808556897,-0.0115160628728567,6.98017748163299e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,27374,-0.0266767300616479,0.00258879580624881,-0.0317507698418956,-0.0216026902814003,7.451674601352e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,23337,0.0342881277245815,0.00332738372905741,0.027766455615629,0.0408097998335341,7.57619235766329e-25
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,28132,-0.0331815634387639,0.00323306951926431,-0.0395183796965219,-0.0268447471810058,1.14142284098656e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,28344,0.0412895100754925,0.00402466318425186,0.0334011702343588,0.0491778499166261,1.18930113003135e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,28553,-0.0163587679225205,0.00160041649817816,-0.0194955842589497,-0.0132219515860913,1.749572917499e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,23893,-0.0361533317205851,0.00354831897494638,-0.04310803691148,-0.0291986265296902,2.49367108111616e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,28307,-0.0273664322685787,0.00269007253664587,-0.0326389744404046,-0.0220938900967528,2.8780101047195e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,28521,0.0270776603564128,0.00266396677937125,0.0218562854688452,0.0322990352439805,3.14380631174822e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,28176,0.0363023617009793,0.00357981408597275,0.0292859260924727,0.0433187973094859,4.00368976751403e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,28452,0.0292827356310037,0.00289312464511255,0.0236122113265831,0.0349532599354243,4.872435593648e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,28428,-0.0253993418925035,0.00251282431028182,-0.0303244775406558,-0.0204742062443511,5.59630128307986e-24
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,28091,-0.0133614421603191,0.00133017229853728,-0.0159685798654522,-0.010754304455186,1.06096421401672e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,23893,0.0239734116602913,0.00238824030751346,0.0192924606575649,0.0286543626630177,1.15475638822102e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,23337,-0.0242261564175354,0.00242172669719549,-0.0289727407440385,-0.0194795720910322,1.6379049413605e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,27544,0.0241312644933726,0.00241449540216697,0.0193988535051253,0.0288636754816198,1.76958457305291e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,28176,0.0185318853152741,0.00185745804934692,0.0148912675385542,0.0221725030919941,2.10155659075411e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,28384,0.0205074959526052,0.00205633808315313,0.016477073309625,0.0245379185955853,2.19042113169605e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23188,0.0299361406359217,0.00300285201393319,0.0240505506886127,0.0358217305832308,2.31611585300681e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,28307,0.0268197628955012,0.00269533150149838,0.0215369131525644,0.032102612638438,2.74180820790439e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,28224,0.0452825234429256,0.00457223004304685,0.0363209525585538,0.0542440943272974,4.37019000516739e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,28174,0.0650165983319328,0.00656526124959936,0.052148686282718,0.0778845103811475,4.40108562318207e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,23071,0.0413591037188694,0.00418245324892832,0.0331614953509699,0.0495567120867689,5.17795124524504e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,27702,0.0365116130990274,0.00369485532302005,0.0292696966659081,0.0437535295321467,5.4532030092339e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,23893,0.0129271724677776,0.00130986052328991,0.0103598458421293,0.0154944990934258,6.26850236177887e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,23775,0.0864892266855527,0.00877360596873107,0.0692929589868398,0.103685494384266,7.01111378710105e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,28553,-0.0163364389160684,0.00166010841891934,-0.0195902514171503,-0.0130826264149864,8.18384357575909e-23
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,23337,0.0255435884045303,0.00261239947926764,0.0204232854251657,0.0306638913838948,1.54893277953343e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,27965,0.0274047438927444,0.00281378100496793,0.0218897331230072,0.0329197546624815,2.22094558128914e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,28233,0.0421905664960932,0.00434747676268166,0.0336695120412371,0.0507116209509492,3.12197309546745e-22
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,28135,0.0324105855909746,0.00339029400380716,0.0257656093435126,0.0390555618384366,1.2724414877925e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,28320,0.0492916301732109,0.0051880501055499,0.0391230519663331,0.0594602083800887,2.23730704335763e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,28452,-0.0373985310083331,0.00394489800248775,-0.0451305310932091,-0.0296665309234571,2.72788431126901e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,28452,-0.022563957373915,0.00239654575261082,-0.0272611870490322,-0.0178667276987978,5.06666251501661e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,28091,0.0217547031720668,0.00231067556128974,0.0172257790719389,0.0262836272721946,5.08729078399894e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,28091,-0.0485860654387053,0.00516887661786433,-0.0587170636097194,-0.0384550672676913,5.8721920495391e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",28091,0.0514955837990632,0.0054884942777193,0.0407381350147334,0.062253032583393,6.91523041748125e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,23812,-0.00930312964202664,0.000995161233919413,-0.0112536456605087,-0.00735261362354459,9.66067443838603e-21
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,27544,0.0379408233103372,0.00411749553320983,0.0298705320652459,0.0460111145554285,3.34236557173877e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,28266,0.0280784097012467,0.00304949696190945,0.0221013956559042,0.0340554237465892,3.5603329868561e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,28182,0.0299981331121816,0.00325845508161123,0.0236115611522236,0.0363847050721396,3.60461393074376e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,23738,0.0495844184143707,0.00538941444340935,0.0390211661052884,0.0601476707234531,3.85434141540132e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,23393,0.0333548427612443,0.00364306942976443,0.026214426678906,0.0404952588435826,5.8315468204189e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,28135,-0.0173794199811607,0.00190599552637312,-0.021115171212852,-0.0136436687494694,8.126571839136e-20
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,28307,-0.0171346475619454,0.00188428402225405,-0.0208278442455634,-0.0134414508783275,1.02054357243323e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,28521,-0.0174869668030801,0.00192406293171554,-0.0212581301492426,-0.0137158034569176,1.06686234204998e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,23337,0.0174126313364248,0.00192262112043037,0.0136442939403813,0.0211809687324683,1.4471992551878e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,28428,-0.0182075962493472,0.00201546563915322,-0.0221579089020876,-0.0142572835966069,1.75824500097353e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,28224,0.0258547928926299,0.00286605558272903,0.020237323950481,0.0314722618347788,1.97840570061818e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,28187,0.0248831971827965,0.00275973516825896,0.0194741162530089,0.030292278112584,2.0616569523153e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,28452,0.0172920832131955,0.00191848858060442,0.0135318455952109,0.0210523208311802,2.11997756891986e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",23738,-0.0618070860140821,0.00690706681885921,-0.0753449369790461,-0.048269235049118,3.86527876500891e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,23163,0.0485854956416448,0.0054385805255132,0.037925877811639,0.0592451134716507,4.42862730488855e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,28224,-0.0281683422884469,0.00315637016640453,-0.0343548278145998,-0.021981856762294,4.75147410246453e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,23337,0.0137074937280207,0.00153853666941898,0.0106919618559594,0.0167230256000819,5.49612207938876e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,28307,0.0322088094911489,0.00361572824762551,0.0251219821258029,0.0392956368564949,5.50186394755901e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,28187,-0.0161199156085841,0.00181162190509006,-0.0196706945425606,-0.0125691366746076,6.01613075558865e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,23493,0.036679405733841,0.004144328318329,0.0285565222299162,0.0448022892377659,9.31454623089316e-19
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,28291,-0.0139269488659443,0.00157547436413202,-0.0170148786196431,-0.0108390191122455,1.0129740759419e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,28428,-0.0271555459800393,0.00308474365709476,-0.0332016435479451,-0.0211094484121336,1.40388983380943e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,23530,0.0315493578560758,0.00359148616765522,0.0245100449674716,0.0385886707446801,1.6759720954171e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,23846,0.0206541662635809,0.00235878267533664,0.0160309522199211,0.0252773803072407,2.14947118350306e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,23862,0.027520617744892,0.00314720983146099,0.0213520864752285,0.0336891490145556,2.38619650438561e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,28428,-0.0171522060330371,0.00197046431198279,-0.0210143160845234,-0.0132900959815509,3.35469161456819e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,28224,-0.0201922933417051,0.00231994704471548,-0.0247393895493474,-0.0156451971340627,3.38196998103811e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,28281,-0.0301143378289511,0.00346211950886808,-0.0369000920663325,-0.0233285835915696,3.5502254900428e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,28187,-0.0443486533302314,0.00510484692569169,-0.0543541533045871,-0.0343431533558757,3.89996258986396e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,23198,0.0303210058693837,0.00349165419983915,0.0234773636376989,0.0371646481010684,4.07386412917963e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,28187,-0.0335169834552792,0.0038829385507919,-0.0411275430148313,-0.0259064238957271,6.34879225171493e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,23872,-0.0151280024908342,0.00175435591159105,-0.0185665400775527,-0.0116894649041158,6.91456040092454e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,28304,-0.0181925516935957,0.00211121414687736,-0.0223305314214753,-0.014054571965716,7.21853945072321e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,23353,-0.0177970565682439,0.00207242574967692,-0.0218590110376106,-0.0137351020988771,9.43102434618561e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,23862,0.0432237807952561,0.00503405267151267,0.0333570375590913,0.0530905240314209,9.5233228019969e-18
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,28176,-0.0180114233642809,0.00210227244280593,-0.0221318773521805,-0.0138909693763813,1.10977991298206e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,28237,0.015342340224359,0.00179162665114279,0.0118307519881191,0.0188539284605989,1.15114131594761e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,23846,0.0152456569978987,0.00178268538070845,0.0117515936517101,0.0187397203440873,1.28054417589182e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,27702,-0.0230583877628499,0.0026980170874774,-0.0283465012543056,-0.0177702742713942,1.33394124163081e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,28117,-0.0241569775106578,0.00282742412496196,-0.0296987287955832,-0.0186152262257323,1.36334894791872e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,27562,0.0340857575966906,0.00398992187909987,0.0262655107136549,0.0419060044797264,1.37470434730293e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,28307,-0.0172212011225106,0.00201656893772882,-0.0211736762404591,-0.0132687260045621,1.41029043350954e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",28224,-0.0450940645698076,0.0052846406190007,-0.0554519601830489,-0.0347361689565662,1.49584694741438e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,28176,0.0288604649762241,0.00338641033666701,0.0222231007163567,0.0354978292360914,1.63919144882245e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,28224,0.0302888043986858,0.00358515319823685,0.0232619041301416,0.03731570466723,3.093281950757e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,27641,0.0338817489468157,0.00402017169370573,0.0260022124271524,0.0417612854664789,3.68691835805436e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",23795,-0.0517574279273819,0.0061452552720895,-0.0638021282606773,-0.0397127275940864,3.89621286323678e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,27965,0.0294421300708427,0.00350299084654902,0.0225762680116067,0.0363079921300788,4.48472865119551e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,28144,0.0474973379990122,0.00567096563652551,0.0363822453514222,0.0586124306466022,5.75009138777932e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,27544,0.0287794322027431,0.00344545483530134,0.0220263407255524,0.0355325236799337,6.97183029587186e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,23862,0.015752619957174,0.00188709818043212,0.0120539075235271,0.019451332390821,7.34406096323634e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",23738,-0.0492145715771146,0.00590126527253422,-0.0607810515112816,-0.0376480916429475,7.85040779932158e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,28187,0.036479121059778,0.00437698344255241,0.0279002335123753,0.0450580086071808,8.14576750657918e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,27918,0.0258930533754547,0.00310741381722278,0.019802522293698,0.0319835844572113,8.26241209977138e-17
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,28521,0.0209351472584183,0.00252488442158457,0.0159863737921125,0.025883920724724,1.16667217344126e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,23198,0.0356029783434333,0.00429376880327465,0.027187191489015,0.0440187651978516,1.17563285034026e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,23893,-0.0102860574576371,0.00124262817329903,-0.0127216086773032,-0.00785050623797102,1.32120218060774e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,23862,0.0206197339538264,0.00251281645857783,0.0156946136950139,0.025544854212639,2.40474470478768e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,23846,0.0362972578165479,0.0044303992282751,0.0276136753291287,0.0449808403039671,2.67978619381248e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,23337,0.0227188408061725,0.00277623831109074,0.0172774137164346,0.0281602678959103,2.9011745792197e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,28336,-0.0240742413683033,0.00294493928123728,-0.0298463223595283,-0.0183021603770782,3.08656787143732e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,28553,0.0306923279686011,0.00375534466586758,0.0233318524235006,0.0380528035137015,3.13220653577499e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,28553,-0.01435707338854,0.00176016275618438,-0.0178069923906614,-0.0109071543864186,3.58385120450981e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,28224,0.0348529026997385,0.00428404865129719,0.026456167343196,0.043249638056281,4.26931395503575e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28553,-0.0159617337251246,0.00196247458025025,-0.0198081839024151,-0.0121152835478341,4.33939403225227e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,27682,0.0192976559522197,0.00237699705787472,0.0146387417187852,0.0239565701856541,4.91416178831631e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,27682,0.0286976071203324,0.00354204736047501,0.0217551942938013,0.0356400199468634,5.6279977532154e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,23846,0.0204912308457074,0.00253274985923497,0.0155270411216068,0.0254554205698079,6.22278258733132e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,23820,-0.0397956683124441,0.00492121237286193,-0.0494412445632535,-0.0301500920616347,6.42757588477559e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,27965,-0.0190280879158129,0.00235335043478891,-0.0236406547679992,-0.0144155210636267,6.43766049971363e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,23662,-0.0187431239663644,0.00231837880583417,-0.0232871464257994,-0.0141991015069294,6.53434584137582e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,28126,-0.0178782422210031,0.00221464235534664,-0.0222189412374825,-0.0135375432045237,7.14589174914377e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,28176,-0.0189786189338391,0.00235119045520444,-0.0235869522260398,-0.0143702856416384,7.19378366042747e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,28428,-0.0247552804684474,0.00307126761129321,-0.0307749649865821,-0.0187355959503127,7.90843360031337e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,28396,0.0169955398347555,0.00211085090956716,0.0128582720520039,0.0211328076175071,8.49532526619465e-16
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23198,-0.0491575608942583,0.00614345850717382,-0.061198739568319,-0.0371163822201976,1.28518072023193e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,27940,0.0198914407064085,0.00248841920144591,0.0150141390715745,0.0247687423412425,1.36074321514766e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,23337,-0.027836301305517,0.00348396444104068,-0.0346648716099567,-0.0210077310010772,1.41332998106706e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,27084,0.020231912109251,0.00253747697565883,0.0152584572369597,0.0252053669815423,1.6062374682371e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27562,0.0340885053904245,0.00427725067424524,0.0257050940689038,0.0424719167119451,1.65139462611463e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,28428,0.0744443337733884,0.00935288831102968,0.0561126726837703,0.0927759948630066,1.79130529326748e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,28307,-0.0222806356697688,0.00280350049201375,-0.0277754966341158,-0.0167857747054219,1.97454206617979e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,27702,0.0425292802983254,0.00535843576218468,0.0320267462044434,0.0530318143922074,2.15118715659837e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,23832,-0.0182458996142635,0.00231872583004843,-0.0227906022411584,-0.0137011969873686,3.72819019092181e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,27682,0.0290226908414924,0.0036924394970245,0.0217855094273244,0.0362598722556604,3.97932209636317e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,23852,-0.0103098786899704,0.00131313372154537,-0.0128836207841993,-0.00773613659574146,4.28819908876295e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,23337,-0.0161128193337104,0.00205547269291797,-0.0201415458118297,-0.0120840928555912,4.73549189622307e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,23775,0.0369116264141665,0.00471076194030268,0.0276785330111733,0.0461447198171598,4.86092628950191e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,28184,-0.0166942763103925,0.00213114525600868,-0.0208713210121695,-0.0125172316086154,4.91194538923463e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,28091,0.0419063084481455,0.00535164541661225,0.0314170834315855,0.0523955334647055,5.028107321849e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,23846,0.014871759799452,0.00190270067481423,0.0111424664768161,0.0186010531220879,5.67143810771564e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,28091,0.0287940161756215,0.00368664179660565,0.0215681982542744,0.0360198340969686,5.90045920346472e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,27969,0.0271639590791346,0.00348149156719228,0.0203402356074377,0.0339876825508315,6.28568285843143e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,28091,-0.0154010471057506,0.00197635302079618,-0.0192746990265111,-0.0115273951849901,6.78726920256502e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,28091,0.0365470089805662,0.00469249591308039,0.0273497169909287,0.0457443009702038,7.01982063464454e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,28428,-0.0412398665833103,0.0053000745877195,-0.0516280127752405,-0.0308517203913801,7.43886019347284e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,28237,-0.0176953781294828,0.00227442036166704,-0.0221532420383502,-0.0132375142206154,7.48922605123212e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,23893,-0.0352448825467227,0.00453132964571563,-0.0441262886523253,-0.0263634764411201,7.66226031785329e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,28326,0.0356492343826404,0.0045872090011398,0.0266583047404064,0.0446401640248744,8.02179806612497e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,28187,-0.0203166170226039,0.00261538777032998,-0.0254427770524507,-0.0151904569927571,8.23664406908247e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,27965,0.0121696977821438,0.00157106719188696,0.0090904060860454,0.0152489894782423,9.79320515248102e-15
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,28091,0.0293323773866896,0.00379010082899412,0.0219037797618611,0.0367609750115181,1.03389982996259e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,23337,-0.0213344970878677,0.00275694649898239,-0.0267381122258732,-0.0159308819498622,1.04704746231357e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,28411,-0.0219512267174681,0.0028473186825677,-0.0275319713353008,-0.0163704820996354,1.30494669651701e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,28237,0.0154092599696537,0.00199939992495523,0.0114904361167415,0.019328083822566,1.33091797220164e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,28521,-0.0133822400809273,0.00174462213178909,-0.0168016994592339,-0.00996278070262065,1.76690169624154e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",28452,-0.0377648483753197,0.00493711166430622,-0.0474415872373599,-0.0280881095132795,2.08651266566389e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,23846,0.0304788136201099,0.00399747398039072,0.0226437646185441,0.0383138626216757,2.54079043762931e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,28174,-0.0235895424620783,0.00309625169731973,-0.029658195788825,-0.0175208891353317,2.64197022110094e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23071,0.0287831330349093,0.00377795310262825,0.0213783449537579,0.0361879211160607,2.66069909565184e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,23738,-0.0584534772369227,0.00768392542156996,-0.0735139710631999,-0.0433929834106456,2.90399913489611e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,23337,0.039183952799329,0.00515477356735179,0.0290805966073194,0.0492873089913385,3.03765018892667e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,28452,-0.0320515025503253,0.00422270635528299,-0.04032800700668,-0.0237749980939706,3.28996467866372e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,28176,-0.0169633614477583,0.00223677723306614,-0.021347444824568,-0.0125792780709487,3.45807334750311e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,28173,0.0377103858219659,0.00497485945175168,0.0279596612965326,0.0474611103473992,3.55655116477915e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,28192,0.0221166105502763,0.00292334701492626,0.0163868504010208,0.0278463706995318,3.98125598591868e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,28113,0.0348977325061632,0.00461277691955413,0.0258566897438371,0.0439387752684893,3.98342507573404e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,23795,0.022402065502886,0.00296478334206062,0.0165910901524472,0.0282130408533248,4.30451470877515e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,28195,0.0201740485709196,0.00267045079707718,0.0149399650086483,0.0254081321331909,4.33056836008337e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,28452,0.0134817206043728,0.00178556188735426,0.00998201930515845,0.0169814219035872,4.46899491062158e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,27528,-0.0285319659737388,0.00378392620102241,-0.0359484613277427,-0.0211154706197348,4.83316932525183e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,28023,-0.0117100137577716,0.00155313200940052,-0.0147541524961966,-0.00866587501934656,4.85632414957359e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,28176,-0.0198854215095373,0.00263891504355328,-0.0250576949949018,-0.0147131480241729,5.01252501465878e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,28091,0.030063081121239,0.00400802475851791,0.0222073525945439,0.0379188096479341,6.53436741839049e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,28120,-0.0187019140317762,0.00249607712257687,-0.0235942251920269,-0.0138096028715255,6.95492580068913e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,23337,0.0109784379377038,0.00147062607087717,0.00809601083878454,0.013860865036623,8.61213810978918e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,27785,0.073622256804993,0.00987883615807846,0.0542597379351592,0.0929847756748268,9.42400409698855e-14
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,23738,0.0555499071930419,0.00746334020299297,0.0409217603951757,0.0701780539909081,1.01744347514086e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,23198,0.0151269836578544,0.00203988976017157,0.0111287997279181,0.0191251675877907,1.25239827341642e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,28452,0.0189073112388717,0.00255459447400067,0.0139003060698304,0.023914316407913,1.38593693125252e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,23872,-0.0316127379545664,0.00427666036464426,-0.0399949922692691,-0.0232304836398636,1.49483481367787e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,23198,0.0118990022042545,0.00160980946074925,0.00874377566118598,0.0150542287473231,1.50031263144149e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,28521,0.0150483435123667,0.00203888573281378,0.0110521274760517,0.0190445595486818,1.61794690116891e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,27968,-0.0290010191175887,0.00393459551783408,-0.0367128263325435,-0.0212892119026339,1.74338048531494e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,23846,0.0146406540726055,0.0019875108435609,0.0107451328192261,0.0185361753259849,1.81091479050216e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,28194,-0.0465890892175182,0.00633848120155025,-0.0590125123725567,-0.0341656660624797,2.03292050921279e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,23775,0.0157534857993615,0.00214324714426962,0.0115527213965931,0.01995425020213,2.04167410860564e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,28266,0.0175292504310478,0.002388254744803,0.012848271131234,0.0222102297308617,2.19720785606447e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,28176,0.0236859103717701,0.00322805584048928,0.0173589209244111,0.0300128998191291,2.23470971374836e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,27544,0.0280662320964093,0.0038285217410519,0.0205623294839476,0.0355701347088711,2.35033686280198e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,27829,-0.0136131905338909,0.0018578871837315,-0.0172546494140047,-0.0099717316537772,2.41324676825654e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,27562,0.0290509456876957,0.00396625083331271,0.0212770940544028,0.0368247973209886,2.46300638405807e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,23725,0.0257776017790158,0.00352034261638253,0.018877730250906,0.0326774733071255,2.51210785141482e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,28199,-0.0250300940675081,0.00342738234342765,-0.0317477634606263,-0.0183124246743899,2.88922996779931e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,28307,-0.0135633147541389,0.00185784344358255,-0.0172046879035607,-0.00992194160471715,2.94101573515498e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,23738,0.0490768032117054,0.00672246236587611,0.0359007769745882,0.0622528294488226,2.95901804509931e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,28187,-0.0180334594444398,0.00247270189306408,-0.0228799551548454,-0.0131869637340342,3.11073470424638e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,23163,0.0164284203803255,0.00225507167756663,0.0120084798922949,0.0208483608683561,3.3172339253668e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,28307,0.0108286544843439,0.00148935175059511,0.00790952505317746,0.0137477839155103,3.66853324648916e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,27544,0.0217999705389056,0.00299968510036909,0.0159205877421822,0.027679353335629,3.76164624946901e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,28553,-0.0108978169335161,0.00149984692478043,-0.0138375169060857,-0.00795811696094642,3.7990996185128e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,27965,-0.0281076959047937,0.00386879533851534,-0.0356905347682838,-0.0205248570413036,3.82140405823301e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,23188,0.0341422595880735,0.00469960303883753,0.0249310376319519,0.043353481544195,3.85051093890129e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,28176,0.0369056080925775,0.00508877700661217,0.0269316051596176,0.0468796110255373,4.20151174642026e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,27562,-0.022941537296876,0.00316444021708052,-0.0291438401223539,-0.0167392344713982,4.28396068821835e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,28452,-0.0138432600577141,0.00191198710629104,-0.0175907547860445,-0.0100957653293836,4.5922305589154e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,23521,0.0127219864070035,0.00175944530255195,0.00927347361400171,0.0161704992000054,4.95280661893187e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,28363,-0.0167906391254167,0.00232420805216878,-0.0213460869076676,-0.0122351913431659,5.16614316463171e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23393,0.0214609945250477,0.00297122463529991,0.0156373942398599,0.0272845948102355,5.24313843733792e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,23198,0.0110416747274836,0.0015290835967281,0.00804467087789651,0.0140386785770706,5.31576112026715e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,27562,0.0278035231169246,0.00385242084092991,0.0202527782687019,0.0353542679651472,5.44585504048427e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,23301,0.0280144545186595,0.00388216044205544,0.0204054200522308,0.0356234889850881,5.50973248355116e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,28091,0.0190567291703245,0.00265868733623511,0.0138457019913037,0.0242677563493453,7.81384818767421e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,28363,0.0233896906789659,0.00326698792439256,0.0169863943471565,0.0297929870107753,8.29990426423424e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,28187,-0.0153349134654073,0.00214462833344049,-0.0195383849989507,-0.011131441931864,8.86442362712378e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23198,-0.0370590016342105,0.00518316157488759,-0.0472179983209901,-0.0269000049474308,8.94277829582764e-13
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,28452,0.0152022316076007,0.0021368489699503,0.0110140076264981,0.0193904555887033,1.15124159421231e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,23216,0.0132948792937017,0.00187743887710797,0.00961509909457004,0.0169746594928333,1.46785304819663e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,27965,-0.0162093206102185,0.00229182710065622,-0.0207013017275047,-0.0117173394929323,1.55561983543216e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,27969,0.0344553213368101,0.00487384351086661,0.0249025880555116,0.0440080546181086,1.59216043924626e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,23738,-0.0539727264489951,0.00764742357916283,-0.0689616766641543,-0.038983776233836,1.74020639281089e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,27977,-0.0192105799393949,0.00272415369812007,-0.0245499211877102,-0.0138712386910795,1.80533585774217e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,28277,0.0307455709996644,0.00436442931888971,0.0221912895346406,0.0392998524646883,1.90279246285002e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,23775,0.0291613052123702,0.00414622834907629,0.0210346976481807,0.0372879127765597,2.0730132837348e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,28224,0.0300309385309073,0.00427366751949549,0.0216545501926961,0.0384073268691184,2.15856788956498e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,28176,0.0331903092207226,0.00472946057318612,0.0239205664972778,0.0424600519441674,2.30522777662327e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,28428,0.0175115755462299,0.00249753973168157,0.012616397672134,0.0224067534203257,2.40992191009318e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,27544,-0.0158316478360974,0.00225920752046552,-0.0202596945762098,-0.011403601095985,2.48001123748876e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,23337,0.0128321368903125,0.00183213207135103,0.00924115803046449,0.0164231157501605,2.55628495024993e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,28452,0.021501190584808,0.00308323850229488,0.0154580431203101,0.027544338049306,3.1574072557647e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,23738,0.0394662661362008,0.00568489641933326,0.0283238691543076,0.050608663118094,3.95705874561619e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,27702,0.0141964632564359,0.00204895464024935,0.0101805121615472,0.0182124143513246,4.34210670668539e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,28156,-0.0281949025841149,0.00407623668895027,-0.0361843264944574,-0.0202054786737724,4.71518144895592e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,27702,0.0244982833352232,0.00354668615750998,0.0175467784665037,0.0314497882039428,5.04382522497535e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,23738,0.02769756247002,0.00401208901292362,0.0198338680046897,0.0355612569353503,5.20060568904742e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,28452,-0.0153137192295468,0.00222064290641537,-0.019666179326121,-0.0109612591329727,5.45765562765604e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,27562,0.0258101581212724,0.00375013373036419,0.0184598960097586,0.0331604202327862,6.00861251188259e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,23862,0.0233222429759209,0.00338957979395351,0.016678666579772,0.0299658193720698,6.10886407149635e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,28143,-0.0189922503094203,0.00276763769923139,-0.0244168201999138,-0.0135676804189268,6.9184288951186e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,27500,0.0326785513495208,0.00479095894084958,0.0232882718254556,0.042068830873586,9.2359495643254e-12
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,23862,0.0106319035999481,0.00156443854647603,0.00756560404885505,0.0136982031510411,1.1010858452124e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",23188,0.0163831073874437,0.00242459840119598,0.0116308945210996,0.0211353202537878,1.44179157591336e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",23795,0.0191323143249589,0.00283372122572576,0.0135782207225364,0.0246864079273814,1.49531627641167e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,28276,-0.0404781227472897,0.00599932491003727,-0.0522367995709628,-0.0287194459236167,1.53725612054259e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,23795,0.0261766303076932,0.00388958274040667,0.0185530481364961,0.0338002124788903,1.73600556705446e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,28194,-0.0144524505259718,0.00214803797618716,-0.0186626049592987,-0.010242296092645,1.75049894012294e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,27910,0.0106554403135523,0.00158438596998998,0.00755004381237197,0.0137608368147327,1.78636679429703e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,23775,0.0171117511840584,0.00254422166355777,0.0121250767234852,0.0220984256446317,1.78678387958564e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,27544,-0.0334746260580954,0.0049786292886089,-0.0432327394637689,-0.023716512652422,1.80674622393668e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,28500,0.0271446284615168,0.0040397537281704,0.0192267111543028,0.0350625457687307,1.85939868692262e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,28182,0.0518550304263766,0.00772323618934682,0.0367174874952568,0.0669925733574963,1.92746391616872e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,28215,-0.0176610265691425,0.00263092970601402,-0.02281764879293,-0.012504404345355,1.94481131227622e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,23872,-0.0238505457341275,0.00355837948871731,-0.0308249695320134,-0.0168761219362416,2.09248041760814e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,28521,-0.0329402292377124,0.00492923308523014,-0.0426015260847635,-0.0232789323906613,2.39017067070197e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,28299,-0.0104841453845321,0.00157504293318816,-0.0135712295335809,-0.00739706123548326,2.85707323492394e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,28553,0.0136431389186536,0.00205174319403432,0.00962172225834638,0.0176645555789609,2.99322683142599e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,28553,0.0123117114093694,0.00185334148278554,0.00867916210310975,0.0159442607156291,3.12925236152972e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,28187,-0.022708943736025,0.00342124103382904,-0.0294145761623299,-0.0160033113097201,3.2454287492417e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,27544,0.022898191563091,0.00345887534033907,0.0161187958960264,0.0296775872301556,3.65487891692619e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,28111,-0.0151219525275491,0.00228495039544867,-0.0196004553026285,-0.0106434497524697,3.70472783225465e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,28137,0.0369524705872194,0.0055894702291619,0.025997108938062,0.0479078322363767,3.8833524723917e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,28336,0.0257841425797283,0.00390067723088947,0.018138815207185,0.0334294699522717,3.90692462343226e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,28091,0.0240445557237134,0.0036444459909949,0.0169014415813634,0.0311876698660634,4.25327367647959e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,27833,0.0160083962158702,0.002426774483587,0.0112519182280397,0.0207648742037007,4.28314063991388e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,28182,-0.0142407900065852,0.00216137530596871,-0.0184770856062839,-0.0100044944068865,4.51322430486474e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,28291,-0.0130658287861579,0.00198853736784776,-0.0169633620271395,-0.00916829554517626,5.09926325584215e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,27682,-0.0221014993141898,0.0033661838893236,-0.028699219737264,-0.0155037788911155,5.26903427490109e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,28224,0.0155809328023738,0.00238130116886579,0.0109135825113968,0.0202482830933507,6.13155676250806e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,23071,0.0173720298223525,0.00265790476685601,0.0121625364793147,0.0225815231653903,6.45119408314627e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,28522,-0.0188844396699406,0.00289275893282012,-0.024554247178268,-0.0132146321616132,6.76932269302952e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,27544,0.0153080095796478,0.00234952686070174,0.0107029369326724,0.0199130822266233,7.37677190059078e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,27850,0.020783299928382,0.00319154252732512,0.0145278765748247,0.0270387232819392,7.5423633396052e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,28521,-0.0340663870000269,0.00523140989848508,-0.0443199504010577,-0.0238128235989961,7.5442886963148e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23198,-0.0305359537573912,0.00469121340022004,-0.0397307320218225,-0.0213411754929599,7.7106809881417e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,23893,-0.0101261713756762,0.00155704114111898,-0.0131779720122694,-0.00707437073908298,8.00398718761865e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,28307,-0.0161994973143258,0.00249138873227187,-0.0210826192295787,-0.0113163753990729,8.04743244351252e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",23056,0.0323393432670947,0.00497417070092749,0.0225899686932769,0.0420887178409126,8.11759732969405e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,23725,0.0157941243625524,0.00243160553347629,0.0110281775169389,0.0205600712081659,8.44834656401421e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",28155,-0.0244258394768416,0.00376106679389772,-0.0317975303928811,-0.0170541485608021,8.47592793580142e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,28336,-0.0208969235023952,0.00322108221642421,-0.0272102446465866,-0.0145836023582037,8.86836227633479e-11
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,28176,0.0278576324021501,0.00431135733072051,0.0194073720339379,0.0363078927703623,1.05395218945695e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,27376,0.0377672143501356,0.00584543068991364,0.0263101701979049,0.0492242585023663,1.05774246922302e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,28091,0.0227339007559383,0.00352486034319732,0.0158251744832716,0.029642627028605,1.1397691592855e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,27562,0.0277900396916967,0.00431587531887709,0.0193309240666976,0.0362491553166958,1.22220982855681e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,28091,-0.0370938340764653,0.00576488574682529,-0.0483930101402429,-0.0257946580126878,1.25922057156309e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,28087,-0.0124478525996998,0.00193509314049601,-0.0162406351550719,-0.00865507004432758,1.27383082220438e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,28144,-0.0380189164908717,0.00591625518288602,-0.0496147766493283,-0.0264230563324151,1.3294385565543e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,27713,-0.0178935035060876,0.00278920294575991,-0.023360341279777,-0.0124266657323981,1.42837244670788e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,27519,-0.02003506369679,0.00312317290605048,-0.0261564825926489,-0.0139136448009311,1.43138115941046e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,28224,-0.0303705916347517,0.00473677514873765,-0.0396546709262775,-0.0210865123432259,1.46218857773425e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,23862,-0.0223295044513952,0.00348334298348764,-0.0291568566990309,-0.0155021522037594,1.47886043119957e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,28199,0.0418278285571946,0.0065307636408663,0.0290275318210966,0.0546281252932925,1.53000968539713e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,27544,-0.0193277158593969,0.00302599027206015,-0.0252586567926348,-0.013396774926159,1.71605671522113e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,28176,0.0104317216532262,0.00163714491893532,0.00722291761211294,0.0136405256943394,1.8958681024548e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,27965,0.0201514324941453,0.00318609985830103,0.0139066767718753,0.0263961882164154,2.57400864499354e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,28044,0.0316132961245811,0.0049984914515995,0.021816252879446,0.0414103393697161,2.57771187020449e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,23198,0.0123745959239732,0.00195956863923723,0.00853384139106825,0.0162153504568782,2.75135426694522e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,28276,-0.0243867135924197,0.00386363663686763,-0.0319594414006803,-0.0168139857841592,2.7980030868241e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,27965,-0.0109215009257625,0.00173096059578547,-0.014314183693502,-0.007528818158023,2.84125594708896e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,27682,0.0160259022290726,0.00253996619370782,0.0110475684894052,0.0210042359687399,2.84184549337868e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,28044,0.0238117998705357,0.00377740949298007,0.0164080772642948,0.0312155224767766,2.94875048397151e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,27544,0.0274781695755273,0.00436016346866988,0.0189322491769343,0.0360240899741202,2.9809182999718e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,23872,0.0267102245782708,0.00424566500681716,0.0183887211649092,0.0350317279916324,3.20541865709218e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,27544,0.0118509549559501,0.0018865372274851,0.00815334199007934,0.0155485679218209,3.39555515020103e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,23198,0.0250861202822573,0.00399531893880329,0.0172552951622029,0.0329169454023118,3.47073857267238e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,27965,0.0120317203273314,0.001920716983148,0.00826711504036131,0.0157963256143015,3.80244315376126e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,28428,0.0183369240002929,0.00292772231150754,0.0125985882697382,0.0240752597308477,3.82542345946551e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,28377,-0.0171843114327829,0.00274518078088119,-0.02256486576331,-0.0118037571022558,3.90959826146154e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,28187,-0.0148515138990675,0.00237322209795541,-0.0195030292110602,-0.0101999985870749,3.95673277401083e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,28187,0.0108248313996898,0.00173871067436121,0.00741695847794184,0.0142327043214378,4.85919057233902e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,27632,-0.0220562774223521,0.00354276244407628,-0.0290000918127416,-0.0151124630319626,4.86217105641181e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",28176,-0.0344547448193114,0.00555368851450651,-0.0453399743077442,-0.0235695153308787,5.58331214387196e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23198,0.0154911476197162,0.00249899947886202,0.0105931086411467,0.0203891865982858,5.78034158496944e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",23846,0.0291619957493284,0.00470562204542845,0.0199389765402887,0.0383850149583682,5.83934325407938e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,23163,0.0189020946817486,0.00305290176772521,0.0129184072170072,0.02488578214649,6.05894753813487e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,23198,0.0223136597752279,0.0036082358588006,0.0152415174919788,0.0293858020584771,6.35047581916429e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,23862,-0.0100566124836468,0.00162748848027792,-0.0132464899049915,-0.00686673506230206,6.54611035909489e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,28138,-0.0327411770338845,0.00530804716277664,-0.0431449494729267,-0.0223374045948423,7.00055532591928e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,23775,0.0193262940465365,0.00313646179680632,0.0131788289247961,0.0254737591682769,7.30719122806517e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,23846,0.0338323977347662,0.00549412266364728,0.0230639173140175,0.0446008781555149,7.48818779067495e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,27965,0.0305068607723789,0.00495481344153358,0.020795426426973,0.0402182951177847,7.513726665027e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,28091,0.00870598449266573,0.00141421709351845,0.00593411898936956,0.0114778499959619,7.55933288663871e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,23766,-0.0196030880177731,0.00318473234529931,-0.0258451634145597,-0.0133610126209864,7.61192629954377e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,28378,-0.0299036709395142,0.00487285366168669,-0.0394544641164201,-0.0203528777626083,8.53208002814775e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,23795,0.0218012486501544,0.00355808563601742,0.0148274008035602,0.0287750964967485,9.08200857681416e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,23844,0.0151600995619386,0.00247895843742554,0.0103013410245846,0.0200188580992927,9.7744579800394e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,28091,-0.0116090771300174,0.00189841910989661,-0.0153299785854148,-0.00788817567462007,9.77511131568103e-10
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,23775,0.0172715188631514,0.00282888472170396,0.0117269048086116,0.0228161329176911,1.04122177969529e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,28224,-0.0126960948597883,0.00208019442612676,-0.0167732759349967,-0.00861891378457985,1.05239636065473e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,23846,0.0112970482299945,0.00185247044671625,0.00766620615443069,0.0149278903055584,1.08804473316085e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,28091,0.0553602617370369,0.00908221424383986,0.0375591218191108,0.073161401654963,1.10544763336653e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,28091,0.0278964125349184,0.00457772708517499,0.0189240674479754,0.0368687576218614,1.11594996135687e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,28091,0.0296926105536212,0.00487523153643188,0.0201371567422147,0.0392480643650277,1.1401741894891e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,27324,0.0314213346320519,0.00516066372950047,0.021306433722231,0.0415362355418728,1.1540396432207e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,23775,0.0122015919016702,0.00200447579441257,0.00827281934462154,0.0161303644587188,1.16681710287313e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,28053,-0.0272960261829005,0.00448991367740448,-0.0360962569906133,-0.0184957953751878,1.22181919731806e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,28320,-0.0488109597489377,0.00802947654716429,-0.0645487337813797,-0.0330731857164957,1.22501181493204e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,23337,0.0260667004065997,0.00430091292822491,0.0176369110672789,0.0344964897459205,1.37578453475161e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,28521,-0.0191375651420805,0.0031604968897741,-0.0253321390460378,-0.0129429912381233,1.41960630701691e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,28091,0.0184796394737436,0.00306038112814026,0.0124812924625887,0.0244779864848985,1.57655724472176e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,28521,0.0138128707994802,0.0022901805591711,0.0093241169035049,0.0183016246954556,1.64599955805777e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,27871,-0.0175267215640884,0.00290942808241781,-0.0232292006056273,-0.0118242425225495,1.7217087636256e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,23846,-0.0395929365897033,0.00658119679838552,-0.0524920823145389,-0.0266937908648677,1.81309021394174e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,27682,0.0267501809004836,0.00445207192068773,0.0180241199359356,0.0354762418650315,1.89610509317003e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,27607,0.0177844023657036,0.00296753232129068,0.0119680390159739,0.0236007657154334,2.08566719626392e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,27562,0.0225672516856847,0.00377236687544941,0.0151734126098039,0.0299610907615656,2.22786028524221e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,28266,-0.0152532103854189,0.00255712897439369,-0.0202651831752305,-0.0102412375956072,2.47579565543177e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,23337,0.0162138799213119,0.00272446167264714,0.0108739350429235,0.0215538247997003,2.69946955992354e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,23188,0.022488471465838,0.00377981028998414,0.0150800432974691,0.0298968996342069,2.72609187793375e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,28251,-0.0196826929617266,0.00332209939872269,-0.0261940077832231,-0.0131713781402302,3.16346110001238e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,23287,0.0150245770165523,0.00253658248798039,0.0100528753401108,0.0199962786929939,3.20256125832515e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,28176,0.0217362131062429,0.00367017543057225,0.0145426692623213,0.0289297569501645,3.2097320458438e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,28452,0.025871941688688,0.0043710233583591,0.0173047359063042,0.0344391474710719,3.27681564331361e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",23071,-0.0224298387979748,0.00380103683029852,-0.0298798709853599,-0.0149798066105897,3.66401159810983e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,23071,0.0268453954043947,0.00455852552581708,0.0179106853737932,0.0357801054349962,3.938022714037e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,27879,-0.0413612970940453,0.00703113433279354,-0.0551423203863206,-0.0275802738017699,4.08499328261527e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,23775,0.0262504884154255,0.00446650274650535,0.017496143032275,0.035004833798576,4.22856983319006e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,28521,0.019528427412365,0.00332641952074056,0.0130086451517135,0.0260482096730165,4.3874836963355e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,27516,0.047278136918461,0.00805733468097786,0.0314857609437444,0.0630705128931776,4.46903241764869e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,27638,-0.015156531669096,0.00258405356407716,-0.0202212766546872,-0.0100917866835047,4.53125609938427e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,28553,-0.0167450229740528,0.00285780740087676,-0.0223463254797713,-0.0111437204683344,4.69652607959368e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,28210,-0.0373778204505402,0.00638124377319679,-0.0498850582460059,-0.0248705826550745,4.75239377476037e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,28195,-0.0134858633483755,0.00230297645415259,-0.0179996971985146,-0.00897202949823639,4.79863707888189e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,28176,0.0360576236167233,0.00616693545053286,0.0239704301336789,0.0481448170997677,5.06257323394999e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,27562,0.0282128467815513,0.0048267763635134,0.0187523651090651,0.0376733284540376,5.12055817090633e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,23862,0.0160262436998751,0.0027419567512662,0.0106520084673933,0.0214004789323568,5.13715699658102e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,23337,0.027453049732923,0.00471631493634869,0.0182090724576796,0.0366970270081664,5.93092405314615e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,23775,0.0247253692817894,0.00424928146484096,0.0163967776107012,0.0330539609528777,6.00618964699144e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,28176,0.0239333511869364,0.00412068182269643,0.0158568148144514,0.0320098875594214,6.3862800852175e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,28176,-0.0238925989134552,0.0041143313368005,-0.0319566883335842,-0.0158285094933262,6.42218619201273e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,23738,-0.0373224348615686,0.00644559790060026,-0.0499558067467451,-0.0246890629763921,7.11147622295963e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,28237,-0.0119279789688688,0.0020624149881471,-0.0159703123456371,-0.00788564559210052,7.39331398486656e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,27863,-0.0155067866648932,0.00268306288201404,-0.0207655899136407,-0.0102479834161457,7.57172214066972e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,23507,0.0218020585365802,0.00377643678654211,0.0144002424349577,0.0292038746382027,7.87674072007009e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,23733,0.0124672659464006,0.00216029675719919,0.00823308430229014,0.016701447590511,7.97412457641884e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,28452,0.017795988711689,0.0030868627709019,0.0117457376807213,0.0238462397426568,8.24660156184493e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,23725,0.0187076565849467,0.0032492383475052,0.0123391494238365,0.0250761637460569,8.63960377299537e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,28422,0.0219147664029986,0.00381306430959422,0.0144411603561939,0.0293883724498033,9.16147726774339e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,23365,-0.00857711558408588,0.00149420167602237,-0.0115057508690897,-0.00564848029908204,9.5698567052011e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,27965,0.0139732030215554,0.00243610667484261,0.00919843393886386,0.0187479721042469,9.80102224283561e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,28182,0.0288607622203115,0.0050319669273669,0.0189981070426723,0.0387234173979506,9.82289210862484e-09
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,28187,-0.0138713157526071,0.00242024259358911,-0.0186149912360417,-0.00912764026917242,1.00635875168186e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,23775,0.0147227549542553,0.00256903469371673,0.00968744695457046,0.0197580629539401,1.01136479517311e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",27702,-0.0277307846840218,0.00485310108363015,-0.0372428628079369,-0.0182187065601067,1.11460029630552e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,23738,0.0218277629454127,0.0038219826629882,0.0143366769259558,0.0293188489648696,1.13583011981637e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,28181,-0.0226118855923492,0.00397288913032112,-0.0303987482877786,-0.0148250228969198,1.27142665799325e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,23198,0.0230588218143413,0.00405210199752609,0.0151167018991902,0.0310009417294925,1.28133230644881e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,27562,0.0167899707113309,0.00296078558603542,0.0109868309627015,0.0225931104599604,1.43568796991895e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,23725,0.0260135891678641,0.00459399964179002,0.0170093498699557,0.0350178284657725,1.50895828716946e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,28320,-0.0253141631569805,0.00447447337409301,-0.0340841309702028,-0.0165441953437582,1.55109590008817e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,28037,-0.0269867784356495,0.00477517922745778,-0.0363461297214667,-0.0176274271498322,1.60625734495046e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",28307,-0.01326849810206,0.00234795452789021,-0.0178704889767248,-0.00866650722739513,1.60967021969409e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,23337,-0.00864317699394676,0.00153054301220889,-0.0116430412978762,-0.00564331269001732,1.65045325115e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,23845,0.0140929122351184,0.00250261301309233,0.00918779072945742,0.0189980337407794,1.80892100268546e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,23377,0.0165950128532176,0.00295576810313588,0.0108017073710713,0.0223883183353639,1.9942680630619e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",28237,-0.0127464196665328,0.00227298144911878,-0.0172014633068056,-0.00829137602626002,2.06832899388226e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,23703,-0.0330537819847119,0.00589540954017929,-0.0446087846834633,-0.0214987792859605,2.08519200245792e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,28224,0.0105126320409953,0.00189037408175111,0.00680749884076315,0.0142177652412275,2.70446367488477e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,23725,0.00797870294289212,0.00143516819539173,0.00516577327992433,0.0107916326058599,2.7358583935764e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,22492,0.0461834953875109,0.00830854441784677,0.0298987483285312,0.0624682424464905,2.75105695854184e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,23775,0.0101139752416212,0.00182178573490173,0.00654327520121386,0.0136846752820286,2.85956260571469e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,27702,0.0262555542358417,0.00473405310161562,0.0169768101566751,0.0355342983150083,2.94769629567441e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,23846,0.0117353744173106,0.00211798388559617,0.00758412600154211,0.0158866228330791,3.04234938848972e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,23893,-0.00731016794664737,0.00132011350351617,-0.00989759041353905,-0.00472274547975568,3.09995924380016e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,28553,0.0219643086264485,0.00397360780700295,0.0141760373247228,0.0297525799281743,3.27574575593911e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,23188,0.0123184189356553,0.00223436233387814,0.00793906876125419,0.0166977691100565,3.56185196739859e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,28411,0.0233699013869572,0.00424152339903036,0.0150565155248577,0.0316832872490568,3.62378592708048e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,28176,-0.0193447106690905,0.00351838923419718,-0.026240753568117,-0.012448667770064,3.87076014973859e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",28091,-0.0256705496848283,0.00467395458600191,-0.034831500673392,-0.0165095986962645,4.00272140082245e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,28187,-0.0448932022460022,0.0081759784240697,-0.0609181199571788,-0.0288682845348256,4.03417470563731e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,28553,0.00922944445991682,0.00168219794719946,0.00593233648340589,0.0125265524364278,4.13364384762046e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,23795,-0.0171408665554188,0.00312572513245663,-0.0232672878150337,-0.0110144452958038,4.20509146949753e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,28307,-0.0101465682934533,0.00185726086134767,-0.0137867995816947,-0.00650633700521187,4.71592778773539e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,23337,0.0196761654535479,0.00360690267489473,0.0126066362107543,0.0267456946963416,4.94311927131177e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,28224,0.00647513736285504,0.00118743024439872,0.00414777408383355,0.00880250064187652,4.99233896758325e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,28091,-0.0132883055859326,0.00244722468662719,-0.0180848659717219,-0.00849174520014333,5.68372585069492e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,27965,0.0192600311651228,0.00354776479003434,0.0123064121766555,0.0262136501535901,5.7212824449621e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,23725,0.0216138165605832,0.00398681393816344,0.0137996612417829,0.0294279718793836,5.97359974450488e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,28452,0.0218574781535626,0.00404352372939813,0.0139321716439423,0.0297827846631829,6.51284928771766e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,23846,0.0199530730681902,0.003699098806745,0.01270283940697,0.0272033067294104,6.95481713764134e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,23188,-0.0117533052954153,0.00217905108311443,-0.0160242454183196,-0.00748236517251104,6.96690773149454e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,23795,-0.0216262427184386,0.00401529744687438,-0.0294962257143124,-0.0137562597225649,7.27413436905833e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,28452,0.0463482942301981,0.00862237241909065,0.0294484442887805,0.0632481441716158,7.70340885042702e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,23725,-0.0140396445862779,0.00261931081602652,-0.0191734937856899,-0.00890579538686596,8.3974350604863e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,28195,0.0197386946585668,0.00368618483883059,0.0125137723744588,0.0269636169426747,8.63323459205359e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,27268,0.0144949411690312,0.00271308244713349,0.0091772995726496,0.0198125827654129,9.23522372428935e-08
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23188,0.0175470729267999,0.003295958020898,0.0110869952058399,0.02400715064776,1.02558388183282e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,23862,0.0404302413783731,0.00759432445378824,0.0255453654489482,0.0553151173077981,1.02571780649077e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',23775,0.0149443845668346,0.00280917657537306,0.00943839847910336,0.0204503706545657,1.04795252955674e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,28553,0.0217365788710998,0.00408909083831695,0.0137219608279985,0.029751196914201,1.07017004714181e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,28174,-0.0236940019195079,0.00446163278865115,-0.0324388021852641,-0.0149492016537516,1.10085581704577e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,23488,-0.00290596154504126,0.000547593488052814,-0.00397924478162477,-0.00183267830845774,1.12587139716791e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",27702,0.0213849347178921,0.00402999228894366,0.0134861498315626,0.0292837196042217,1.12642569998464e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,28187,-0.00860307478650023,0.00162894039342217,-0.0117957979576077,-0.00541035161539279,1.29155784689939e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,27562,0.0292586503659698,0.00554611171790304,0.0183882713988798,0.0401290293330598,1.33376197438093e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,28340,0.0366204246740572,0.00694470961499041,0.023008793828676,0.0502320555194384,1.35092334337899e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,28176,-0.0424963362589492,0.00807234251180083,-0.0583181275820789,-0.0266745449358196,1.41649954699151e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,23872,0.025800232779799,0.00490212100656968,0.0161920756069224,0.0354083899526755,1.42889832727437e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,28452,-0.0223075208449811,0.00423989237862491,-0.0306177099070859,-0.0139973317828763,1.44043357670716e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,28091,-0.0160095640677379,0.0030430849396766,-0.021974010549504,-0.0100451175859718,1.4435139337966e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,23071,0.0170039306395765,0.00323405731889247,0.0106651782945473,0.0233426829846057,1.4711157855238e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,28485,-0.0191578851807998,0.00364462507527442,-0.0263013503283377,-0.012014420033262,1.47899486408482e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,28142,-0.0103512133721799,0.00197117424415002,-0.0142147148907139,-0.00648771185364583,1.52132330687551e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,23163,0.022153702911626,0.00422624614872758,0.0138702604601199,0.0304371453631321,1.60295985766948e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,23795,-0.0272800109841538,0.00520470380868706,-0.0374812304491804,-0.0170787915191272,1.60709959313807e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,27872,-0.00901329034815958,0.00172186814493501,-0.0123881519122322,-0.00563842878408695,1.66540651313998e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23188,0.0119251257940885,0.0022787724611543,0.00745873177022601,0.0163915198179509,1.68108813215346e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,27965,-0.0143949130365666,0.00275113347557453,-0.0197871346486927,-0.00900269142444057,1.68568295101325e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,27702,-0.0231599284540829,0.00442975877022,-0.0318422556437141,-0.0144776012644517,1.72354578756693e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,28288,-0.0109298832488877,0.00209061682007152,-0.0150274922162278,-0.00683227428154749,1.72508790625988e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,23188,-0.00922588526285491,0.00176842908995884,-0.0126920062791742,-0.00575976424653558,1.83413408609751e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,28363,-0.0254924083514871,0.00488967202622682,-0.0350761655228917,-0.0159086511800826,1.86587908004595e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,23198,0.0256228085439187,0.00491510968964811,0.0159891935522084,0.035256423535629,1.8733335093084e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,23795,-0.0348427607240464,0.00668716870764516,-0.0479496113910309,-0.0217359100570618,1.90014957942865e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,23337,-0.0222937639451811,0.00428579215750752,-0.0306939165738959,-0.0138936113164664,1.99052545539393e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,27639,-0.0197352623307454,0.00379768621295576,-0.0271787273081387,-0.0122917973533521,2.04348298571595e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,27562,0.0213555037714007,0.00410961105233563,0.0133006661088229,0.0294103414339785,2.04545843053198e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,28224,0.00921530677258021,0.00177444149471612,0.0057374014429366,0.0126932121022238,2.07969292046787e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,28496,0.0183973482032097,0.00354328871093956,0.0114525023297682,0.0253421940766512,2.09286893647361e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,28381,-0.0130339812222242,0.00251416480367118,-0.0179617442374197,-0.00810621820702873,2.1840813957614e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,28187,0.0112128703595603,0.00216481459388123,0.0069698337555531,0.0154559069635675,2.23892871213926e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,23738,0.010744347490368,0.00207474347670953,0.00667785027601731,0.0148108447047187,2.25335083166313e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,28152,0.00614140341814102,0.00118718991622747,0.00381451118233519,0.00846829565394686,2.31869923195741e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,28176,0.0256727512182333,0.00496350533884512,0.0159442807540968,0.0354012216823697,2.32808564228588e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,23872,-0.00985746859373242,0.0019057571247249,-0.0135927525581932,-0.00612218462927162,2.32888137360321e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",23337,-0.0310261731871058,0.00599848277526104,-0.0427831994266174,-0.0192691469475941,2.33095131880092e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,28082,-0.0272868363924554,0.0052760964253775,-0.0376279853861953,-0.0169456873987155,2.33459125434385e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,28307,-0.00954931090041408,0.00184642859491984,-0.013168310946457,-0.00593031085437119,2.334605196424e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,28336,0.0146858368010298,0.00283998188913391,0.00911947229832731,0.0202522013037322,2.34298656107309e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,27373,0.00685112950773276,0.00132501897532755,0.00425409231609075,0.00944816669937476,2.34997587108567e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,28176,0.0199445293334367,0.00385929077871967,0.0123803194071462,0.0275087392597273,2.38319860705468e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,28182,0.0129696615798704,0.00250970045129367,0.00805064869533478,0.017888674464406,2.38464058282725e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,23893,-0.00580961469009331,0.00112608283622865,-0.00801673704910146,-0.00360249233108517,2.50074657848651e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,23872,-0.0207342288598581,0.0040209471087775,-0.028615285193062,-0.0128531725266542,2.53544879359094e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,27900,-0.0119257186500166,0.00231459235489964,-0.0164623196656199,-0.00738911763441336,2.58916369281948e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,23795,-0.0131011067654266,0.00254602152447364,-0.0180913089533949,-0.00811090457745827,2.68617915195183e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,28091,0.0299772742236417,0.00582687263248734,0.0185566038639665,0.0413979445833168,2.69807937783677e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,23720,0.0148484985041208,0.00289153181556159,0.00918109614562006,0.0205159008626215,2.84122601260524e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,28091,0.0206372100337723,0.0040200969703327,0.0127578199719202,0.0285166000956244,2.86282358580246e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,23056,0.013791024280666,0.0026873530494553,0.00852381230373356,0.0190582362575983,2.89275498635441e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,23846,-0.0225345727968016,0.00439839949880151,-0.0311554358144525,-0.0139137097791506,3.02482199305869e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,28320,-0.00932159191933563,0.00182072412135515,-0.0128902111971917,-0.00575297264147953,3.07996470094298e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,28091,-0.0323704732547991,0.00632296717785377,-0.0447634889233925,-0.0199774575862058,3.08355771871553e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,27385,-0.0240552589521674,0.00470329942161771,-0.0332737258185381,-0.0148367920857967,3.16609606177527e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,27682,-0.0132699597980815,0.00259544412333563,-0.0183570302798194,-0.00818288931634369,3.19549187759171e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,23198,0.025272947753075,0.00495290572199211,0.0155652525379705,0.0349806429681795,3.37571061450035e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,28031,-0.0132366377593337,0.00259471041101003,-0.0183222701649133,-0.00815100535375402,3.39360127674004e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,28237,-0.00821844899337027,0.00161251799641537,-0.0113789842663444,-0.00505791372039615,3.47935128111623e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,28428,-0.0437296948579654,0.00862784293136358,-0.0606402670034381,-0.0268191227124928,4.0360553909247e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,28091,-0.0110850010239457,0.00218884519931191,-0.0153751376145971,-0.00679486443329438,4.12463631285845e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,27544,0.0130313808270673,0.00257602780722166,0.00798236632491287,0.0180803953292218,4.24809971769684e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,28452,0.0116553983604935,0.00230477070034122,0.00713804778782467,0.0161727489331623,4.28378791854071e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,23725,0.0193893792025839,0.00383685948465591,0.0118691346126583,0.0269096237925095,4.37122344374611e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,27969,0.0114486721105557,0.00227030560492841,0.006998873124896,0.0158984710962154,4.61661149774592e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,27562,0.0226384594736585,0.00449319619885676,0.0138317949238992,0.0314451240234177,4.72438619385193e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,23337,0.0126926488841494,0.00252011435228145,0.00775322475367778,0.017632073014621,4.77563901444414e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,23815,0.0158061390795678,0.00314094315489378,0.00964989049597597,0.0219623876631596,4.88182546765198e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",27682,0.0311400213005396,0.00618878413471087,0.0190100043965063,0.0432700382045729,4.89226627456373e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,28307,0.00901184877509906,0.00179108963225764,0.00550131309587408,0.012522384454324,4.89661540570326e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,28187,0.0151568104488591,0.00301268186332792,0.00925195399673636,0.0210616669009818,4.90918502303558e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,27562,0.0174747458884925,0.00347777429636426,0.0106583082676186,0.0242911835093665,5.07392664693081e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,23872,-0.024586474364386,0.0049016095454913,-0.034193629073549,-0.0149793196552231,5.31367373402475e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,27682,0.0192739761045149,0.00384819708258556,0.0117315098226472,0.0268164423863826,5.51721873678914e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,28291,-0.00870721348533993,0.00174253556044954,-0.012122583183821,-0.00529184378685884,5.86174287965809e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,27702,0.0148285601214852,0.00296912183282854,0.00900908132914128,0.0206480389138291,5.94212848497673e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,23373,-0.0129091883970989,0.00258571724312213,-0.0179771941936183,-0.00784118260057953,6.00321622906139e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,28307,0.00973135995280401,0.00195215103749648,0.00590514391931092,0.0135575759862971,6.23462183537692e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,23071,-0.0201989635101464,0.0040527158016383,-0.0281422864813575,-0.0122556405389353,6.27159004643216e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,23337,-0.0362759438160794,0.00727986984493865,-0.0505444887121591,-0.0220073989199997,6.30380403862662e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,23846,0.0189433223374607,0.00380242871226883,0.0114905620614138,0.0263960826135076,6.34031185476927e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,23893,-0.00508729212643767,0.00102195520466459,-0.00709032432758027,-0.00308425992529507,6.46920478646396e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,28187,-0.0174716472279209,0.00350996208522756,-0.0243511729149669,-0.0105921215408749,6.47132107633876e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,28521,0.0138458621892283,0.00278219327727121,0.00839276336577672,0.0192989610126799,6.50876128472388e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,23738,-0.0395185814181857,0.00794338612489743,-0.0550876182229846,-0.0239495446133867,6.56935920694417e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,27500,-0.0302833767557473,0.00609108886439529,-0.042221910929962,-0.0183448425815325,6.67499872232506e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,28224,0.00858999369471213,0.00173148651930059,0.00519628011688297,0.0119837072725413,7.05200655241587e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,28176,-0.0403899384821421,0.00815177519833322,-0.0563674178708752,-0.024412459093409,7.28460737810597e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,28494,-0.00997840837881724,0.00202087717190373,-0.0139393276357486,-0.00601748912188593,7.95116011113725e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,27905,0.00935185254569281,0.0018950439265621,0.0056375664496311,0.0130661386417545,8.0653614027831e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,27562,0.0156189991052692,0.00316642025143314,0.00941281541246023,0.0218251827980782,8.1573027577255e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,28330,-0.03720737615583,0.00755994147167963,-0.0520248614403221,-0.0223898908713379,8.62999337222245e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,28176,-0.0185769485051694,0.00378834333559084,-0.0260021014429275,-0.0111517955674114,9.45652663635631e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,23663,-0.00894462889544222,0.0018264803918662,-0.0125245304635,-0.00536472732738447,9.78561209002924e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,23775,0.0223219963395096,0.00456064927735871,0.0133831237558865,0.0312608689231326,9.92128892799438e-07
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,23725,0.0196124600465861,0.00401199080194489,0.0117489580747741,0.0274759620183981,1.02291441600435e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,28204,0.0191240150668379,0.00391335786137579,0.0114538336585413,0.0267941964751344,1.0302131307719e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,28176,-0.0211668945286489,0.00434106430835044,-0.0296753805730158,-0.0126584084842821,1.08865249336039e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,23775,0.0217700886869555,0.00446542173145541,0.0130178620933029,0.0305223152806081,1.09366821679412e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,27682,0.00769572107949958,0.00157863077103781,0.00460160476826546,0.0107898373907337,1.09447536084927e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,28176,-0.0140256541309804,0.00288863911203442,-0.0196873867905679,-0.00836392147139293,1.20754750337012e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,28261,-0.00879534958664453,0.00181173111981526,-0.0123463425814824,-0.00524435659180662,1.21233463681555e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,28174,-0.00730134244588582,0.00150411905729371,-0.0102494157981815,-0.00435326909359014,1.21501225170053e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,23589,0.00885580068013512,0.00182500965144696,0.00527878176329909,0.0124328195969712,1.22713362600826e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,23071,0.0258919469472252,0.00533939946048596,0.0154267240046727,0.0363571698897776,1.2475245134506e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,28093,-0.0235551208744626,0.00485869825226774,-0.0330781694489073,-0.0140320723000178,1.25358827731863e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,28553,-0.00854588485465935,0.00176706193188089,-0.0120093262411459,-0.00508244346817281,1.33026211593143e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,28176,0.0250462943370988,0.00518193391311849,0.0148897038673865,0.035202884806811,1.349357678155e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23198,-0.0172115106981886,0.00356316683040042,-0.0241953176857734,-0.0102277037106038,1.3713063116435e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,27965,0.0173572978956202,0.00359545073795364,0.010310214449231,0.0244043813420093,1.38937252494081e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,23738,0.031705054868098,0.00657236423342012,0.0188232209705945,0.0445868887656014,1.4158369526533e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,23862,-0.00696559697340754,0.00144544038952739,-0.00979866013688122,-0.00413253380993386,1.45156592468755e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,28320,0.0111202819324286,0.00230790094142204,0.00659679608724145,0.0156437677776158,1.45496975430662e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,28176,-0.0211911689083399,0.00439997593527285,-0.0298151217414747,-0.0125672160752051,1.47076786040869e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,23862,-0.0122433249976468,0.00254601032133763,-0.0172335052274686,-0.00725314476782504,1.52743709851709e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,27562,-0.017337208742579,0.00361589871082359,-0.0244243702157933,-0.0102500472693648,1.63755113904154e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,23775,-0.00991570361531043,0.00206821478764131,-0.0139694045990874,-0.00586200263153346,1.64206985334531e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,28176,-0.0140752237737815,0.00294044829034155,-0.0198385024228509,-0.00831194512471201,1.70353815360217e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",28091,0.0332740188373465,0.00697302493569304,0.0196068899633881,0.0469411477113049,1.83486262535546e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,28276,-0.0162026896463696,0.00339981238125959,-0.0228663219136384,-0.00953905737910078,1.89077890301166e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,28264,-0.017695871401984,0.00371646478444642,-0.024980142379499,-0.010411600424469,1.93130573498425e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,27682,-0.0156545575995265,0.00329143596334276,-0.0221057720876783,-0.00920334311137467,1.98315187468107e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,28187,-0.0381112866998343,0.00801524872137461,-0.0538211741937285,-0.0224013992059401,1.9957718681026e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,28091,-0.0239799690132579,0.00504338266187974,-0.0338649990305422,-0.0140949389959736,1.99687686743473e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,23775,0.0254156267843502,0.00534626424192161,0.0149369488701839,0.0358943046985166,2.00694067021048e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,28307,-0.0106940311466223,0.00225625082463449,-0.0151162827629059,-0.00627177953033874,2.15037699608384e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,28144,-0.0226159075200478,0.00477367495087802,-0.0319723104237687,-0.0132595046163269,2.17286732885189e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,22744,-0.0148191280933952,0.00313003432718258,-0.020953995374673,-0.00868426081211732,2.20925712853066e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,23862,-0.0158605719126966,0.00335017155092177,-0.0224269081525033,-0.00929423567288997,2.2112167067659e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,28521,0.0144307843718323,0.00305370240007808,0.00844552766767925,0.0204160410759853,2.3045341483996e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,28389,-0.0137079695810627,0.00290082709924813,-0.019393590695589,-0.00802234846653638,2.30605784347905e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,27965,-0.0133088364299463,0.00281677714244684,-0.0188297196291422,-0.00778795323075053,2.31409632731764e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,28224,0.0245500154857303,0.00520427430697394,0.0143496378440614,0.0347503931273992,2.4016322172962e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,27965,-0.0106914297305613,0.00227235171695118,-0.0151452390957857,-0.00623762036533702,2.55071617851185e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,28471,0.0218250546902968,0.0046418863348536,0.0127269574739837,0.0309231519066098,2.59131423116872e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,28336,0.016957629653275,0.00360775550231835,0.00988642886873105,0.024028830437819,2.60966551493492e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,27887,-0.0197911947011723,0.00421175541981352,-0.0280462353240068,-0.0115361540783378,2.62638296999998e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,27702,-0.0134136892889085,0.00285541984336502,-0.0190103121819039,-0.00781706639591303,2.64468010729626e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,23775,0.0175426234722096,0.00373787924980658,0.0102163801425887,0.0248688668018305,2.70460049929014e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,23725,0.012851018954226,0.00273888473514926,0.00748280487333345,0.0182192330351186,2.71973092809548e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,28553,-0.00501135308478479,0.00106897517641768,-0.00710654443056345,-0.00291616173900613,2.77165300932902e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,23480,-0.0103207376213122,0.00220270099688549,-0.0146380315752078,-0.00600344366741665,2.80854360142896e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,23687,0.0136994342690265,0.00292716685761733,0.0079621872280965,0.0194366813099564,2.88321310398398e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,28277,0.0160617315319033,0.00343834568138043,0.00932257399639769,0.022800889067409,3.00596410760632e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,28307,-0.0100920916174431,0.0021616078575128,-0.0143288430181682,-0.005855340216718,3.04369177619288e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,28336,-0.0316034051164679,0.00677095728602356,-0.0448744813970741,-0.0183323288358618,3.06290193598509e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,28176,-0.0257331909049095,0.00551646660727698,-0.0365454654551724,-0.0149209163546467,3.10341916107937e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,28307,0.0112729528342387,0.00241768515911419,0.0065342899223749,0.0160116157461025,3.13503686123851e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,23198,0.0164051179926594,0.00351842793534719,0.00950899923937892,0.0233012367459399,3.1393673036087e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,28260,-0.0154286069398749,0.00331345792278365,-0.0219229844685308,-0.00893422941121889,3.23333896916078e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,27082,-0.00726275691320287,0.00156005481393829,-0.0103204643485219,-0.00420504947788382,3.24806696901982e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,23846,-0.0165361849055107,0.00355325426889924,-0.0235005632725532,-0.00957180653846821,3.27603178593757e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,23393,0.0176395260107168,0.00379199938108263,0.0102072072237948,0.0250718447976387,3.30892212155027e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,28320,-0.0407511421814784,0.00876229038585473,-0.0579252313377537,-0.0235770530252031,3.32238134317324e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,23188,0.0164088945547415,0.00353022445602648,0.00948965462092959,0.0233281344885534,3.36823982275164e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,28521,-0.0184191586314427,0.00396909401026572,-0.0261985828915635,-0.0106397343713219,3.48866659693182e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,23815,-0.0152741559841963,0.00329157731965892,-0.0217256475307278,-0.00882266443766478,3.49628295688662e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,27918,0.0142430546762566,0.00307390055626206,0.00821820958598296,0.0202678997665302,3.61080913198444e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",28091,0.030403916147934,0.00656195029140685,0.0175424935767765,0.0432653387190914,3.61382396433504e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,28176,0.0159751779200148,0.00345143501578701,0.00921036528907227,0.0227399905509573,3.6985596005443e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,28404,-0.0096406954765964,0.00208409950978377,-0.0137255305157726,-0.0055558604374202,3.74741947396467e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,23738,0.00937234563976657,0.00203028310375957,0.00539299075639781,0.0133517005231353,3.92734939755395e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,23795,-0.0353267672730614,0.00766558525852862,-0.0503513143797775,-0.0203022201663453,4.07710901747274e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,27682,-0.00666524503702381,0.001447095047002,-0.00950155132914773,-0.00382893874489988,4.12417921350591e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,23071,0.011285609151469,0.00245025096596975,0.0064831172581683,0.0160881010447697,4.12881436728301e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,27562,0.0140542806651248,0.00305372537441051,0.00806897893128023,0.0200395823989694,4.19633720403635e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,28224,0.0195177182960291,0.00424185698986341,0.0112036785958969,0.0278317579961614,4.21849390376933e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",23795,-0.0130783378972326,0.00284988132470719,-0.0186641052936587,-0.00749257050080652,4.47474374635217e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,23071,0.0110476186516392,0.00241292756378994,0.00631828062661096,0.0157769566766675,4.70739940716717e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,23843,-0.00771271061722568,0.00168517984113799,-0.0110156631058561,-0.00440975812859522,4.74552041203103e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,23163,0.0210363387172373,0.0046000058778132,0.0120203271967235,0.0300523502377512,4.83022828057015e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,28224,-0.0234977133776543,0.00514722263090113,-0.0335862697342205,-0.0134091570210881,5.01303459150854e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,28291,-0.00842705573172303,0.00184623362716232,-0.0120456736409612,-0.00480843782248488,5.02893144907491e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",28176,0.0299679015436137,0.00657051107669356,0.0170896998332943,0.0428461032539331,5.11323750198167e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,23198,-0.0291625629367634,0.00642524544911081,-0.0417560440170206,-0.0165690818565063,5.68737175079537e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,28336,0.0140692180612401,0.00310056960626828,0.00799210163295426,0.0201463344895259,5.71252555848032e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,27508,0.00875062967949428,0.00193280837967073,0.00496232525533966,0.0125389341036489,5.99593984747006e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,23795,-0.0232539055736133,0.00514893645650142,-0.0333458210283561,-0.0131619901188705,6.32454731937484e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",23738,-0.0313711526456246,0.00695136353395765,-0.0449958251721816,-0.0177464801190676,6.42392275755983e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,27702,-0.014675610762278,0.00325819309390134,-0.0210616692263247,-0.00828955229823142,6.6889894503228e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,27702,0.0143887936249765,0.00319980635945905,0.00811717316043676,0.0206604140895163,6.92734133153242e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,23795,-0.0208650363081819,0.00464208164697612,-0.0299635163362551,-0.0117665562801087,6.99774232586946e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,28553,-0.00961790491212312,0.00214311354363925,-0.013818407457656,-0.00541740236659018,7.22371905301738e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",28363,0.021495818661564,0.00479268158724314,0.0121021627505675,0.0308894745725606,7.31540249228248e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,28428,-0.0215074754320937,0.00479685216637589,-0.0309093056781904,-0.0121056451859969,7.36588378866821e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,27702,0.0180753801597016,0.00403416943824792,0.0101684080607357,0.0259823522586675,7.47416858490808e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,28091,-0.0247980261090723,0.0055371186320627,-0.0356507786279152,-0.0139452735902294,7.54628694303823e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",28121,0.0198168858411642,0.00442562783923357,0.0111426552762664,0.028491116406062,7.57280044474181e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,28404,0.00852398386164503,0.00190437099153234,0.00479141671824165,0.0122565510050484,7.63464803232172e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",28521,-0.0203843300480761,0.00455649633257087,-0.029315062859915,-0.0114535972362372,7.71799386372348e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,27528,-0.0328751080682362,0.00735557588092371,-0.0472920367948467,-0.0184581793416258,7.87472927567446e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,27965,-0.0107182457945627,0.00239997881561323,-0.0154222042731646,-0.00601428731596072,8.00168424815067e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,28428,0.019484206414127,0.00437082811537847,0.0109173833079852,0.0280510295202688,8.31280159210636e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,23163,-0.00952815269534654,0.00214143509174528,-0.0137253654751673,-0.0053309399155258,8.65022022973346e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,23198,0.0127441119917612,0.00286458400006447,0.00712952735163484,0.0183586966318875,8.67318077137162e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,23585,0.00952917413338281,0.00214283024449119,0.00532922685418008,0.0137291214125855,8.74740689291299e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,23846,-0.00848711170067045,0.00191327912797263,-0.0122371387914968,-0.0047370846098441,9.20993947741343e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,23893,-0.00816825922645427,0.00184474704817363,-0.0117839634408746,-0.00455255501203396,9.56001127364007e-06
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,28091,0.0280763504759763,0.0063610010746944,0.0156087883695753,0.0405439125823774,1.01938052896881e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,23775,0.00904499126751028,0.00205012605012738,0.00502674420926062,0.0130632383257599,1.02908569841744e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,23738,-0.0263716924283545,0.00599151192087023,-0.0381150557932602,-0.0146283290634489,1.0796975411589e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,27682,0.0171526305809471,0.00389826132957806,0.00951203837497415,0.0247932227869201,1.08619215978385e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,23071,-0.00965912504947662,0.00219699406914705,-0.0139652334250048,-0.00535301667394841,1.1049271777848e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,27544,-0.0311662597241904,0.00709461064159812,-0.0450716965817227,-0.0172608228666581,1.12240825057433e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,28224,0.0180429889919906,0.00411355695455445,0.00998041736106385,0.0261055606229173,1.15751980022159e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,27562,0.0157065166349695,0.00358113739100876,0.00868748734859236,0.0227255459213467,1.15934334064079e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,23893,-0.00924803046369343,0.00211213506260522,-0.0133878151863997,-0.00510824574098721,1.19994402658924e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,23337,-0.0126165435411822,0.00288188245954421,-0.0182650331618888,-0.00696805392047555,1.2035882255216e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,22885,0.0157209614590029,0.00359751068919755,0.00866984050817572,0.0227720824098301,1.24819097252344e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,23795,0.0129149647824255,0.00295715173004187,0.0071189473915434,0.0187109821733075,1.2628504253051e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,28270,0.014432256535734,0.00331373188357911,0.00793734204391896,0.0209271710275491,1.33359565572798e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,28187,0.0119478313241285,0.00274460939745078,0.00656839690512493,0.017327265743132,1.34637621836079e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,28336,-0.0101219463558874,0.0023279629173411,-0.0146847536738759,-0.00555913903789884,1.37873482464153e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,28238,-0.0273281032964317,0.00628659656234006,-0.0396498325586182,-0.0150063740342452,1.38467821817253e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,22397,-0.00715983815542874,0.0016479342912458,-0.0103897893662705,-0.00392988694458698,1.4005745574094e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,23725,-0.0166965335144609,0.00384475589981804,-0.0242322550781043,-0.00916081195081758,1.4134059138595e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,28521,0.0143607615255939,0.00330802244878354,0.00787703752597816,0.0208444855252096,1.4219964300785e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,28428,0.00677139576779819,0.00156031704703777,0.00371317435560416,0.00982961717999221,1.43132991135471e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,28061,-0.00721406357066944,0.00166457564926794,-0.0104766318432346,-0.00395149529810428,1.47016581096359e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,28224,0.0195529170248319,0.00451740012104342,0.0106988127875868,0.028407021262077,1.50743237560796e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",23862,0.0121491482415906,0.00281209703806249,0.00663743804698807,0.017660858436193,1.56435636390416e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,28187,-0.00867364993624707,0.00201445117945142,-0.0126219742479719,-0.00472532562452228,1.67010357709226e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,28320,-0.0194263383250535,0.00451230888604137,-0.0282704637416946,-0.0105822129084124,1.6740446724392e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,23198,0.0114489719999871,0.00266182236399962,0.00623180016654788,0.0166661438334264,1.70587039396009e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,28202,-0.0153776244752181,0.0035764957532794,-0.0223875561516457,-0.00836769279879047,1.71654365134541e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,27544,0.0119648847724082,0.00278303421373484,0.00651013771348792,0.0174196318313285,1.71986880597657e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,23337,0.0108942004405701,0.00253397792088617,0.00592760371563322,0.015860797165507,1.72073616453342e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,27544,0.0149818339107459,0.00348715106834245,0.00814701781679466,0.0218166500046971,1.74270711960248e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,22706,0.0142715578695689,0.00333233824559044,0.00774017490821163,0.0208029408309262,1.85359535433475e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,23893,0.0093517422529175,0.00218528368203833,0.00506858623612236,0.0136348982697126,1.88112186771161e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,28320,-0.00965181147663594,0.00225792169113091,-0.0140773379912525,-0.00522628496201936,1.92068847390775e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,27562,0.0142739204288977,0.00334004819945187,0.00772742595797206,0.0208204148998234,1.93015942816547e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,23775,0.00642978112962324,0.00150466913742892,0.00348062962026256,0.00937893263898393,1.93420494641841e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,23337,-0.0341816308483808,0.00800853606760302,-0.0498783615408827,-0.0184849001558789,1.97878833748668e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,28224,-0.0249047438518481,0.00584207404619224,-0.0363552089823849,-0.0134542787213113,2.02358147293656e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,28063,-0.0100022065309089,0.00234954334489,-0.0146073114868933,-0.00539710157492451,2.07782036385679e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",28091,-0.0121346124576995,0.00285211046429068,-0.0177247489677093,-0.0065444759476898,2.10093442688625e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,23738,-0.028086138756834,0.006608019825932,-0.0410378576156607,-0.0151344198980073,2.14289009950164e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,28307,0.0129651282949187,0.00305129116895731,0.00698459760376236,0.018945658986075,2.15352879181376e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,28187,-0.0102887940031439,0.00242203141160922,-0.015035975569898,-0.00554161243638984,2.16377417586624e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,28428,0.00900289648101287,0.00212050043187961,0.00484671563452883,0.0131590773274969,2.18655212696421e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,22802,0.00918838671371964,0.00216454842387945,0.00494587180291591,0.0134309016245234,2.19513015944522e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,23337,-0.0105214857146234,0.00248793780618535,-0.0153978438147467,-0.00564512761450013,2.35628033673699e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,23872,-0.00751779857443748,0.00177895329189473,-0.0110045470265511,-0.0040310501223238,2.3880013312306e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,23188,0.0125193344372148,0.0029640215373127,0.00670985222408193,0.0183288166503477,2.41170030554585e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,23795,0.00724681134797877,0.00171939874076622,0.00387678981607698,0.0106168328798806,2.50993234334714e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,28348,0.0117507583102655,0.00278876314954653,0.00628478253715429,0.0172167340833767,2.52099004947856e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23393,-0.0103598215414615,0.00246127764883071,-0.0151839257331697,-0.00553571734975333,2.57320313320066e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,23795,0.0156788431919774,0.00372580203289075,0.00837627120751151,0.0229814151764433,2.58380483017282e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,27965,-0.017271320092851,0.00410815799482079,-0.0253233097626997,-0.00921933042300221,2.62877391451494e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,27562,0.0146806391198634,0.00349247362333963,0.00783539081811776,0.0215258874216091,2.63638666850414e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,23862,-0.0172200577805193,0.00409687673473977,-0.0252499361806093,-0.0091901793804294,2.64107173104525e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,27320,-0.0346289682039306,0.00824512378858178,-0.0507894108295509,-0.0184685255783103,2.6784002129813e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",23795,-0.020098215652201,0.00479082648637951,-0.0294882355655049,-0.0107081957388972,2.73684298889425e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,28363,0.0167644030857933,0.00400368545495189,0.00891717959408756,0.024611626577499,2.83215743403452e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,23795,0.0111167575688653,0.00265577336022694,0.00591144178282053,0.0163220733549101,2.8507991458252e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,28553,-0.00831620455623068,0.00198698229791746,-0.0122106898601489,-0.00442171925231246,2.85586469104554e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,28176,0.0130565559960689,0.00312064349240096,0.00694009475096305,0.0191730172411748,2.87379202753808e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,28140,0.00688238200290387,0.00164518347633879,0.00365782238927983,0.0101069416165279,2.8811233292148e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,27682,-0.0312384207807877,0.00747519635197772,-0.0458898056306641,-0.0165870359309114,2.93765525737594e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",28044,0.0212609752234606,0.00508936050101085,0.0112858286414793,0.0312361218054419,2.95578388606287e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,23188,-0.0139109798528326,0.00333271336600402,-0.0204430980502005,-0.00737886165546475,3.00296934096134e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23071,-0.0113996756749131,0.00273230667423845,-0.0167549967564204,-0.00604435459340569,3.02803288282297e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",23198,-0.0244091431844172,0.0058543933360878,-0.0358837541231493,-0.0129345322456851,3.06549266745638e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",23795,0.0175490157289664,0.0042095508019996,0.00929829615704718,0.0257997353008856,3.07213963819047e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,23775,-0.010276019575069,0.00246629280237246,-0.0151099534677191,-0.00544208568241903,3.1028871504323e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,27562,0.0275726499370996,0.00662509653616794,0.0145874607262104,0.0405578391479887,3.16639239335445e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,28452,-0.0108235388418771,0.00260070135364287,-0.0159209134950171,-0.00572616418873708,3.16708853373374e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,23502,0.00668927870963638,0.00160752635677369,0.00353852705035996,0.00984003036891281,3.17671226090021e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,28070,-0.00799892547565889,0.00192303557826329,-0.0117680752090549,-0.00422977574226284,3.19850273146117e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,23198,-0.0106299015104171,0.00255728637786528,-0.015642182811033,-0.00561762020980115,3.24020210040756e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,27920,-0.014448794513733,0.00347617931995192,-0.0212621059808388,-0.00763548304662724,3.24100915388648e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,28176,-0.00813865115375678,0.00195877233630934,-0.0119778449329231,-0.00429945737459046,3.26281852129325e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,27562,0.0111488946003516,0.00268497894898209,0.00588633586034672,0.0164114533403565,3.3011006558877e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23071,0.0190282018193731,0.0045852142892168,0.0100411818125081,0.028015221826238,3.33806845391374e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,23846,0.0125378326109101,0.00302366351415061,0.00661145212317494,0.0184642130986453,3.38660405515862e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,27657,0.0154908701131663,0.00373833718504394,0.00816372923048022,0.0228180109958525,3.4263426941377e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,23460,-0.0037864334522469,0.000916191553066821,-0.00558216889625787,-0.00199069800823593,3.59619951219262e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,28091,0.0108214801113802,0.00262153693012357,0.00568326772833802,0.0159596924944224,3.67124676940695e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,23845,-0.00410485268263999,0.000994409323909962,-0.00605389495750352,-0.00215581040777647,3.67287308084709e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,23775,-0.0109921059418545,0.00266725200154084,-0.0162199198648746,-0.00576429201883447,3.78288009620159e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,23738,0.0135708946763539,0.00330043794956055,0.00710203629521523,0.0200397530574926,3.93828055453389e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,23725,0.0116473243294359,0.00283470047091618,0.00609131140644022,0.0172033372524316,3.9899069027104e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",27682,-0.0256586869220161,0.00625519810150627,-0.0379188752009684,-0.0133984986430638,4.10803895038987e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,23188,-0.0160923311105586,0.00392442297227326,-0.0237842001362142,-0.00840046208490301,4.13557265811687e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,23845,-0.00517205797230471,0.00126375189793119,-0.00764901169224983,-0.00269510425235959,4.27927800509596e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,22395,0.0305439689152242,0.00746771126682883,0.0159072548322397,0.0451806829982087,4.32624321427886e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",27910,-0.0264160666032957,0.00646748763224902,-0.0390923423625038,-0.0137397908440877,4.43064704180494e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,28320,-0.0235455161754103,0.0057649245692314,-0.0348447683311039,-0.0122462640197168,4.43368951932292e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,23795,0.0166258041593547,0.00407166312426873,0.00864534443578802,0.0246062638829214,4.45466696203832e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,28553,-0.00625975633788549,0.00153312133722019,-0.00926467415883707,-0.00325483851693391,4.45763597475727e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,28176,-0.0183092179706908,0.00448655579330568,-0.0271028673255699,-0.00951556861581166,4.49838291801677e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,28452,0.0122682451341067,0.00300655570563778,0.00637539595105665,0.0181610943171567,4.50618169049594e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,28428,0.00827522966730544,0.00202962018849348,0.00429717409785822,0.0122532852367526,4.56992755562557e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,28187,-0.00789004231946011,0.00193539093043907,-0.0116834085431207,-0.00409667609579953,4.58011839093841e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,28521,-0.0122850679658246,0.00301392660938292,-0.0181923641202152,-0.00637777181143413,4.5921284816711e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,28091,0.01481230122838,0.00363782201030926,0.00768217008817387,0.0219424323685862,4.67891013887307e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,23775,0.0241926693406383,0.00594226869926997,0.0125458226900692,0.0358395159912075,4.69058145255166e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",28187,-0.0103503430715676,0.0025459222203982,-0.0153403506235481,-0.00536033551958715,4.80680776094215e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,28224,-0.00721181374760802,0.00177394364341816,-0.0106887432887076,-0.00373488420650843,4.80774144701137e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,28224,0.00964881398520605,0.00237774441056988,0.00498843494048909,0.014309193029923,4.96344993620155e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,23188,0.00959309226957732,0.00236428372625295,0.00495909616612153,0.0142270883730331,4.97623070798565e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,23775,0.017202606694664,0.00424015926420904,0.00889189453681427,0.0255133188525137,4.98517032320939e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,27136,-0.00863671523893868,0.00213138099830474,-0.012814221995616,-0.00445920848226139,5.08863702242991e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,28452,0.0163154924229364,0.004027928728088,0.00842075211588395,0.0242102327299889,5.1223876509222e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,23725,0.0131007447206615,0.00323604815089699,0.00675809034490341,0.0194433990964196,5.17376152913399e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,23188,-0.0117259374545205,0.00289868294605251,-0.0174073560287834,-0.00604451888025755,5.24334758812472e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,27840,-0.031638815606259,0.0078364330468496,-0.0469982243780842,-0.0162794068344338,5.41915164348144e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,28086,-0.0171516296132096,0.00425073282868619,-0.0254830659574345,-0.00882019326898467,5.47510862286487e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,23163,0.0131545065668961,0.0032604598949692,0.00676400517275645,0.0195450079610357,5.48813296530264e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,27431,-0.0156921374816885,0.00389168253582773,-0.0233198352519109,-0.00806443971146617,5.54007529360371e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,28553,-0.00445546622731493,0.00110533431241454,-0.00662192147964742,-0.00228901097498244,5.57133501154168e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,28120,-0.00548744718740818,0.00136421725655926,-0.00816131301026432,-0.00281358136455204,5.77551011460326e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,23198,0.0146903308284656,0.00365352915445914,0.00752941368572565,0.0218512479712055,5.81694015286007e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,23795,0.0122327723454028,0.00304435260148206,0.00626584124649801,0.0181997034443077,5.88285371938357e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,27910,0.0167916743697882,0.00417951648653049,0.00859982205618846,0.024983526683388,5.89450434059618e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,23549,-0.0174537640040511,0.00434866312274,-0.0259771437246215,-0.00893038428348067,5.9986510611452e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,28122,0.014543933884145,0.00362805383642094,0.00743294836475995,0.02165491940353,6.12003595097697e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,23198,0.0138271212030914,0.00345036622812209,0.00706440339597205,0.0205898390102107,6.15732792081993e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,23198,0.00892915640051671,0.0022283411773538,0.00456160769290326,0.0132967051081302,6.16642542393655e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,23738,0.0305818787602468,0.00763915638678608,0.0156091322421461,0.0455546252783475,6.26534227119874e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,28320,-0.0110777067336715,0.00279497482730103,-0.0165558573951815,-0.00559955607216148,7.40596013025512e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,23795,0.00787546358287299,0.00198845396702556,0.00397809380750289,0.0117728333582431,7.49805681846891e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,27544,-0.0193800646554929,0.00489945126049557,-0.0289829891260642,-0.00977714018492158,7.65473161900714e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,23893,-0.00808146808427202,0.00204406775724896,-0.01208784088848,-0.00407509528006406,7.71992881222811e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,28176,-0.0140130002665779,0.00354560476450804,-0.0209623856050136,-0.00706361492814212,7.76192920383964e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,27562,0.0158697824451199,0.00401724508327936,0.00799598208189239,0.0237435828083475,7.82102601347416e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,27702,-0.00967160110522527,0.00244840033818883,-0.0144704657680754,-0.00487273644237516,7.828863325821e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,28428,0.00621243543559422,0.00157346355758079,0.00312844686273586,0.00929642400845257,7.89125308268831e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,28428,-0.00797490094152562,0.00202062462181812,-0.0119353252002891,-0.00401447668276211,7.94096226336855e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,27951,-0.00752116089301276,0.00190652981872494,-0.0112579593377136,-0.00378436244831186,8.0012238968189e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,23337,-0.0252248067413481,0.0063941605084788,-0.0377573613379665,-0.0126922521447296,8.00416323680983e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,23846,-0.025990372696786,0.00659185856380153,-0.038910415481837,-0.013070329911735,8.07662987379808e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,28095,0.049243618692211,0.012496545343388,0.0247503898191706,0.0737368475652515,8.14819868900677e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,28146,-0.00799791167524953,0.00203130132245358,-0.0119792622672585,-0.00401656108324052,8.25902652479693e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,23846,-0.00890382137855267,0.00227406797743222,-0.0133609946143198,-0.00444664814278553,9.05162330783746e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,28096,0.00840871521799531,0.00215294741033957,0.00418893829372975,0.0126284921422609,9.41821127893711e-05
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,27562,0.0137911533501794,0.00354434129353088,0.00684424441485888,0.0207380622854999,0.00010005252257913
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",28091,-0.00907837070618136,0.00233387801961166,-0.0136527716246202,-0.0045039697877425,0.000100548800192615
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,27682,-0.00860680438295744,0.00221329622289551,-0.0129448649798326,-0.00426874378608223,0.000101025623922585
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,23198,0.0104687957916598,0.00269472594254173,0.00518713294427806,0.0157504586390416,0.000102647736306693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,28176,0.0277727822804982,0.00715082781339909,0.013757159766236,0.0417884047947604,0.00010304780803371
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",23775,-0.0276785975945945,0.00713007963905454,-0.0416535536871414,-0.0137036415020476,0.000103903094772984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,23893,-0.00805939898134755,0.00208334190535077,-0.0121427491158351,-0.00397604884686003,0.000109799528914309
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,27928,-0.0182769265324355,0.00473696444430552,-0.0275613768432743,-0.00899247622159664,0.000114405755244676
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,28078,-0.0115010771969919,0.00298240007586269,-0.0173465813456828,-0.00565557304830102,0.000115365468516168
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,27562,0.0220266784825276,0.00572038623270278,0.0108147214664302,0.033238635498625,0.000118115404365682
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,23775,0.0122934045898859,0.00319642933211516,0.00602840309894014,0.0185584060808316,0.000120384606621497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,23071,-0.00714525164604652,0.00186129441070727,-0.0107933886910328,-0.00349711460106027,0.00012393608556197
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,23337,-0.0225822786512445,0.00588489250359623,-0.0341166679582931,-0.0110478893441959,0.000124706718201925
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,28125,-0.0266818828548548,0.00695763089237699,-0.0403188394039137,-0.0130449263057959,0.000125884636429176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,23846,0.0101567830588029,0.00264880901400502,0.00496511739135309,0.0153484487262528,0.000126158112112327
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,28224,-0.0209090962291696,0.00545844906692355,-0.0316076564003398,-0.0102105360579995,0.000128111509457191
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,23775,0.00808382932542352,0.0021106529296756,0.00394694958325935,0.0122207090675877,0.000128465285551635
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,28428,-0.0175056567844415,0.00457326642866015,-0.0264692589846154,-0.0085420545842676,0.000129558413047161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,27597,0.0099742727403333,0.00260915614274499,0.00486032670055312,0.0150882187801135,0.000132236529359124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,28187,-0.00714498454922137,0.0018695277901591,-0.0108092590179332,-0.00348071008050954,0.000132759033617927
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,23893,-0.0053751464809048,0.00140659476184923,-0.00813207221412929,-0.00261822074768032,0.000133038114057579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,28176,0.0168999832106563,0.0044270887698999,0.00822288922165247,0.0255770771996601,0.000135152210160372
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,28176,0.0221001343961065,0.00579042190672404,0.0107509074589274,0.0334493613332856,0.000135553664189794
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,28195,-0.00996783385898403,0.00261206603992277,-0.0150874832972327,-0.00484818442073539,0.000135882145093831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,28176,-0.0087580699607061,0.00229727187472064,-0.0132607228351585,-0.00425541708625365,0.000137928934255198
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,28176,-0.00682083244492186,0.00179183305887965,-0.010332825240326,-0.00330883964951774,0.00014117565405252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,28237,-0.00872618919347317,0.0022929216541487,-0.0132203156356046,-0.00423206275134172,0.000141697838580443
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,28224,-0.00823778084749176,0.00216628944908746,-0.0124837081677032,-0.00399185352728034,0.000143420426595871
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,27237,0.015346447328186,0.00404141966777421,0.00742526477934851,0.0232676298770234,0.000146603353989133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,27965,-0.00874437736951343,0.00230656254694343,-0.0132652399615225,-0.00422351477750431,0.000150304954444701
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,28553,0.00694247469940587,0.0018321246018373,0.00335151047980477,0.010533438919007,0.000151380972827515
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,23198,0.0214760632005504,0.00567849980474684,0.0103462035832466,0.0326059228178542,0.00015596639110718
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,28276,0.0146589164680121,0.00387664811293291,0.00706068616666359,0.0222571467693606,0.000156308689869268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,28176,0.0198929179370619,0.00526141395185569,0.00958054659142478,0.0302052892826991,0.000156580387466231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,28307,0.0210901924906616,0.00558145727122732,0.010150536239056,0.0320298487422671,0.000158024605634246
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,23188,0.0121215030216634,0.00321020322444448,0.0058295047017522,0.0184135013415746,0.000159809564861423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,23725,0.0171695531647965,0.00454745823397402,0.0082565350262074,0.0260825713033855,0.000159988252517239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,27965,-0.0266350649708972,0.00705508449836559,-0.0404630305876938,-0.0128070993541007,0.000160145258713789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,27477,-0.019247000726424,0.00509823484864354,-0.0292395410297653,-0.00925446042308265,0.000160197560171023
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,28182,0.00764505221355153,0.00202529602217819,0.00367547201008227,0.0116146324170208,0.000160475678784023
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,23198,0.0155314225905106,0.00411752971841331,0.00746106434242055,0.0236017808386007,0.000162330826424998
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,23337,0.0141406382863737,0.00375727546498179,0.00677637837500937,0.021504898197738,0.000167938516594502
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,27682,0.00925536173519221,0.00245989038770624,0.00443397657528798,0.0140767468950964,0.000168563631908396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,23337,0.00724033068011767,0.00192594991188728,0.0034654688528186,0.0110151925074167,0.000170767057452574
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,28194,-0.0126734820953635,0.00337266562645617,-0.0192839067232176,-0.00606305746750938,0.000171824511436775
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,23665,0.0126132797418173,0.00335708056711119,0.00603340183027938,0.0191931576533552,0.000172225978214041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,23738,0.00759217107664497,0.00202106984760128,0.00363087417534645,0.0115534679779435,0.000172710703716172
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,22614,-0.027236457713267,0.00726733736033013,-0.0414804389395141,-0.01299247648702,0.000178843092889203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,28452,-0.0278621008952846,0.00743920980663428,-0.0424429521162878,-0.0132812496742814,0.000180530941018584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,28452,0.00969194869331086,0.00258876629714001,0.00461796675091644,0.0147659306357053,0.000181579870836046
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,27702,-0.0151134666654031,0.00404014976639003,-0.0230321602075276,-0.00719477312327862,0.00018379188533381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,27544,0.0168853363213299,0.00451647466790651,0.00803304597223317,0.0257376266704267,0.000185415149612429
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,23795,-0.0317847918032349,0.00850423925029991,-0.0484531007338227,-0.0151164828726471,0.00018627685478373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,28452,-0.0151932618398307,0.00406668817122511,-0.023163970655432,-0.00722255302422954,0.000187314965279796
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,23056,-0.0119392872314568,0.00319734698284309,-0.0182060873178293,-0.00567248714508435,0.000188823795949979
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,28176,-0.023044431874861,0.00617170006839732,-0.0351409640089197,-0.0109478997408022,0.000188918179642529
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,28452,0.00850191828197067,0.00227713565964947,0.00403873238905771,0.0129651041748836,0.000189128608070846
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",23846,0.0188585421203227,0.00505410925028239,0.00895248798976922,0.0287645962508762,0.000190914674261997
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,23725,-0.0236257612616498,0.00635279294351544,-0.03607723543094,-0.0111742870923595,0.000200508266896446
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,27885,-0.00740396682445391,0.00199093933517664,-0.0113062079214001,-0.0035017257275077,0.000200539102364212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,23893,-0.00426590182449302,0.00114878513368124,-0.00651752068650824,-0.0020142829624778,0.000204956253646528
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,27881,0.00750307816203011,0.00202170539100423,0.00354053559566183,0.0114656207283984,0.000206629663964605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,28224,-0.0100602340150997,0.00271929301368212,-0.0153900483219167,-0.00473041970828278,0.000216369057935231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,23337,0.011434241556943,0.00309133667440409,0.00537522167511101,0.017493261438775,0.00021711677988274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,28411,-0.0150460095380306,0.00407108711067187,-0.0230253402749475,-0.00706667880111379,0.000219589074587232
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,27562,0.00714178761164571,0.00194165598384051,0.00333614188331831,0.0109474333399731,0.000235337986286393
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,23846,-0.0177285979595199,0.00482693371761245,-0.0271893880460403,-0.0082678078729995,0.000240385966880073
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,28224,0.0133702839935486,0.00364525319727169,0.00622558772689612,0.0205149802602012,0.000245037133199461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,28470,0.0123719540703989,0.00337665262681838,0.00575371492183486,0.0189901932189629,0.000248786549684036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,22764,-0.0106784375929431,0.00291581625452153,-0.0163934374518053,-0.00496343773408089,0.000250579846764424
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,27910,-0.0197626428241137,0.00540220964517331,-0.0303509737286534,-0.00917431191957406,0.000254408950101712
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,27702,-0.00930118288882294,0.00254612960642054,-0.0142915969174072,-0.00431076886023869,0.00025960421650601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,27702,0.00971766746859779,0.00266046460330861,0.00450315684611292,0.0149321780910827,0.000260056332232772
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,28553,-0.0152406543852953,0.00417356885892447,-0.0234208493487873,-0.00706045942180334,0.000260967604276453
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,28187,-0.0103832780895343,0.00284612623560025,-0.0159616855113108,-0.00480487066775784,0.000264545776694012
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,23198,0.0153691309072807,0.00421743845958694,0.00710295152649032,0.0236353102880711,0.000268824812303168
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,28320,-0.00880022594490117,0.00241519857024566,-0.0135340151425827,-0.00406643674721968,0.000269241213270637
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,23198,0.0114999011853494,0.00316330236612354,0.00529982854774723,0.0176999738229515,0.000278139280675582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23071,-0.00633133359338672,0.00174565033837519,-0.00975280825660209,-0.00290985893017136,0.000287440956669668
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,28320,-0.0115916260449071,0.00319616912065587,-0.0178561175213926,-0.00532713456842154,0.000287542876271796
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,23198,0.00780448650266115,0.00215264817407199,0.00358529608148004,0.0120236769238423,0.000288989056367348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,28187,-0.00658225915862394,0.00181572646102242,-0.0101410830222279,-0.00302343529501999,0.000289315777654905
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,28288,-0.00727390994135585,0.00200700455607937,-0.0112076388712714,-0.00334018101144028,0.000290296091449014
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,23738,-0.0188972805254798,0.00522530261416398,-0.0291388736492412,-0.00865568740171845,0.000299238253915853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,28319,-0.0272803398885245,0.00754901447431411,-0.0420764082581802,-0.0124842715188689,0.000302309250423057
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,23198,-0.013892705475627,0.00384719564469983,-0.0214332089392387,-0.00635220201201536,0.000305514550304939
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,23846,-0.0241799110136407,0.00671597919604649,-0.0373432302378919,-0.0110165917893896,0.000318427653259323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,23846,-0.00668209742821071,0.00185726797933051,-0.0103223426676985,-0.00304185218872292,0.000321557403974934
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,23775,-0.0163855899983889,0.00456455105561443,-0.0253321100673932,-0.00743906992938465,0.000331663631693749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,27544,0.0103235927948643,0.00287652748316857,0.00468559892785387,0.0159615866618747,0.000332642314990686
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,23337,-0.0127877555627478,0.00356367995539368,-0.0197725682753195,-0.00580294285017623,0.000333450109238539
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,28115,-0.0211492582833542,0.00590299053199544,-0.0327191197260653,-0.00957939684064312,0.000340500053315315
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,28553,-0.00988537654781722,0.00276062800447559,-0.0152962074365894,-0.00447454565904506,0.000343055606758991
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,28176,-0.0141623079898806,0.00395539888458271,-0.0219148898036627,-0.00640972617609852,0.000343513459512153
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,23337,0.0166570916468097,0.00465956593245899,0.00752434241919007,0.0257898408744293,0.000351181789256802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,28358,-0.0142305650781059,0.00398633339185853,-0.0220437785261486,-0.00641735163006319,0.000357792221082145
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,28091,0.0108053229516756,0.00302820608519566,0.00487003902469212,0.0167406068786591,0.000360005441530528
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,28496,-0.00916588566403651,0.00256894850703042,-0.0142010247378161,-0.00413074659025687,0.000360372616305824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,28428,0.0160185489061579,0.00449178352179205,0.00721465320344544,0.0248224446088703,0.000362805126073453
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,28325,-0.00988459841313944,0.00277798742522712,-0.0153294537665846,-0.00443974305969429,0.000374034007771735
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,23337,0.00771125394644913,0.002168299645728,0.00346138664082225,0.011961121252076,0.000376773615314748
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,28274,-0.00929992661086128,0.00261530528660075,-0.0144259249725987,-0.00417392824912382,0.000377213567242492
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,23738,0.0122634884021898,0.00344983002806203,0.00550182154718818,0.0190251552571913,0.000378988414161622
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,23795,-0.0111937150395567,0.00314959072097401,-0.0173669128526657,-0.00502051722644764,0.000380122464271926
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,28320,-0.0209680435947816,0.00590500689681084,-0.0325418571125309,-0.00939423007703239,0.000384550363343336
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,23700,0.00976347665198212,0.00275371441131902,0.00436619640579685,0.0151607568981674,0.000392526038715655
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,23846,0.021777240627083,0.00614468954454894,0.00973364911976712,0.033820832134399,0.000394747007771096
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,28176,0.00842034041718294,0.00237829100975495,0.00375889003806325,0.0130817907963026,0.000400013102602875
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,28187,0.0108928777290497,0.00307947671763673,0.00485710336248168,0.0169286520956177,0.000404967056887475
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,23337,0.0222041764689657,0.00629349432728192,0.00986892758749312,0.0345394253504382,0.000419333712349185
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,23775,0.0204923346500952,0.00581399403385157,0.00909690634374611,0.0318877629564443,0.0004248287204052
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,28176,0.0246003919391929,0.00698720981790299,0.0109054606961031,0.0382953231822828,0.000430967658273912
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,23071,0.00868578300797903,0.00246812828299337,0.00384825157331203,0.013523314442646,0.000433719882958552
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,27910,-0.00754781586419589,0.00214637723867587,-0.0117547152520006,-0.00334091647639119,0.000437909140660896
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,27734,-0.0104202194554794,0.00296383088894901,-0.0162293279978194,-0.00461111091313932,0.000439140614921088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,23725,-0.0124778689128483,0.00355093595852823,-0.0194377033915636,-0.00551803443413297,0.000442291380148658
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,23348,0.0153973255776711,0.00438600332188354,0.00680075906677938,0.0239938920885629,0.000448008144640569
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,27562,0.0160495787916481,0.00457224032010681,0.00708798776423871,0.0250111698190574,0.000448447602462156
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23071,-0.00484328679403338,0.00137996117188206,-0.00754801069092221,-0.00213856289714455,0.000449422680749049
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,23846,0.00598645104618787,0.00170769728648432,0.0026393643646786,0.00933353772769715,0.000456468954397864
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,23862,-0.00596883892032669,0.00170318402666209,-0.00930707961258438,-0.00263059822806899,0.00045827356059757
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,23642,-0.0170431109090264,0.00486337879378483,-0.0265753333448447,-0.00751088847320816,0.000458524493731745
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,28553,-0.00710716543901871,0.0020321549372528,-0.0110901891160342,-0.00312414176200322,0.000470612072094932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23071,-0.0117420451297627,0.00335835132940413,-0.0183244137353948,-0.00515967652413059,0.000472517665437817
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,28224,0.00669583412760775,0.00191527284598415,0.00294189934947882,0.0104497689057367,0.000472976862365226
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,23577,-0.0233601476976134,0.00668455474922638,-0.0364618750060971,-0.0102584203891297,0.000475563894792965
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,23893,-0.00609131610542569,0.00174340082619355,-0.00950838172476504,-0.00267425048608634,0.000476832063349377
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,28187,-0.0172434230684786,0.00494336826281982,-0.0269324248636055,-0.00755442127335177,0.000487038426078359
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,28224,-0.0115477998689749,0.00331058228754403,-0.0180365411525612,-0.00505905858538855,0.000487120195007507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,28277,0.00779344105451224,0.00223516044944606,0.00341252657359796,0.0121743555354265,0.000489674155483761
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,23725,-0.0113740364728434,0.00327568011305654,-0.0177943694944343,-0.00495370345125261,0.000517001982785209
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,27761,0.00701725277790015,0.00202112014689369,0.00305585728998851,0.0109786482658118,0.000517455381410524
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,23071,0.0146978732950231,0.00423396919920668,0.00639929366457803,0.0229964529254682,0.000518666791502936
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,28176,-0.0143758007425462,0.00414339403456049,-0.0224968530502847,-0.00625474843480762,0.000522069475238727
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23198,-0.0115546015764349,0.00333365060268576,-0.018088556757699,-0.00502064639517081,0.000529119949808416
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,28176,-0.0136827320241544,0.00396136391249595,-0.0214470052926465,-0.00591845875566236,0.000553056031973936
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,23071,-0.00876616479341092,0.00254414549501643,-0.0137526899636431,-0.00377963962317871,0.000570760190573636
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,23700,-0.0162854429892838,0.00472720289968027,-0.0255507606726572,-0.0070201253059105,0.000571945975780142
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,23872,-0.00602475821382285,0.00174912810962476,-0.00945304930868738,-0.00259646711895832,0.000573237413839048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,28152,-0.0107419953741685,0.00311966964796734,-0.0168565478841845,-0.00462744286415251,0.000575472517562006
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",28320,-0.025466180955064,0.00740978846225425,-0.0399893663410823,-0.0109429955690456,0.000589410976550968
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,23056,-0.0110302007431418,0.00320961057832931,-0.0173210374766673,-0.00473936400961636,0.000590068150291189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,23893,-0.00521047519611712,0.00152013940298302,-0.00818994842596384,-0.00223100196627041,0.000609901543945626
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,27562,0.011795486730148,0.00344146518907333,0.00505021495956429,0.0185407585007317,0.000610144578210253
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,28223,-0.012056056617949,0.00351962451627762,-0.0189545206698531,-0.00515759256604486,0.000614810701819976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,27965,0.0153948186733974,0.0045005380102824,0.00657376417324387,0.0242158731735509,0.000625582413269571
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,23775,0.0145174891334489,0.00424616059520039,0.00619501436685614,0.0228399639000417,0.000629645166186474
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,27562,-0.0175812842688495,0.00514379030736868,-0.0276631132712921,-0.00749945526640688,0.00063182944403619
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,28224,-0.0177482762089142,0.00519485444304144,-0.0279301909172754,-0.00756636150055297,0.000635185759963076
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,28470,0.0106957713273168,0.00313278157621393,0.00455551943793749,0.0168360232166961,0.000640716498947081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,23692,-0.00652790075460302,0.00191377213646572,-0.0102788941420758,-0.00277690736713022,0.000648301859504128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,23163,0.0154912285703172,0.00456466093005052,0.00654449314741822,0.0244379639932162,0.000690630882170909
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,27682,0.026460790808127,0.0078118962889268,0.0111494740818305,0.0417721075344236,0.000706971215097249
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,28336,0.00969491796597245,0.00286423572569632,0.00408101594360765,0.0153088199883372,0.000713219552583217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,23725,0.0102989776803943,0.00304625462975616,0.00432831860607227,0.0162696367547164,0.000723744351598605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,23872,-0.0207987909573147,0.00615324882248306,-0.0328591586493815,-0.00873842326524791,0.000725671956804995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,27651,0.00936172985743293,0.00277421879329298,0.00392426102257869,0.0147991986922872,0.00074039092004994
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,23188,0.0103907257215926,0.00308881520622223,0.004336647917397,0.0164448035257882,0.000769504084564848
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,28224,0.0264533159632403,0.00787990559144521,0.0110087010040077,0.0418979309224729,0.000788800599799903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],28091,-0.0128409013049542,0.00382743721536646,-0.0203426782470725,-0.00533912436283596,0.000794813636103228
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,28134,-0.0257177725132754,0.00766735911367877,-0.0407457963760857,-0.010689748650465,0.000797030758178951
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,28072,-0.0134018433992288,0.00399574172822143,-0.0212334971865428,-0.00557018961191482,0.000797487215815348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,23198,-0.0138355566689447,0.00412651494782537,-0.0219235259666824,-0.00574758737120696,0.000801140323607201
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,23725,0.00902902092464646,0.00269357208800715,0.00374961963215245,0.0143084222171405,0.000803373840069425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,23725,0.0256789838117152,0.00766904539595571,0.010647654835642,0.0407103127877884,0.000814079528574951
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,28072,-0.0156376973032554,0.00468279807141765,-0.024815981523234,-0.00645941308327676,0.000840714007627578
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,28187,0.0124703460202587,0.00373454139748197,0.00515064488119405,0.0197900471593234,0.000841317974853649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,28187,-0.00442570473046469,0.00132694559044247,-0.00702651808773193,-0.00182489137319745,0.000853305782171463
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",28224,0.0164521736162688,0.00493778139805205,0.00677412207608678,0.0261302251564508,0.000863673063369682
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,28224,0.00811409138473667,0.00243561278317186,0.00334029032971982,0.0128878924397535,0.000865096653914137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,27412,0.0250209060991151,0.0075149716780559,0.0102915616101256,0.0397502505881047,0.00087124815197224
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,23846,-0.0138157612765467,0.00414953025730247,-0.0219488405808595,-0.00568268197223383,0.000871415160995278
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,23071,-0.015325065058158,0.00460640626541632,-0.024353621338374,-0.00629650877794204,0.0008795430990219
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,28521,0.00780003146655204,0.00234964321181678,0.00319473077139115,0.0124053321617129,0.000902381013525269
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23188,-0.0132842632840584,0.00400969839049004,-0.0211432721294189,-0.00542525443869796,0.000924313842001339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23071,-0.00968831140694923,0.00292485619026374,-0.0154210295398662,-0.0039555932740323,0.000926394267902667
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,23738,0.0106294501229142,0.00321960449598636,0.00431902531078097,0.0169398749350475,0.000963192244208591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,28521,0.0170423539384744,0.00516755067994588,0.00691395460578046,0.0271707532711683,0.000975106338985061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,28187,0.00667758278383919,0.0020275872868261,0.00270351170166003,0.0106516538660183,0.000991182083566469
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,27562,-0.0165312963012678,0.00502229829655878,-0.026375000962523,-0.00668759164001256,0.000997515631755207
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,28430,-0.00716024644779463,0.00217559667578333,-0.01142441593233,-0.00289607696325931,0.000998951252957794
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,28176,-0.0104172922103831,0.00316585445420664,-0.0166223669406281,-0.0042122174801381,0.0010012694720743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,28553,-0.0158926990374271,0.00483397835169861,-0.0253672966067564,-0.0064181014680978,0.00101129360912647
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",27489,-0.0103754809924078,0.00315844173890407,-0.0165660268006598,-0.00418493518415581,0.00102110003947608
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,23549,-0.0238776866656313,0.00728058414319925,-0.0381476315863018,-0.00960774174496074,0.00104090983472468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,23623,-0.0207367235313076,0.00632387232750282,-0.0331315132932131,-0.00834193376940206,0.00104282740750924
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,28553,-0.00908187829712563,0.00277107262659275,-0.0145131806452474,-0.00365057594900384,0.0010489768004851
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,28115,-0.0146759241984223,0.00448410441815462,-0.0234647688580054,-0.0058870795388393,0.00106587109687845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,23337,-0.0276635723845209,0.00845513535035881,-0.0442356376712242,-0.0110915070978176,0.00107017651364161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,28091,-0.025609735499737,0.0078318419793291,-0.040960145779222,-0.0102593252202519,0.00107695810960668
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,28411,-0.00762826909486253,0.00233287052576474,-0.0122006953253614,-0.00305584286436365,0.00107710994744069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,23327,0.00469569959653561,0.00143872696109065,0.00187579475279793,0.00751560444027329,0.0011009174311102
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,28307,0.00527152023096302,0.00161626902476726,0.00210363294241919,0.00843940751950684,0.00110941343197212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,23862,-0.0104023270205059,0.00318968870634902,-0.01665411688495,-0.00415053715606185,0.00111083445381065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,27682,-0.0184853253665736,0.00568689174142044,-0.0296316331797577,-0.00733901755338955,0.00115333971516601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,23393,0.0074518681891951,0.00229262638386816,0.0029583204768135,0.0119454159015767,0.00115420743834532
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,28176,-0.0107993655939318,0.00332914787835535,-0.0173244954355083,-0.00427423575235534,0.00118049648310675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,28521,0.013349211156926,0.00411635537537102,0.00528115462119882,0.0214172676926532,0.00118427288417555
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,23337,-0.00612749367504966,0.00188957738198926,-0.00983106534374862,-0.0024239220063507,0.00118533745382456
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,28521,0.00765829054060667,0.00236244045153924,0.00302790725558977,0.0122886738256236,0.00118961242497215
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,27532,0.00863861957072775,0.00266642951081897,0.00341241772952257,0.0138648214119329,0.00119767952463452
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,23795,0.0105896723559821,0.00327014414123252,0.0041801898391664,0.0169991548727979,0.00120413756624436
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,23766,0.00561901917549182,0.00173542789621844,0.00221758049890368,0.00902045785207996,0.00120608155991086
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,27928,-0.0105145766967978,0.00324780738120311,-0.0168802791639559,-0.0041488742296397,0.00120748682695266
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,27750,-0.00741994101504306,0.00229644824225531,-0.0119209795698635,-0.00291890246022265,0.0012347981259156
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,23287,-0.0223544840929388,0.00692896247264442,-0.0359352505393218,-0.00877371764655572,0.00125602231532547
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,23337,0.0169657623094912,0.00526063655608721,0.00665491465956025,0.0272766099594221,0.00126128622098409
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,28033,0.0131050774422277,0.00407113150571177,0.00512565969103266,0.0210844951934228,0.00128773337745864
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,23071,-0.0144407319442531,0.00449392739987747,-0.0232488296480129,-0.00563263424049322,0.00131359316101178
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,28165,-0.0205923462600539,0.00641549824081097,-0.0331667228120434,-0.00801796970806436,0.00132984930525347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,28521,0.00707114216958104,0.00220820667746699,0.00274305708174574,0.0113992272574163,0.0013652707784104
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,23846,0.00704189965057952,0.00219956783457162,0.00273074669481913,0.0113530526063399,0.00136897047050037
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,27682,0.00894235780484014,0.00279476673874925,0.00346461499689161,0.0144201006127887,0.00137735621954411
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,27702,-0.00758672891127401,0.00237124001849493,-0.0122343593475241,-0.00293909847502394,0.00137832058642827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,27682,-0.00720750220682737,0.00225478913823546,-0.0116268889177689,-0.00278811549588587,0.00139247394965419
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,23393,0.0114965844970669,0.00359758893069142,0.00444531019291173,0.0185478588012221,0.00139708363906011
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,28336,-0.00651205859714347,0.00204426893765333,-0.010518825714944,-0.00250529147934295,0.00144650939451619
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,27562,0.0137197655556055,0.00431775997234047,0.00525695600981812,0.0221825751013928,0.00148704778875946
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,23862,-0.0177262944037327,0.00558676961446369,-0.0286763628480816,-0.0067762259593839,0.00151112841472078
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,28187,-0.00905050190906879,0.00285594050999282,-0.0146481453086547,-0.00345285850948287,0.00153122997919609
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,28091,-0.00633486021908414,0.00199956794945929,-0.0102540134000243,-0.00241570703814393,0.0015359544630662
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,23725,-0.0150913727960974,0.00476563372970225,-0.0244320149063138,-0.00575073068588099,0.00154370051741461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,28307,-0.0151601687203843,0.00479939314217711,-0.0245669792790515,-0.00575335816171719,0.00158604260030223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,23337,0.0115031395750826,0.00364358768675321,0.00436170770904635,0.0186445714411189,0.00159554255624825
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",23777,0.00852924535771845,0.00270331629219981,0.00323074542500683,0.0138277452904301,0.00160640675126805
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,28224,0.0142248802451178,0.00451227917325089,0.00538081306554606,0.0230689474246895,0.00162058130462508
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23163,-0.011406849272118,0.00363671587577737,-0.0185348123886417,-0.00427888615559436,0.00171145044620312
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",27965,-0.0122695405488841,0.00391381720467111,-0.0199406222700395,-0.0045984588277287,0.00172073437409384
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,28142,-0.0140218101718656,0.00447994811107694,-0.0228025084695764,-0.00524111187415475,0.00175041912010808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,27682,-0.0161876956288181,0.0051728668334813,-0.0263265146224415,-0.00604887663519478,0.00175377272793147
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,23198,-0.0127582799448273,0.00407890509351632,-0.0207529339281192,-0.00476362596153525,0.00176296727833483
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,23393,0.0112054595489277,0.0035836053558298,0.00418159305150131,0.0182293260463541,0.00176896087953105
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,23795,-0.0179091872180328,0.00572889818674468,-0.0291378276640524,-0.0066805467720132,0.00177346360527253
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,23738,0.0228099612797379,0.00730315613246746,0.0084957752601017,0.0371241472993742,0.00179049392546065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,27682,-0.00719912084215891,0.00230786021928849,-0.0117225268719643,-0.00267571481235346,0.00181410747287412
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",28142,-0.0229914666386375,0.00737930722639965,-0.0374549088023809,-0.00852802447489422,0.00183713745698824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,28268,-0.0250779227516271,0.00805070995301647,-0.0408573142595394,-0.00929853124371483,0.00184131933890882
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,27863,-0.00697183108727397,0.00224399819125568,-0.0113700675421351,-0.00257359463241284,0.00189263778062187
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,28224,-0.00600726811021448,0.00193511122895027,-0.00980008611895701,-0.00221445010147196,0.00190884427007643
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,27544,-0.0233639689264548,0.00753020845358901,-0.0381231774954893,-0.00860476035742036,0.00191958736380699
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,23738,0.0159114267826929,0.00513119717061055,0.00585428032829625,0.0259685732370896,0.00193147131726582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,28415,0.0195147053782122,0.00629743883360768,0.00717172526434117,0.0318576854920833,0.00194474813145564
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,27176,0.0133558003181184,0.0043196597492167,0.00488926720965368,0.0218223334265831,0.00199105379497157
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,27702,0.00658403206153648,0.00213063785578545,0.002407981864197,0.010760082258876,0.00200240622787795
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,23393,-0.00730988450233576,0.00236562247967413,-0.0119465045624971,-0.00267326444217446,0.00200359796060977
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,23725,0.014469514692592,0.00468415828916625,0.00528856444582618,0.0236504649393579,0.00201041984211044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,22978,0.0105774320316199,0.00342895919915756,0.00385667200127104,0.0172981920619687,0.00203975233675773
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,23738,-0.014299245376694,0.00463837041204035,-0.0233904513842931,-0.00520803936909492,0.00205286656276909
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,28494,-0.00957515178544936,0.00310624385167743,-0.0156633897347371,-0.0034869138361616,0.00205431305672873
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,27965,0.0183581473667258,0.00595806906884465,0.00668033199179028,0.0300359627416613,0.00206351568587028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,23071,-0.00856959780727547,0.00279327969925259,-0.0140444260178105,-0.00309476959674039,0.00215794106093863
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,23846,0.00702537744847043,0.0022971902984744,0.0025228844634606,0.0115278704334803,0.00222882153016062
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,27623,0.0150879001411464,0.00493384836025212,0.00541755735505224,0.0247582429272405,0.00223003830400836
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,23071,0.0157123042718492,0.00514126533807227,0.0056354242092275,0.0257891843344708,0.00224480657386252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23198,-0.00929416247961365,0.00304207588157976,-0.01525663120751,-0.00333169375171732,0.00225162874923917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",27544,0.0107551499382941,0.00354006333656052,0.00381662579863544,0.0176936740779527,0.00238279327924339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,23826,0.00733323972675963,0.00241770326995816,0.00259454131764163,0.0120719381358776,0.00242281480559688
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,28224,-0.00930370580277503,0.00306781394922427,-0.0153166211432546,-0.00329079046229546,0.00242610613867485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,23775,-0.0488367544540216,0.0161074651442536,-0.0804073861367588,-0.0172661227712845,0.0024325498117607
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,23469,-0.0113962446043194,0.00376121240377202,-0.0187682209157126,-0.00402426829292626,0.00244869386054808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,28091,-0.0171743411100916,0.00567445458778337,-0.028296272102147,-0.00605241011803618,0.00247539741178296
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,27544,-0.00624051396824137,0.00206218578754028,-0.0102823981118203,-0.00219862982466241,0.00247906018708554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,23846,-0.0144340372198161,0.00477085510219065,-0.0237849132201098,-0.00508316121952239,0.00248518828719694
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,23725,0.0127779973618969,0.0042253129921271,0.00449638389732777,0.021059610826466,0.00249596144797572
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,23235,-0.00698305410135805,0.00231106841359379,-0.0115127481920019,-0.00245336001071422,0.00251741608317757
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,28091,-0.00486949678032744,0.00161412690317914,-0.00803318551055856,-0.00170580805009632,0.00255687660449864
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,27871,0.0136418400257505,0.00452946590245801,0.00476408685693285,0.0225195931945682,0.00259937584103802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,28122,-0.0120959895079583,0.00401691793146853,-0.0199691486536366,-0.00422283036227994,0.00260395968837554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,28307,0.0115247961344979,0.00383105941357577,0.00401591968388935,0.0190336725851064,0.00262985290870444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,23845,-0.00458015924709987,0.00152262320096586,-0.00756450072099296,-0.00159581777320678,0.002631857981172
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,23163,0.00993716944208895,0.003303689549764,0.00346193792455151,0.0164124009596264,0.00263341844341234
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,28521,-0.0152846225887171,0.00508168595251139,-0.0252447270556394,-0.00532451812179474,0.00263388114161965
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,23862,0.00568362330135935,0.00189082654363662,0.00197760327583158,0.00938964332688713,0.0026507713820473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,23738,0.0086754762881648,0.00288618015362262,0.00301856318706447,0.0143323893892651,0.00265100922457674
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,22978,0.0113506470187378,0.00377722769058244,0.0039472807451962,0.0187540132922793,0.00265849439780767
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23198,-0.00524252171383427,0.00174708834626055,-0.00866681487250494,-0.00181822855516359,0.00269629125539606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,28091,0.02124127700254,0.00711655682738979,0.00729282562085602,0.035189728384224,0.00284037066345916
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,23198,0.00873591431969978,0.00292683004307264,0.00299932743527741,0.0144725012041221,0.00284087627408822
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,23795,-0.00657725178361396,0.00220408331564437,-0.0108972550822769,-0.00225724848495099,0.0028468297968339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,23775,-0.0199970570466786,0.00670223419318239,-0.0331334360653161,-0.00686067802804117,0.00285130698507563
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,28378,-0.00583241731830192,0.00195674217475346,-0.0096676319808187,-0.00199720265578515,0.00287855450294674
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,28276,-0.017402087679342,0.00584334302247241,-0.0288550400033879,-0.00594913535529607,0.00290282918797044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,23846,0.0136819637503596,0.00459825189167091,0.00466939004268462,0.0226945374580346,0.00292832712941268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,23198,0.00630734803150545,0.00212737589134077,0.00213769128447754,0.0104770047785334,0.00303139833154781
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,27842,0.0118173778362688,0.00398787147699032,0.00400114974136775,0.0196336059311698,0.00304587978546265
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],27601,0.00961938826893252,0.00324857112534216,0.00325218886326189,0.0159865876746031,0.00306789762248862
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,28307,-0.0143928421831681,0.00487212909294507,-0.0239422152053405,-0.00484346916099576,0.00313822557762535
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,23100,0.00786249627634381,0.00266432036205326,0.00264042836671943,0.0130845641859682,0.00317031695839608
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,28176,0.0161434890477943,0.00547303868763724,0.0054163332200253,0.0268706448755633,0.00318406877060456
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,23795,-0.015722415525197,0.0053306318313337,-0.026170453914611,-0.00527437713578294,0.00318653174331145
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,27910,0.0126606457883038,0.0042945251246203,0.00424337654404802,0.0210779150325596,0.00320009046405907
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,28224,0.00707961191076945,0.00240441657463239,0.00236695542448996,0.0117922683970489,0.00323824604537964
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,28291,-0.00654424670566733,0.00222347519230635,-0.0109022580825878,-0.00218623532874689,0.00325048307732683
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,28367,-0.00401682799655858,0.00136485170359428,-0.00669193733560338,-0.00134171865751379,0.00325258268674991
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,28091,-0.00772799573535842,0.0026300937594192,-0.01288297950382,-0.00257301196689679,0.00330289431946706
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,23319,0.00644150244454165,0.00219231062833304,0.00214457361300888,0.0107384312760744,0.00330420485804502
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,28320,0.00766594827394082,0.00261288374607024,0.00254469613164315,0.0127872004162385,0.00334996999913054
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,27702,0.00840255308685564,0.00286756623994162,0.00278212325657007,0.0140229829171412,0.00339016465020786
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,27965,0.00865759635015832,0.00295888100393047,0.0028581895824546,0.014457003117862,0.00343660556682297
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,28135,-0.00454480107618798,0.00155395451650515,-0.00759055192853807,-0.00149905022383789,0.0034509915481399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,28091,0.0064363948219646,0.00220078542343053,0.00212285539204076,0.0107499342518884,0.00345186191674406
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,23026,0.0194009444156199,0.0066392308698569,0.0063880519107004,0.0324138369205395,0.00347942663141385
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,28521,-0.00765507810586216,0.00262165499163075,-0.0127935218894584,-0.00251663432226589,0.00350371660946553
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,28224,-0.0163601107069323,0.0056068935446582,-0.0273496220544623,-0.0053705993594022,0.00352724631676419
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,23393,-0.0103649542159432,0.00355555664182687,-0.0173338452339238,-0.00339606319796253,0.00355863572615956
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",28195,-0.018482045789463,0.00634505866823313,-0.0309183607791999,-0.00604573079972603,0.00358456370978202
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,23147,-0.00538639158872929,0.00185796346288079,-0.00902799997597563,-0.00174478320148295,0.00374606777740209
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,28553,0.00857128474794219,0.00296653138120313,0.00275688324078405,0.0143856862551003,0.00386355657917936
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,23725,0.0193085589811721,0.00668417843803254,0.0062075692426283,0.0324095487197159,0.00387193139069734
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,28521,-0.0107873784296363,0.00373622481535226,-0.0181103790677267,-0.00346437779154585,0.00388929501005999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,28428,0.0126898319471078,0.00439632606570761,0.00407303285832084,0.0213066310358947,0.00389892180649447
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,28176,0.00781196643822849,0.00270773316928639,0.00250480942642717,0.0131191234500298,0.00391638817173269
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",23071,-0.00772005388952675,0.00267699859805271,-0.0129669711417101,-0.00247313663734344,0.00393213280276405
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,23846,-0.0175789563902098,0.00610273433217652,-0.0295403156812758,-0.00561759709914383,0.00397392650110824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,23725,0.0140019076834774,0.0048622678260103,0.00447186274449725,0.0235319526224576,0.00398400913720426
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,27562,-0.0156389013265604,0.00543081260539358,-0.0262832940331318,-0.004994508619989,0.00398409158944303
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,27562,0.0064005047456859,0.00222410650719014,0.00204125599159323,0.0107597534997786,0.00400783231484577
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,27918,-0.00483291595669797,0.00168038040665997,-0.00812646155375151,-0.00153937035964442,0.00402946797967466
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,23337,-0.0216689835549339,0.00754742025536183,-0.0364619272554431,-0.00687603985442475,0.0040948544632711
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,28470,-0.00394882102961031,0.00137661912714947,-0.00664699451882328,-0.00125064754039735,0.00412736817871701
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23056,-0.011894673146115,0.00414698598429679,-0.0200227656753367,-0.00376658061689332,0.00413098584491701
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,28411,0.00576479250322869,0.00201323633407556,0.00181884928844059,0.00971073571801679,0.00419367721922028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,28320,-0.00817169814154947,0.00286331738057031,-0.0137838002074673,-0.00255959607563167,0.00432138202853729
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,27500,-0.010334558877585,0.00362245791720938,-0.0174345763953154,-0.00323454135985461,0.00433527534723975
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,28553,-0.0139347817544056,0.00488521435272364,-0.0235098018857439,-0.00435976162306727,0.00434161441093325
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23188,0.00858393235154254,0.00301115096216807,0.00268207646569313,0.014485788237392,0.00436595978054906
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,28091,-0.016935504507504,0.00594139932127039,-0.0285806471771939,-0.00529036183781399,0.00436928470353812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,23862,-0.00506759973419978,0.00178359448208425,-0.0085634449190849,-0.00157175454931465,0.00449781695791283
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,28224,0.00545730336206933,0.00192101218325849,0.00169211948288269,0.00922248724125596,0.00450259935887035
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,23071,0.0082443816425791,0.00290623543952004,0.00254816018111983,0.0139406031040384,0.00456091988669937
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23188,0.00667159893403275,0.00235418606584501,0.00205739424497653,0.011285803623089,0.00460191107475649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,23893,0.00579261872523385,0.00204427225086967,0.00178584511352931,0.00979939233693839,0.00460676823784856
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,27702,0.00822058759645407,0.00290347013417067,0.00252978613347955,0.0139113890594286,0.00463930026464338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,27965,0.00625457396629733,0.00221344864205528,0.00191621462786898,0.0105929333047257,0.00472087333795766
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,26395,-0.00932912698189229,0.00330216431169567,-0.0158013690328158,-0.00285688493096878,0.00472931790717535
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,23795,0.00733817346071689,0.00259781298092248,0.00224646001810882,0.012429886903325,0.00473568299178028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,28362,-0.012929730813267,0.0045783889492044,-0.0219033731537076,-0.00395608847282639,0.00474498137539988
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,28044,0.00490790727185265,0.00174072314409203,0.00149608990943227,0.00831972463427303,0.00481375744000103
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,23775,0.0062987142411692,0.00223796716349514,0.00191229860071872,0.0106851298816197,0.00488963534286182
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,22875,0.0134501563626042,0.00477903742254788,0.00408324301441035,0.022817069710798,0.00489090667499454
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,23775,-0.0101087643597268,0.00359426731145885,-0.0171535282901861,-0.00306400042926743,0.00492031180766098
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,28022,-0.00521290470378052,0.00185576960651171,-0.00885021313254348,-0.00157559627501757,0.00497260777910186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,23769,-0.00361951172690649,0.00128873437815581,-0.00614543110809189,-0.0010935923457211,0.0049801351196344
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,28252,-0.00428358600288127,0.00152526214263951,-0.00727309980245471,-0.00129407220330784,0.00498184784732114
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,27970,0.0128358120493384,0.00457095046756217,0.00387674913291656,0.0217948749657603,0.00498650162444714
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,23198,-0.017027365756761,0.0060639479172417,-0.0289127036745548,-0.0051420278389673,0.0049896988300444
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,23775,-0.0053003038946728,0.00188967800208822,-0.00900407277876572,-0.00159653501057989,0.00503775228735325
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,23775,0.0130840163482686,0.00466815860686241,0.00393442547881824,0.0222336072177189,0.00506986887383746
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,23163,0.00956913023642678,0.00342025606548188,0.00286542834808229,0.0162728321247713,0.00514973534656903
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,28378,-0.0130843705253398,0.00468629195359312,-0.0222695027543823,-0.00389923829629726,0.00524099904051109
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,27702,-0.0173907873512939,0.00622913468967165,-0.0295998913430503,-0.00518168335953743,0.00524441360132684
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,27682,0.0100392400899023,0.00360174812375288,0.00297981376734663,0.0170986664124579,0.00531814933389882
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",27562,0.0154966746993631,0.00556591478679089,0.00458748171725296,0.0264058676814732,0.0053694898599967
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,28195,-0.00495731292494756,0.00178232449839386,-0.00845066894179954,-0.00146395690809559,0.0054165110405273
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,22978,0.0079434899444675,0.00285956367165095,0.00233874514803163,0.0135482347409034,0.00547612653470073
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,23738,0.00742792161660891,0.00267489162273715,0.0021851340360441,0.0126707091971737,0.00549221568296998
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,28224,0.00675399401670581,0.00243640233029499,0.00197864544932762,0.011529342584084,0.00557294054882581
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,23795,-0.00667984307902359,0.00241183220475124,-0.011407034200336,-0.00195265195771115,0.00561663464514849
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,28031,0.00854534638052477,0.00308814419489708,0.0024925837585265,0.014598109002523,0.00565864802363595
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",28091,0.00820083511275514,0.0029758654716449,0.00236813878833113,0.0140335314371791,0.00585898446462195
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,27520,-0.0161280218921582,0.0058533130463226,-0.0276005154629505,-0.00465552832136591,0.0058665013991879
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,28176,-0.0185407155178909,0.00672964838547526,-0.0317308263534224,-0.00535060468235943,0.00587155833336217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,28307,-0.0127317428009553,0.00462164198261819,-0.021790161086887,-0.00367332451502369,0.00587638639470874
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,28276,-0.00582377336784635,0.00212210123444049,-0.00998309178734971,-0.00166445494834299,0.00606704378621558
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,28176,0.0175808763876895,0.00641047049302713,0.00501635422135631,0.0301453985540226,0.0061007305225984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,28244,-0.0096775734260496,0.00352999474568274,-0.0165963631275878,-0.00275878372451144,0.00611929586846954
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,23893,0.00380165411425326,0.00138714612609219,0.00108284770711257,0.00652046052139395,0.00613671209462688
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,23738,-0.00856730435001508,0.00313529336457137,-0.014712479344575,-0.0024221293554552,0.0062895181567573
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,28428,-0.0120614134305501,0.00441581024846887,-0.0207164015175491,-0.00340642534355108,0.00631017898845501
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",27544,-0.00555198036603733,0.00203762552089856,-0.00954572638699852,-0.00155823434507615,0.00643946265987167
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,23198,-0.0214424300570693,0.0078776508004115,-0.0368826256258758,-0.00600223448826272,0.0064949968594423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,23188,0.0146331500973833,0.00537805853910876,0.00409215536073012,0.0251741448340364,0.00651533824005597
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,23075,0.00758373848949991,0.00278816931109196,0.00211892663975967,0.0130485503392401,0.00653366267207909
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,23393,-0.00630187214854303,0.00231871591974931,-0.0108465553512517,-0.00175718894583439,0.0065760306392277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,20725,0.0193322014213087,0.00711321565037829,0.00539029874656727,0.0332741040960502,0.00657748853020102
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,28260,-0.00560146318226973,0.00206640184236108,-0.00965161079329744,-0.00155131557124203,0.00671752639686364
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,28127,0.0053980994803525,0.00199186477323482,0.00149404452481224,0.00930215443589275,0.00673091383329679
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,23846,-0.00503680806523591,0.00185893311802802,-0.00868031697657083,-0.00139329915390098,0.0067429726414765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,27965,0.00949335302212443,0.00350396391205602,0.00262558375449463,0.0163611222897542,0.00674627348195044
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,28428,0.00853393785354907,0.00315229640975868,0.00235543689042206,0.0147124388166761,0.00678912622511151
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,23393,-0.0134284042738145,0.00496383419143306,-0.0231575192890233,-0.00369928925860568,0.00683027944084545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,28176,-0.0111048067005529,0.00410634250554582,-0.0191532380114227,-0.00305637538968307,0.00684883428423212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,23733,-0.00699425114727056,0.00258682109003474,-0.0120644204837386,-0.00192408181080248,0.00686000587998455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,28307,-0.010117870155934,0.00374261013352613,-0.0174533860176452,-0.00278235429422282,0.00686696831336029
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,28123,0.0114649786177847,0.00425521702811133,0.00312475324268648,0.0198052039928829,0.00705712063332369
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,28224,-0.0145008989629745,0.00539075039289566,-0.02506676973305,-0.00393502819289899,0.00715027887422881
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,23071,-0.0111151111603437,0.00414700476346667,-0.0192432404967384,-0.00298698182394905,0.00736140858249051
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,28195,0.00649135350437188,0.00242243569397338,0.00174337954418406,0.0112393274645597,0.00737352917224985
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23139,0.00500253881461355,0.00186904810715432,0.00133920452459109,0.00866587310463601,0.00744442667041222
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,23467,0.00504274648732771,0.00188418287790187,0.00134974804664004,0.00873574492801537,0.00744789950093945
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,27965,0.0103793413473371,0.00387876863518061,0.00277695482238307,0.0179817278722911,0.00745640369725046
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,23738,-0.0126962557911487,0.00474595679761385,-0.0219983311144719,-0.0033941804678256,0.0074741920341634
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,28224,-0.00617132072342579,0.00230712345812609,-0.0106932827013529,-0.00164935874549867,0.00747950204936386
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,27877,0.00650884871799288,0.0024369202747283,0.00173248497952541,0.0112852124564603,0.00756848643784503
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",27562,-0.0143329383278937,0.00536675149177204,-0.0248517712517669,-0.00381410540402052,0.00757395996834906
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,28224,-0.0229962291454904,0.0086182382945138,-0.0398879762027375,-0.00610448208824339,0.00762748858848568
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",23198,0.015257974990722,0.00572022046323524,0.00404634288278096,0.0264696070986631,0.00764993500035529
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,23007,-0.00991109575634556,0.00371936824058,-0.0172010575078824,-0.00262113400480876,0.00771049457098458
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,27448,-0.00851339106726939,0.00319516826669171,-0.0147759208699851,-0.00225086126455363,0.00771576292043929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,27562,0.0107375997903055,0.00403558687921915,0.002827849507036,0.0186473500735751,0.00780170513375574
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",27544,0.00970108806912071,0.00365222049353862,0.00254273590178502,0.0168594402364564,0.00790684218484875
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,23795,-0.00541686915448156,0.00204232393554362,-0.00941982406814705,-0.00141391424081606,0.00799969793943728
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23071,-0.00565973348081859,0.0021353406195236,-0.00984500109508484,-0.00147446586655233,0.00804261415158696
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,27965,-0.014115718422385,0.00533041963630968,-0.024563340909552,-0.00366809593521804,0.00809805018481093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,28224,-0.00918996676377399,0.0034735747624786,-0.015998173298232,-0.00238176022931594,0.00815721399747515
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,28428,-0.00616931971267572,0.00233188537764357,-0.0107398150528571,-0.00159882437249432,0.00815824065599477
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,28176,-0.00860824635630292,0.00325501753192418,-0.0149880807188743,-0.00222841199373152,0.00818308920547584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,27682,0.00407524261295091,0.00154213751992039,0.00105265307390694,0.00709783215199489,0.00823200609302118
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,23337,0.0057502534109952,0.00218810220287153,0.001461573093367,0.0100389337286234,0.00859538973217314
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,28132,-0.00838537270156488,0.00319357758690344,-0.0146447847718956,-0.00212596063123413,0.00865181274524548
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,28237,-0.00589657414227838,0.00225063834096297,-0.0103078252905658,-0.00148532299399095,0.00879880997771699
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,23725,-0.00956928741763666,0.00365550358634798,-0.0167340744468787,-0.00240450038839463,0.00885612534469105
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,23738,-0.0181170968300944,0.00692413087233721,-0.0316883933398753,-0.00454580032031342,0.00888885903426443
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,23198,-0.0134915470769175,0.00515859815382711,-0.0236023994584187,-0.0033806946954164,0.00891934058936253
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,28091,0.00605536659716463,0.00231600006108334,0.00151600647744127,0.010594726716888,0.00893850460113223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,23163,0.0136118786155223,0.00521071233964227,0.00339888242982341,0.0238248748012211,0.00899966712217802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,28091,-0.00941970915610959,0.00360927146430851,-0.0164938812261543,-0.00234553708606492,0.00906261822632946
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,28091,0.0199499324943569,0.00766015775814267,0.00493602328839724,0.0349638417003165,0.00920901473780008
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,23337,0.00500382191832389,0.00192181468466617,0.0012370651363782,0.00877057870026959,0.00922828425415658
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,23795,-0.0147359357388606,0.00566219828387768,-0.0258338443752609,-0.00363802710246037,0.00926011344717854
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,28553,0.00914378296757372,0.0035137877422276,0.00225675899280763,0.0160308069423398,0.00926599479712517
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,28428,-0.00470985334822217,0.00181821025398795,-0.00827354544603854,-0.0011461612504058,0.0095919314738486
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,23056,-0.00749423319128804,0.00289748854652172,-0.0131733107424706,-0.00181515564010547,0.00970286388024291
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,23393,-0.0151746161291388,0.00586989669745509,-0.0266796136561508,-0.00366961860212683,0.00973940758031178
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23188,0.00624383995799307,0.00241940148293734,0.00150181305143589,0.0109858668645502,0.00986504440863559
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23071,-0.0150148416925934,0.00582591777530354,-0.0264336405321883,-0.00359604285299843,0.0099651676595946
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,28276,-0.0090449452633122,0.0035107187304935,-0.0159259539750795,-0.00216393655154493,0.0099891148203815
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,23337,-0.00432876373793607,0.00168169774076844,-0.00762489130984222,-0.00103263616602992,0.0100578666366799
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,23775,0.00961477377632531,0.00373750022339328,0.00228927333847447,0.0169402742141761,0.0101022853396544
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,27562,-0.0217125998378442,0.00844910431027948,-0.0382728442859919,-0.00515235538969637,0.0101806148903798
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,28064,-0.00671293568383855,0.00261335630437753,-0.0118351140404185,-0.0015907573272586,0.0102131202184495
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,28521,0.00656708870903004,0.00255823256431259,0.00155295288297736,0.0115812245350827,0.010262093478734
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",23862,-0.0108180993935992,0.00421620243045049,-0.0190818561572822,-0.00255434262991626,0.0102986927349885
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,23198,0.00892900790677191,0.00348284417369791,0.00210263332632401,0.0157553824872198,0.0103622027987655
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,28437,0.00410940395691821,0.00160909581240327,0.000955576164607801,0.00726323174922862,0.0106588066563785
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",27682,0.0151730185338792,0.00595038245138671,0.00351026892916128,0.0268357681385972,0.0107800062007074
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,28091,0.0212810236063003,0.00835889715693314,0.00489758517871135,0.0376644620338893,0.0109045356905721
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,27562,-0.00803695418065054,0.00315725256877341,-0.0142251692154464,-0.00184873914585466,0.010915876124473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,23056,-0.00496295138185194,0.00195002496161745,-0.00878500030662215,-0.00114090245708173,0.0109320228952139
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,23056,-0.0170242156633013,0.00669311734681011,-0.0301427256630491,-0.00390570566355349,0.0109800063331061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,28553,-0.00546252063636294,0.00214938732043566,-0.00967531978441684,-0.00124972148830904,0.0110452022871516
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,23071,0.0127500060422872,0.00501955608130363,0.00291167612293213,0.0225883359616424,0.0110896452429133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,28224,0.00658030488823368,0.00259153022969636,0.0015009056380288,0.0116597041384385,0.0111172840462415
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,22663,-0.00398006085343575,0.00157296891661549,-0.0070630799300021,-0.000897041776869394,0.0114036831150461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23056,-0.0105119704671719,0.00415687176683709,-0.0186594391301726,-0.00236450180417124,0.0114513652618093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,28428,-0.0208903905812712,0.00826155594696005,-0.0370830402373129,-0.00469774092522945,0.0114563430865667
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,23751,-0.0144046634262887,0.00569770885892323,-0.0255721727897782,-0.00323715406279917,0.0114729594834795
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,28237,0.00558522514472993,0.00221525106262465,0.00124333306198561,0.00992711722747424,0.0116989836032984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,23893,-0.00251355557824236,0.000997675155931715,-0.00446899888386852,-0.000558112272616198,0.0117615462861749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,28187,-0.00832915591690612,0.00330747624900899,-0.0148118093649637,-0.0018465024688485,0.011798400265651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,23736,0.0137340929069424,0.00545518669245286,0.0030419269897348,0.02442625882415,0.0118215671723777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,28204,-0.0318137796959373,0.0126502782316253,-0.0566083250299229,-0.00701923436195166,0.0119132140802803
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",27682,0.014213976176364,0.0056624215100124,0.00311563001673974,0.0253123223359884,0.0120709392226
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,23725,-0.0070777920236084,0.00282093635586221,-0.0126068272810983,-0.00154875676611848,0.012113201609121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,23240,0.00722594729872133,0.00288017226387592,0.00158080966152453,0.0128710849359181,0.0121189226702419
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,23140,-0.00736710059355053,0.00293710769394297,-0.0131238316736788,-0.00161036951342231,0.0121386969091388
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,28176,0.0154688957599694,0.006169121279033,0.00337741805306472,0.0275603734668741,0.0121654206148428
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,28187,-0.00532470510543724,0.00212502872383606,-0.00948976140415592,-0.00115964880671857,0.0122261840818167
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,23071,0.0077156849743577,0.00308021220466545,0.00167846905321342,0.013752900895502,0.0122547537483497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,27544,-0.00643383751608631,0.00257193488226873,-0.011474829885333,-0.0013928451468396,0.0123706684966279
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,23071,-0.00858233700159186,0.00343511552898136,-0.0153151634383953,-0.00184951056478839,0.0124819845748438
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",23198,-0.01072062760441,0.00429510565977447,-0.0191390346975679,-0.00230222051125201,0.0125667894582358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",23393,0.00769406980971448,0.00308597578994692,0.00164555726141852,0.0137425823580104,0.0126652832967459
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,23071,-0.00987474017652129,0.00397723450764229,-0.0176701198115002,-0.0020793605415424,0.0130419094735755
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,28224,-0.0174835030980731,0.00705633453225192,-0.0313139187812869,-0.00365308741485934,0.0132289160392371
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,28046,-0.00511258949011747,0.0020640909379557,-0.00915820772851064,-0.0010669712517243,0.0132579882770337
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,23795,-0.00749156451256722,0.00302571847579643,-0.0134219727251282,-0.00156115630000623,0.0132946733163072
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,27562,0.00674917297621079,0.00272964611015725,0.00139906660030258,0.012099279352119,0.0134214718098793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,27918,0.0066478382553656,0.00269540913724021,0.00136483634637478,0.0119308401643564,0.0136555285656296
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,27702,-0.0135242819988795,0.00548828932615852,-0.0242813290781502,-0.00276723491960875,0.0137377004758347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,23071,-0.0069924972775453,0.00284095640387948,-0.0125607718291491,-0.00142422272594151,0.0138500281650035
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,28091,0.00334715797142101,0.00136013009326586,0.000681302988619922,0.00601301295422211,0.0138644787920734
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,27431,-0.00502921803389018,0.00205001937034339,-0.00904725599976322,-0.00101118006801714,0.0141632170190988
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,23071,-0.00623680044111248,0.00254277098774248,-0.0112206315770877,-0.00125296930513721,0.0141839435861621
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,28274,-0.00468973711844672,0.00191255509757173,-0.0084383451096873,-0.000941129127206133,0.014209333490765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,23188,0.0074936631028941,0.00305608573114661,0.00150373506984674,0.0134835911359415,0.0142119696811535
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,22833,-0.0133680913838194,0.00545268370299331,-0.0240553514416863,-0.00268083132595254,0.0142275912761579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,28144,0.0151365116389399,0.0061871763159856,0.00300964605960813,0.0272633772182717,0.0144338441355862
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,27881,-0.0111261920144173,0.00456547133410475,-0.0200745158292626,-0.00217786819957196,0.0148146514474823
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,28195,-0.012685727898241,0.00520973269348593,-0.0228968039774734,-0.00247465181900855,0.0148977228509763
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",28109,0.0109326184499709,0.0044908824152789,0.00213048891602427,0.0197347479839175,0.014922554027351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,26744,-0.00657687666095072,0.00270316862030546,-0.0118750871567494,-0.00127866616515203,0.0149797816677254
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,23738,-0.0148415348613227,0.00610002248013381,-0.026797578922385,-0.00288549080026046,0.014980416634328
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,28224,-0.0110970469472794,0.00456270220210099,-0.0200399432633973,-0.00215415063116143,0.0150168412813183
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,28176,-0.00990863132903273,0.00407820485286905,-0.0179019128406561,-0.00191534981740939,0.0151194042234536
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,27965,-0.0163799095182929,0.00674215514589996,-0.0295945336042568,-0.00316528543232895,0.0151268892313987
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,28336,-0.00506130455146892,0.00208647586968124,-0.00915079725604416,-0.000971811846893679,0.015282274266938
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,23071,0.00730108489348573,0.00300978937711389,0.0014018977143425,0.013200272072629,0.0152831765368615
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,28187,-0.00611058271993554,0.00251941628202445,-0.0110486386327035,-0.00117252680716762,0.0152979279360186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,28176,0.0153374306927129,0.00633093820269607,0.00292879181542855,0.0277460695699972,0.0154154811114707
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,23198,-0.00693171700788243,0.00286226583832225,-0.012541758050994,-0.00132167596477082,0.0154532254407072
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,27702,-0.00714585744046959,0.00295564370551385,-0.0129389191032767,-0.00135279577766244,0.015625396074385
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,23198,0.0146487217700058,0.00606761363918935,0.00275619903719469,0.0265412445028169,0.0157754370064058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,28553,-0.0143044799265824,0.0059253990125321,-0.0259182619911453,-0.0026906978620195,0.015780572949186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,27702,-0.0138441376772254,0.00573571454362416,-0.0250861381827288,-0.0026021371717221,0.0157990886589145
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,28091,-0.00461466974438491,0.00191373099638627,-0.008365582497302,-0.000863756991467829,0.0159000904740267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,23056,-0.0147770373642875,0.00615315259273415,-0.0268372164460464,-0.00271685828252853,0.0163341274742959
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",23893,0.00268687259121102,0.00111950840498124,0.000492636117447793,0.00488110906497424,0.0164005826487646
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,28176,0.00692800772615696,0.00288904818266092,0.00126547328814156,0.0125905421641724,0.0164902393322351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",28187,-0.0124542888557325,0.0051955781543103,-0.0226376220381807,-0.00227095567328426,0.0165321592553554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,23738,0.00647713404346525,0.00270361279814612,0.00117805295909885,0.0117762151278317,0.0165948737271262
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,23188,-0.00534112017728437,0.00223056255003086,-0.00971302277534485,-0.000969217579223888,0.0166501617740047
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,28286,0.00493915050226189,0.00206500875718406,0.000891733338181129,0.00898656766634265,0.0167710849489521
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,23872,-0.00363229104847371,0.00151895868467056,-0.00660945007042801,-0.000655132026519409,0.0167963727041112
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,28091,-0.00420934371690823,0.00176317092664606,-0.00766515873313451,-0.00075352870068195,0.0169759166184007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,27702,0.00765495777558916,0.00321148523677658,0.00136044671150706,0.0139494688396713,0.0171500314877704
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,23337,-0.00461611586437151,0.0019374547477384,-0.00841352716993878,-0.000818704558804244,0.0172003631117516
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,27682,-0.00780564710915907,0.00327723826583725,-0.0142290341102001,-0.00138226010811806,0.0172360979500944
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,23110,0.0108548225335596,0.00456562328869077,0.00190620088772573,0.0198034441793936,0.0174379845368028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,28553,0.00652528899661201,0.00274731801322753,0.00114054569068606,0.011910032302538,0.0175484461303111
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",23775,-0.0155715018959011,0.00656539118123804,-0.0284396686111276,-0.00270333518067451,0.017711728757158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,28553,-0.00312589967978952,0.00131818969575752,-0.00570955148347425,-0.000542247876104781,0.0177294539648545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,23846,-0.0143047148100718,0.0060344739638864,-0.0261322837792891,-0.00247714584085447,0.0177719998008767
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,23071,-0.0054172461913114,0.00228603790004793,-0.00989788047540533,-0.000936611907217463,0.0178102407900171
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,27562,-0.00628937706196267,0.00265497648541151,-0.0114931309733692,-0.00108562315055612,0.0178478739018228
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,28091,0.00604310482747982,0.00256082088273193,0.00102389589732525,0.0110623137576344,0.0182900584424413
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,27965,0.0111095627154572,0.004708088529002,0.0018817091986133,0.0203374162323011,0.0182977450498021
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,23071,-0.00770939571485782,0.00326972698568305,-0.0141180606067966,-0.00130073082291903,0.0183913922668379
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,28224,-0.0104943694913625,0.00445341938199871,-0.01922307148008,-0.00176566750264504,0.0184561293323947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,23846,0.00422078045143195,0.00179212042121679,0.00070822442584704,0.00773333647701685,0.0185213978930845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,28134,0.0102786072765234,0.00436443695843581,0.00172431083798918,0.0188329037150575,0.0185254460451536
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,23747,0.0172940842493722,0.00734497943961645,0.00289792454772399,0.0316902439510205,0.0185535001346971
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,27965,0.00887364346090129,0.00377887251005514,0.00146705334119322,0.0162802335806094,0.0188700449775441
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,27702,0.0109797284570872,0.00467801184355201,0.00181082524372529,0.0201486316704492,0.0189275409916913
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,28187,0.00370710912810134,0.00157989105324187,0.000610522663747275,0.00680369559245541,0.0189609435147936
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,28155,-0.0143748560440792,0.00612806951087122,-0.0263858722853868,-0.00236383980277165,0.0189962666873436
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,28031,-0.00453513597668997,0.00193446624886463,-0.00832668982446464,-0.000743582128915291,0.01906537096323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,27702,-0.00588144459653759,0.00251215803383511,-0.0108052743428544,-0.000957614850220775,0.0192293274495367
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23071,-0.00582325633293031,0.00249033750989752,-0.0107043178523294,-0.000942194813531177,0.0193781073311493
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,27965,-0.0205925189655122,0.0088111853078527,-0.0378624421689035,-0.00332259576212088,0.0194416106381456
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,27448,-0.00706544982204001,0.00302369201850827,-0.0129918861783162,-0.0011390134657638,0.0194621415241812
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,23775,-0.0145437201139679,0.00623517447025074,-0.0267646620756593,-0.00232277815227647,0.019681228247045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,23738,-0.0137156149847829,0.00590089642181326,-0.0252813719715369,-0.00214985799802889,0.0201163546988428
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,28428,-0.00927442769378835,0.00399063562674011,-0.017096073522199,-0.00145278186537773,0.0201299506332552
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,27489,0.00719760802695422,0.00310228447934907,0.00111713044743005,0.0132780856064784,0.0203427947018531
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,23056,-0.0141017723606152,0.00608328460566525,-0.0260250101877191,-0.00217853453351134,0.020451611967794
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,27109,-0.0074743700597993,0.00322806035021679,-0.0138013683462242,-0.00114737177337439,0.0205964642754783
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,23056,-0.00900206806215005,0.00389059813269569,-0.0166276404022336,-0.0013764957220665,0.0206874196625821
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,28091,-0.0136633930894785,0.00591160661892371,-0.0252501420625689,-0.00207664411638799,0.0208244593500379
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,28220,-0.00888826689300702,0.00384707069442335,-0.0164285254540768,-0.00134800833193726,0.0208732736511348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,22783,0.00609622891359479,0.00264235778058026,0.000917207663657478,0.0112752501635321,0.0210572181028631
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,28176,-0.01056463971467,0.00458397774730595,-0.0195492360993897,-0.00158004332995035,0.0211912762502189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,23841,0.0169944343785134,0.00737852012214193,0.00253253493911521,0.0314563338179116,0.0212744326529919
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,28195,-0.00430647376770529,0.00187132107963952,-0.00797426308379875,-0.000638684451611838,0.0213818629057695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,23738,-0.00782038893054906,0.00339956920261218,-0.0144835445676689,-0.00115723329342918,0.0214338704228329
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,23795,-0.0104927028541969,0.00456322824018841,-0.0194366302049662,-0.00154877550342766,0.0214906616653428
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,27702,-0.00753507433081586,0.00328919519228057,-0.0139818969076858,-0.00108825175394594,0.021979189559611
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,27562,0.0148540157717838,0.00649201839057519,0.00212965972625645,0.0275783718173112,0.0221425694596236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,27965,0.00940851000823056,0.00411403877899987,0.00134499400139081,0.0174720260150703,0.0222074723964943
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",23393,-0.0108442146621307,0.0047443546438991,-0.0201431497641729,-0.00154527956008843,0.0222801884209941
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,28176,0.0086257960161998,0.00378084084589819,0.00121534795823936,0.0160362440741602,0.0225293134215748
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,28320,0.00396469919471848,0.00173862780140315,0.000556988703968306,0.00737240968546866,0.0225936813565127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,27489,0.0101815405464205,0.00446895386284781,0.00142239097523875,0.0189406901176022,0.0227173776680124
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",27544,-0.0042573736900875,0.001868700571008,-0.00792002680926317,-0.000594720570911823,0.0227191026194032
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,27544,-0.0104262255655695,0.0045812597352783,-0.019405494646715,-0.00144695648442402,0.0228630854228948
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,23188,0.00679831590613508,0.0029876385876722,0.000942544274297561,0.0126540875379726,0.0228861577412965
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,23775,-0.0128548318524198,0.00565295570160023,-0.0239346250275562,-0.00177503867728332,0.0229747517227
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,28521,0.00863135597837228,0.00379801153856424,0.00118725336278638,0.0160754585939582,0.0230577868502218
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,23795,0.0119267460663902,0.00525449837715821,0.00162792924716005,0.0222255628856203,0.0232276421994611
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,23615,0.00923208811971866,0.00406942472152546,0.00125601566552875,0.0172081605739086,0.0232987924916421
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,23846,0.00452076624351538,0.00199677999034855,0.000607077462432218,0.00843445502459855,0.0235813273893601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,23393,0.00562360433432574,0.00248981987748655,0.000743557374452109,0.0105036512941994,0.0239150230718763
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,23738,-0.00976914669996005,0.00432701915740333,-0.0182501042484706,-0.00128818915144952,0.0239729070333257
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,23071,-0.0127124808104638,0.00563630992055015,-0.0237596482547421,-0.0016653133661855,0.024113702149864
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",28187,-0.0058159030793746,0.00257990578380822,-0.0108725184156387,-0.000759287743110487,0.0241844270139377
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,28320,-0.00401611132834921,0.00178633140641112,-0.00751732088491501,-0.000514901771783413,0.0245682098260465
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,23337,-0.0129203007497279,0.00575252081730128,-0.0241952415516384,-0.0016453599478174,0.0247117815794575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,23775,0.00616794229349594,0.00274960393256685,0.000778718585664909,0.011557166001327,0.0248923760902769
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,23337,-0.00667237436448274,0.00298263161185565,-0.0125183323237198,-0.000826416405245674,0.0252907657875917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,23775,0.0114380237824512,0.00511912736107021,0.00140453415475357,0.0214715134101488,0.0254680104897816
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,23337,0.00384809332432564,0.00172247972388771,0.000472033065505722,0.00722415358314556,0.0254897000894278
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,28553,0.00258829404674692,0.0011603187954421,0.000314069207680402,0.00486251888581345,0.0257104104483186
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,27544,0.00866867480218251,0.0038863144873511,0.00105149840697434,0.0162858511973907,0.025718021730582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,23188,0.0129580607045155,0.00582356750794889,0.00154386838893564,0.0243722530200953,0.0260836454211542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,28091,0.00819790948355618,0.00368769088579265,0.000970035347402581,0.0154257836197098,0.0262205736888388
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,27544,-0.00739326173378419,0.00333071708481187,-0.0139214672200155,-0.000865056247552927,0.0264458468203064
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,23393,0.0112755591452881,0.00508377447679743,0.00131136117076515,0.0212397571198111,0.026567794860972
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,23188,0.00484134766896253,0.0021838326364169,0.00056103570158541,0.00912165963633965,0.0266393098164836
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",23071,-0.00713736639252645,0.00322043423192974,-0.0134494174871087,-0.000825315297944161,0.0266824297196507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,23056,-0.0115105446488923,0.00519675657378469,-0.0216961875335103,-0.00132490176427435,0.0267733897023054
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,23795,0.00716196676421919,0.0032405329319099,0.000810522217675792,0.0135134113107626,0.0271063194146041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,23738,0.0155169063002602,0.00702115690786954,0.00175543876083586,0.0292783738396844,0.0271131948009343
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,23056,-0.0115545169011995,0.00522933050785448,-0.0218040046965943,-0.00130502910580471,0.0271455453443734
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,23725,0.00659880412861811,0.00298779438571166,0.000742727132623258,0.012454881124613,0.0272129031490385
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,28521,0.013995150647282,0.00635047099254329,0.00154822750189719,0.0264420737926669,0.027546568843898
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,28496,0.00305341656216298,0.00138658971896806,0.000335700712985577,0.00577113241134038,0.0276658562810021
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,28415,-0.00404027128988117,0.0018349281402944,-0.00763673044485818,-0.000443812134904149,0.0276825765421019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,23725,-0.00772251523955178,0.00350880139029481,-0.0145997659645296,-0.000845264514573946,0.0277528227490485
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,23056,-0.00876743348831313,0.00398418128890937,-0.0165764288145755,-0.000958438162050755,0.0277770106012019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,27702,-0.00741052286462562,0.00337008758461673,-0.0140158945304744,-0.000805151198776831,0.0278924868028037
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23188,0.00463247654037951,0.00210951069632478,0.000497835575582929,0.00876711750517608,0.028102120304434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,23795,-0.00981877169188188,0.00447245249319832,-0.0185847785785506,-0.00105276480521318,0.0281453535919212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,23775,-0.0111641471973771,0.00509293107507373,-0.0211462921045216,-0.00118200229023259,0.0283829031021945
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,28224,0.011273643796027,0.00514631328091113,0.0011868697654412,0.0213604178266128,0.0284870762531787
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,23056,-0.00919675190987655,0.00421465803317109,-0.0174574816548919,-0.000936022164861211,0.0291131534283091
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,28553,-0.00468197478049621,0.00214616040606295,-0.00888844917637959,-0.000475500384612823,0.0291502529625189
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,23725,-0.00653647828004029,0.00299976670118188,-0.0124160210143568,-0.000656935545723803,0.0293418098900772
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,27702,-0.00898169178978855,0.0041357585536679,-0.0170877785549776,-0.000875605024599477,0.0298855736913419
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,23056,-0.0103908053054163,0.00478667438434006,-0.0197726870987228,-0.0010089235121098,0.0299581668055992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,23738,0.0156198594828888,0.00720272376693864,0.00150252089968905,0.0297371980660885,0.0301226230918556
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,28091,-0.00825430230033383,0.00380800987623236,-0.0157180016577493,-0.000790602942918394,0.030196307606317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,23163,0.0088075335036079,0.00406588486367428,0.000838399170806314,0.0167766678364095,0.0303058217121992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,23862,-0.0122207445901599,0.00564694546251716,-0.0232887576966936,-0.0011527314836263,0.0304639883256961
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,23071,-0.00543511343796015,0.00251619966803932,-0.0103668647873172,-0.000503362088603074,0.0307791834699672
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,28276,-0.0110620656356432,0.00513158379104164,-0.0211199698660848,-0.00100416140520159,0.0311168758652225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,27702,-0.0110933244176376,0.00514775298837108,-0.021182920274845,-0.00100372856043031,0.0311716943562848
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,23872,0.0103777618309324,0.00481746713249312,0.000935526251245922,0.019819997410619,0.0312348930244571
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,23393,-0.0186907293239713,0.00867644418009668,-0.0356965599169608,-0.00168489873098186,0.0312352795450712
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,23795,-0.00555242535778975,0.00258547248906238,-0.010619951436352,-0.000484899279227478,0.0317597833699233
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,23056,-0.00695705090086159,0.00324320796041669,-0.0133137385032783,-0.000600363298444875,0.031954152284425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",28176,-0.0138627717418284,0.0064665347023098,-0.0265371797583556,-0.00118836372530119,0.0320597502040334
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,23056,-0.0160129650772524,0.00747102377754459,-0.0306561716812398,-0.00136975847326504,0.0320960201212706
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,28553,-0.00491827461370469,0.00229682662419138,-0.00942005479711978,-0.000416494430289593,0.0322554975526804
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,23256,0.00946089029974125,0.00442355900550215,0.000790714648957039,0.0181310659505255,0.0324662487574343
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,27544,0.00882237328841871,0.00413118044898935,0.00072525960839959,0.0169194869684378,0.0327242990074698
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,23198,0.0106755260133573,0.00500076343465908,0.000874029681425453,0.0204770223452891,0.0327895009543983
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,23738,0.00627241519167614,0.00293939871682177,0.000511193706705472,0.0120336366766468,0.0328602935660243
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,23071,-0.00553600995424228,0.00259467272240362,-0.0106215684901534,-0.000450451418331183,0.0328855490091647
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,23198,0.0042534141411731,0.00199486422966726,0.000343480251025277,0.00816334803132093,0.0330023447432316
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,23188,0.00627175545507141,0.00294516083632059,0.000499240215883062,0.0120442706942598,0.03322242881453
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,28553,0.00809728755682851,0.00380420513970697,0.000641045483002842,0.0155535296306542,0.0333033870729993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,27500,0.00517871490469878,0.0024334145574786,0.000409222372040714,0.00994820743735684,0.0333320306886434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,23795,0.00504822919438014,0.0023780653404605,0.000387221127077567,0.00970923726168271,0.0337783749464262
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,27806,-0.00979918474231389,0.00461984845086899,-0.0188540877060171,-0.000744281778610667,0.0339217753383531
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,28553,-0.00356994185477117,0.00168352729711174,-0.00686965535711017,-0.000270228352432165,0.0339713909757747
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,27870,-0.00816233367809678,0.00385339221409578,-0.0157149824177245,-0.000609684938469058,0.034165243272557
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,22043,0.00761506215731401,0.00359773960140601,0.000563492538558238,0.0146666317760698,0.034302948828373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,23056,-0.0071663984744067,0.00339185053458577,-0.0138144255221948,-0.000518371426618587,0.0346261744782117
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,23056,-0.0040185209125103,0.00190242867802252,-0.00774728112143444,-0.000289760703586159,0.0346705178002112
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,23872,0.00372196176853433,0.00176256753481489,0.000267329400297139,0.00717659413677151,0.0347250943781565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,28307,0.00797287850766804,0.00377985663878539,0.00056435949564867,0.0153813975196874,0.0349268419918622
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,23813,0.00630889424981405,0.00299164969465985,0.000445260848280748,0.0121725276513473,0.0349692846003181
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,23872,-0.0204898565972504,0.00972163423443752,-0.039544259696748,-0.00143545349775288,0.0350711970897649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,23393,-0.0106103200517925,0.00503513336602243,-0.0204791814491964,-0.000741458654388528,0.0351059294360512
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,23071,-0.0103070639584772,0.00489656817799787,-0.019904337587353,-0.000709790329601388,0.0353058688736418
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,28092,0.0154329619096054,0.00733334884051634,0.00105959818219343,0.0298063256370175,0.0353445597115828
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,23337,0.00596396091959711,0.00284252007537309,0.000392621571865842,0.0115353002673284,0.0359048815888215
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",28320,-0.00389917415413793,0.00186189697622537,-0.00754849222753965,-0.000249856080736208,0.0362515398799917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,28307,-0.0118050855656953,0.00564067795314622,-0.0228608143538618,-0.000749356777528664,0.036371546531302
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,28091,-0.0102591479632535,0.00490842189313452,-0.0198796548737971,-0.000638641052709832,0.0366167778563017
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,28176,-0.00478379556139745,0.00229239418307607,-0.00927688816022655,-0.000290702962568348,0.0369141076887776
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,28428,0.00408914828630499,0.00196197121767384,0.000243684699664261,0.00793461187294571,0.0371505240943666
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,28524,0.00805722393972219,0.00387601492104678,0.0004602346944705,0.0156542131849739,0.0376502531795127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,23893,-0.00262052813872191,0.00126116895227219,-0.0050924192851754,-0.000148636992268413,0.0377332334343208
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,28187,0.00785855366192907,0.00378460326663282,0.000440731259328746,0.0152763760645294,0.0378610477144722
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,23725,-0.00479183055568824,0.00230971153617237,-0.00931886516658608,-0.000264795944790406,0.0380302471375287
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,28452,0.00296861360858928,0.00143169211938262,0.000162497054599343,0.00577473016257922,0.0381347520553868
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,23188,-0.00560246639318858,0.00270623698196934,-0.0109066908778485,-0.000298241908528678,0.0384441647781788
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,27918,0.0124016504519891,0.00600419798720991,0.000633422397057694,0.0241698785069205,0.0388852498483989
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,27702,-0.00623600584496121,0.00302060176301534,-0.0121563853004713,-0.000315626389451152,0.0389804557316796
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,22981,0.00871045810122249,0.00422123289590336,0.000436841625251906,0.0169840745771931,0.0390776163430034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,28082,-0.00595112458082666,0.00289022634335434,-0.0116159682138012,-0.000286280947852144,0.0394985201965754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,23862,0.00365593577324235,0.00177843191699444,0.000170209215933248,0.00714166233055145,0.0398215837740121
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,28388,-0.00314175319916675,0.00152934293588476,-0.00613926535350088,-0.000144241044832621,0.0399542858423631
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,28553,-0.00419404335104486,0.00204499854062591,-0.00820224049067165,-0.000185846211418065,0.0402879002354275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,23071,0.00816644800041806,0.00399750111028333,0.00033134582426274,0.0160015501765734,0.0410748495590058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,23795,0.0121655488116978,0.00596801136040326,0.000468246545307374,0.0238628510780881,0.0415150501363823
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,23687,-0.0120958430520073,0.00593625745215955,-0.02373090765824,-0.000460778445774548,0.041598942451496
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,23188,-0.0127941058263602,0.00628889708617761,-0.0251203441152684,-0.000467867537452139,0.04192306706632
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,23071,0.00615646739900665,0.00302967826775717,0.0002182979942026,0.0120946368038107,0.042159711075352
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,27965,-0.00576945443426746,0.00284200350875519,-0.0113397813114276,-0.000199127557107278,0.042359291139613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,27965,0.00833484541000682,0.00410927249800122,0.000280671313924426,0.0163890195060892,0.0425389035829058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,28404,-0.0091487789532171,0.00451285869257722,-0.0179939819906685,-0.000303575915765745,0.0426442244340061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,27910,-0.0103043211715585,0.00508760460360663,-0.0202760261946275,-0.000332616148489537,0.0428380926629598
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,23188,-0.0138720323649298,0.00685929395382079,-0.0273162485144185,-0.000427816215440998,0.0431495750882174
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,22978,-0.0113924837839221,0.00563444216413601,-0.0224359904256287,-0.000348977142215545,0.0431944938341079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,23738,0.00484966911033648,0.00240681157752421,0.000132318418389021,0.00956701980228394,0.0439183552283832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,23725,0.00537535527097614,0.00266930771619193,0.000143512147239951,0.0106071983947123,0.0440456119197883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,23071,-0.00687864773840539,0.00341585432731249,-0.0135737222199379,-0.000183573256872916,0.0440482714500556
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,23337,-0.00405992410428484,0.00201783536165739,-0.00801488141313332,-0.000104966795436361,0.0442293576586688
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,27562,0.0103257654798575,0.00513900133046623,0.000253322872143706,0.0203982080875713,0.0445156798833388
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,27544,0.00477013135536132,0.00237594501558339,0.000113279124817878,0.00942698358590476,0.0446873258389419
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,23775,-0.00625567436264669,0.00312266055161555,-0.0123760890438132,-0.00013525968148021,0.0451547671921909
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,23795,0.00432307117504691,0.00216157843679112,8.63774389363121e-05,0.0085597649111575,0.0455158973916119
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,27918,-0.0043162019779143,0.00216180799146283,-0.00855334564118145,-7.90583146471529e-05,0.0458815621347145
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,23757,-0.0130383271917841,0.00653462622916031,-0.0258461946009383,-0.00023045978262988,0.0460251226431962
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",28187,0.00619981823728784,0.00310770843235753,0.000108709709867084,0.0122909267647086,0.0460546043566382
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,22936,-0.00704049463035345,0.00352990096762127,-0.0139591005268911,-0.000121888733815754,0.0461059483267079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",23738,-0.0195895173184804,0.00986031725584783,-0.0389157391399422,-0.000263295497018687,0.0469668544904495
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,27562,0.00720030833627888,0.00362430967606449,9.66613711924835e-05,0.0143039553013653,0.0469688369883305
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,27965,-0.0107816657106006,0.00543360416453598,-0.0214315298730911,-0.000131801548110091,0.0472369891232516
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,23337,-0.00413748701034503,0.00208577311689632,-0.00822560231946182,-4.93717012282372e-05,0.0473042679755107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,27917,-0.00778922772340378,0.00393268521019933,-0.0154972907353945,-8.11647114130941e-05,0.0476416326832231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,28322,-0.0203380447231317,0.0102715144254162,-0.0404702129969474,-0.000205876449315998,0.0477083158423712
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,23188,0.0130008681752525,0.00656912165786812,0.000125389725831041,0.0258763466246741,0.0478179450698927
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,23188,-0.0117622806578707,0.00594705833039205,-0.0234185149854392,-0.00010604633030231,0.0479595199275835
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,27777,0.0099650195624491,0.00503920971871994,8.81685137580253e-05,0.0198418706111402,0.0479954105229559
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,28091,-0.0119459513496049,0.00604336257341203,-0.0237909419934925,-0.000100960705717364,0.0480846358259715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,23795,-0.00499161224991164,0.00252866864793562,-0.00994780279986547,-3.54216999578164e-05,0.048392382873244
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,27489,-0.00639512570019117,0.00324234751515977,-0.0127501268299043,-4.01245704780241e-05,0.0485768070583664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,23188,-0.00726807594828928,0.00368677929006004,-0.014494163356807,-4.19885397715918e-05,0.0486912818062428
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,23775,-0.0063409238515181,0.00321863725424674,-0.0126494528698417,-3.23948331944941e-05,0.0488425425535336
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,23738,-0.0101251396125124,0.00514007335826876,-0.0201996833947192,-5.05958303056147e-05,0.0488679342030314
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,28452,0.00519023159754717,0.00263971689041679,1.6386492330267e-05,0.0103640767027641,0.0492843386367346
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,23738,0.0108465141395542,0.00551987179996361,2.75654116255724e-05,0.0216654628674829,0.0494266001380744
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",23725,-0.00571240036985343,0.00290892656872645,-0.0114138964445573,-1.09042951495948e-05,0.0495709243365984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,23725,0.00501835178920096,0.00255775140718535,5.15903111767378e-06,0.0100315445472843,0.0497721825377339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,28195,-0.00689302352272466,0.00351428405448683,-0.0137810202695188,-5.02677593047611e-06,0.0498386691773366
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,23135,-0.0112013244325714,0.00571364477606562,-0.02240006819366,-2.58067148277419e-06,0.0499550114986315
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,28452,0.00527515572007606,0.00269191122553866,-9.90281979721883e-07,0.0105513017221318,0.0500485565817324
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,23188,-0.00348463090619046,0.00178296187710412,-0.00697923618531454,9.97437293361525e-06,0.0506652621314497
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,23862,0.00475120960360469,0.00243424386476222,-1.99083713292589e-05,0.00952232757853864,0.0509710842275335
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",23846,-0.0070169550704016,0.00359632732539606,-0.0140657566281779,3.18464873746826e-05,0.0510515335741577
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,23188,-0.00575257929660429,0.0029541019532529,-0.01154261912498,3.74605317713939e-05,0.0515085463338045
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,23872,-0.00319668957582957,0.00164256942732679,-0.00641612565339008,2.27465017309382e-05,0.0516482228822073
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,23393,-0.00536931147900889,0.00276650521878631,-0.0107916617078301,5.30387498122765e-05,0.0522911172674717
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,27508,0.00759295981943802,0.00393214225070582,-0.000114038991945395,0.0152999586308214,0.0534935364047375
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,23725,-0.00798401976005248,0.0041533744699822,-0.0161246337212176,0.000156594201112633,0.0545803503800789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,27442,-0.0116764758796267,0.00607501494511142,-0.0235835051720451,0.000230553412791646,0.0546099504059358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,28224,-0.00503629286575074,0.00262217230043749,-0.0101757505746082,0.000103164843106747,0.0547850670770757
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23170,0.0102939632898238,0.00536078384294042,-0.000213173042339407,0.020801099621987,0.0548405262884232
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,23725,0.00663665655747034,0.00345812017339288,-0.000141258982379711,0.0134145720973204,0.0549771513996976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,28336,0.00390834885096896,0.00203661440209091,-8.34153771292305e-05,0.00790011307906714,0.0549890396749374
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,23071,0.00776374582160925,0.00406612160348528,-0.000205852521221907,0.0157333441644404,0.0562262941316426
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,23775,0.00662344706289264,0.00347103447738153,-0.000179780512775162,0.0134266746385604,0.0563767007830935
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,27562,0.00732534024161389,0.00384073318049111,-0.000202496792148689,0.0148531772753765,0.0564951776475016
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,23738,0.00353248376728163,0.0018525426600685,-9.84998464526356e-05,0.00716346738101589,0.0565546830239926
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,28091,0.00358569052424967,0.00188136186037994,-0.000101778722095011,0.00727315977059436,0.0566731788450707
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,23795,-0.00972777611167304,0.00510435573065621,-0.0197323133437592,0.000276761120413126,0.0566908752148666
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,23738,0.00640729818641288,0.00337526886196575,-0.000208228783039986,0.0130228251558658,0.0576677110984468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,23071,-0.00401892531702037,0.00211856624889322,-0.00817131516485108,0.000133464530810336,0.0578401015205288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,27965,-0.00647038314967198,0.00341749904499,-0.0131686812778524,0.000227914978508425,0.058327051196583
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",23337,-0.0132534285542525,0.00700715053019885,-0.0269874435934423,0.000480586484937224,0.0585813668360833
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,23056,-0.00682548719771554,0.00362093752575235,-0.0139225247481901,0.000271550352759073,0.0594416659956244
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,27562,-0.00732802812297406,0.00388758519648051,-0.0149476951080759,0.00029163886212774,0.0594427840131946
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,27544,-0.00574241705925481,0.00304721843983498,-0.0117149652013314,0.000230131082821763,0.0595108316244897
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,23862,0.0111675263957045,0.00594181741447574,-0.000478435736667993,0.0228134885280769,0.0601911782695839
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,28048,0.00391857082552089,0.0020859179101732,-0.000169828278418585,0.00800696992946037,0.0603117635633153
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,23299,0.00464716224833372,0.00247806566243185,-0.000209846450032702,0.00950417094670015,0.0607614310852033
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,28176,0.0106238233100858,0.00566533798034952,-0.000480239131399256,0.0217278857515709,0.0607711468667307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23071,0.00355393396053939,0.00189605444770035,-0.000162332756953295,0.00727020067803208,0.0608901624012631
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,23444,0.00533197630845858,0.00284504579370434,-0.000244313447201916,0.0109082660641191,0.0609253970441681
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,23163,0.0054807685113038,0.0029248512284798,-0.00025193989651661,0.0112134769191242,0.0609619907506081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,27562,-0.00612202763020369,0.00326728858115152,-0.0125259132492607,0.000281857988853296,0.0609777622133725
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,23587,0.00553602490815696,0.00295517589807934,-0.000256119852078552,0.0113281696683925,0.0610349485417148
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,23872,0.00506838749073039,0.00270601789783111,-0.000235407589018599,0.0103721825704794,0.0610797881961676
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,28176,-0.0060252870651673,0.00321715562797063,-0.0123309120959897,0.000280337965655137,0.0610978578936935
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23071,-0.00616774899580018,0.00329604650195556,-0.0126280001396331,0.000292502148032715,0.0613221672351081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,23795,-0.00794408305408565,0.00425217858706688,-0.0162783530847367,0.000390186976565439,0.0617411443886293
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,27682,-0.00396098592690469,0.00212078631928992,-0.00811772711271293,0.000195755258903548,0.0618149018385382
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,28320,-0.0132864197180788,0.00711970203256461,-0.0272410357019054,0.000668196265747831,0.0620309561491956
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,23337,-0.010380425000393,0.00557151255421093,-0.0213005896066464,0.000539739605860448,0.0624572249689715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,28176,-0.0130701248771669,0.00701754761614753,-0.026824518204816,0.000684268450482301,0.0625442058111467
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,23841,0.00701044100698677,0.00376744430467583,-0.000373749830177848,0.0143946318441514,0.0627854599736871
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,27562,-0.0108692790156923,0.00584922648014371,-0.0223337629167739,0.00059520488538939,0.063145298446534
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,23071,-0.0058622794465034,0.00315888112437858,-0.0120536864502854,0.00032912755727862,0.0634935637794303
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,23198,0.00801023006815479,0.00431904655918932,-0.000455101187856272,0.0164755613241659,0.0636618765611713
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,28428,-0.00754180161179019,0.00407358259313663,-0.015526023494338,0.000442420270757611,0.0641234281275077
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,23738,0.00760939086497785,0.00411147723107452,-0.000449104507928212,0.0156678862378839,0.0642153454683549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,23846,0.00928586142607466,0.00503577779674097,-0.000584263055537652,0.019155985907687,0.0651988106879241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,27562,-0.00687536278206013,0.00373140471525393,-0.0141889160239578,0.000438190459837564,0.0654030105846537
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,23846,0.0078901189022039,0.00428330508535061,-0.000505159065083288,0.0162853968694911,0.0654783141103851
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,28428,-0.00651650232875704,0.00354286850254966,-0.0134605245937544,0.000427519936240303,0.0658771727549806
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,24857,0.00387768244279527,0.00210824683050951,-0.000254481345003364,0.00800984623059391,0.0658841113293279
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,23725,0.00983578606805686,0.00534949681076147,-0.000649227681035617,0.0203207998171493,0.065981003583675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,23163,-0.00808089675204262,0.00440058302463306,-0.0167060394803234,0.000544245976238178,0.0663225503936412
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,27682,0.00705980012903412,0.00385417698219018,-0.000494386756058641,0.0146139870141269,0.0670028453364934
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,23738,0.0102941441239105,0.00562138423247328,-0.000723768971737171,0.0213120572195581,0.0670761886525642
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,28428,-0.0044516367232499,0.00244247999121753,-0.00923889750603625,0.000335624059536452,0.0683761948999573
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,23188,0.0039982064810844,0.00219660031593538,-0.000307130138148938,0.00830354310031774,0.0687445936921005
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,23337,-0.00878197190469128,0.00483124839251771,-0.018251218754026,0.000687274944643435,0.0691161210413157
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,23188,0.00370084878515638,0.00203816354538981,-0.000293951763807652,0.00769564933412041,0.069417632255686
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,28553,0.00283125432571209,0.00156026184899728,-0.000226858898322573,0.00588936754974676,0.0695955837022667
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,28367,-0.00575232323769002,0.0031807469333401,-0.0119865872270366,0.000481940751656584,0.0705421220142337
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,23163,0.00834594094103048,0.00462078983404244,-0.000710807133692697,0.0174026890157537,0.070904468903156
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,23163,-0.00457929372398111,0.00253614555229323,-0.00955013900647584,0.000391551558513615,0.0709920213415197
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,28336,0.0036218635727972,0.00200934219969512,-0.000316447138605228,0.00756017428419963,0.0714755039029826
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,27544,-0.00745657611344887,0.00414434675254315,-0.0155794957484334,0.000666343521535703,0.0719954233576063
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,23056,0.00601018868848886,0.0033419114756226,-0.000539957803731432,0.0125603351807092,0.0721222201820129
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,23393,-0.00410689113204218,0.00228560652863592,-0.00858667992816858,0.000372897664084221,0.0723724053034793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,27965,-0.0138531401882705,0.00770983965019069,-0.0289644259026442,0.00125814552610325,0.0723761024495776
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,28237,0.00291877156804359,0.00163006149964413,-0.000276148971258909,0.00611369210734609,0.0733698516705983
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,28307,0.00511110084454813,0.00285647377890553,-0.000487587762106717,0.010709789451203,0.0735765128515274
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,23795,0.00804318190774407,0.00450416822922088,-0.000784987821528865,0.016871351637017,0.0741573935664691
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,23163,-0.00572236886238178,0.00320639774958348,-0.0120069084515654,0.000562170726801845,0.0743275972451897
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,28176,0.00678109651034229,0.00380663789948236,-0.000679913772643132,0.0142421067933277,0.0748599712216427
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,23071,0.00605718773718689,0.00340052859490888,-0.000607848308834519,0.0127222237832083,0.0748849624198407
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,23056,-0.0070698583553756,0.00397271137777148,-0.0148563726558077,0.000716655945056503,0.0751537493959796
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,23188,-0.00486170581085271,0.00273382353095775,-0.0102199999315299,0.000496588309824489,0.0753588521660858
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,28140,-0.00346367081008928,0.00194843220280496,-0.00728259792758699,0.000355256307408437,0.0754687593117168
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,23165,-0.00834926671532265,0.00469970595050346,-0.0175606903783094,0.00086215694766412,0.0756552934942943
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,23725,-0.0099401766754727,0.00560002472873728,-0.0209162251437978,0.00103587179285237,0.0759067981585811
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",27544,-0.00599984418531905,0.00338593108986592,-0.0126362691214562,0.000636580750818144,0.0764068760605914
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,28452,-0.00406254986314585,0.00229320633288911,-0.00855723427560851,0.000432134549316812,0.0764785307323641
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,28096,0.00514804031889191,0.00290783698024907,-0.000551320162396272,0.0108474008001801,0.0766710490298311
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,27544,0.00765658389131879,0.00432549540644553,-0.000821387105314448,0.016134554887952,0.0767206071245993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,23071,-0.00475405508229875,0.00268964663296484,-0.0100257624829098,0.000517652318312336,0.0771512427665088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,23071,-0.00509941929601455,0.0028888333742473,-0.0107615327095393,0.000562694117510148,0.0775404494742517
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,23188,-0.00517661094638653,0.00293392455344769,-0.010927103071144,0.00057388117837093,0.0776781474057466
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,23188,-0.0036479953260754,0.00207621094606192,-0.00771736878035676,0.000421378128205967,0.0789234038218639
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,23337,-0.00997136327439013,0.00568642859922673,-0.0211167633288745,0.00117403678009425,0.0795229991285963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,23188,0.00586073590960468,0.0033454568631631,-0.000696359542195,0.0124178313614044,0.0798129690361336
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,23893,-0.00272407557919624,0.00155513783219511,-0.00577214573029866,0.000323994571906178,0.0798448108368008
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,23188,0.00664659816996577,0.00379519175708703,-0.000791977673924804,0.0140851740138563,0.0799038997309525
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,23163,0.00555675258313122,0.0031742876526883,-0.000664851216137848,0.0117783563824003,0.0800365195167451
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,23071,-0.00468701437174845,0.00267878849459601,-0.00993743982115663,0.000563411077659724,0.0801873831378617
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,28428,0.00315492336916093,0.00180338381837304,-0.00037970891485023,0.00668955565317209,0.0802246778837364
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,28380,0.00299718404162092,0.00171535172410879,-0.000364905337632316,0.00635927342087415,0.0806011905183867
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,27544,-0.0058025879724406,0.00332288977601754,-0.012315451933435,0.000710275988553785,0.0807791070843592
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,28452,0.00383250519359442,0.00219579086296854,-0.000471244897823919,0.00813625528501275,0.0809282980637218
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,23071,0.00790343943605587,0.00452883349916624,-0.000973074222309956,0.0167799530944217,0.0809741719199316
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,28176,-0.00657023694946834,0.00376561016236254,-0.0139508328676989,0.000810358968762232,0.0810305810980278
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,27773,-0.00647741122178456,0.00371750643034617,-0.013763723825263,0.000808901381693933,0.0814482324731417
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,23100,0.00588625443751869,0.00337868621505476,-0.000735970543988637,0.012508479419026,0.0814915696554572
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,23071,-0.00405360683958258,0.00233021292679099,-0.00862082417609293,0.000513610496927766,0.0819450039124097
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,23795,0.00770767595424789,0.00443320174667513,-0.000981399469235361,0.0163967513777312,0.082113665256895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,28091,-0.00511937716764275,0.00295340139211251,-0.0109080438961833,0.000669289560897768,0.0830385112217901
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,23725,0.00522968393570788,0.00301971367761686,-0.000688954872421163,0.0111483227438369,0.0833137032525754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,22978,-0.0109008418947363,0.0062959861751342,-0.0232409747979993,0.00143929100852672,0.0833946859250996
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,27702,0.00586604393725598,0.00339624180634575,-0.000790590003181693,0.0125226778776937,0.0841399910901355
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,23056,-0.00654230247639377,0.00378947463651962,-0.0139696727639722,0.000885067811184693,0.0842815993134491
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",27544,0.00593357184491859,0.00343780468507475,-0.000804525337827924,0.0126716690276651,0.0843627693813217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,23071,-0.00628596037967135,0.0036430173831074,-0.0134262744505618,0.000854353691219149,0.0844540703998086
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,27682,0.00708839156906927,0.00410818145629397,-0.000963644085266911,0.0151404272234055,0.0844606469625242
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,23163,-0.00711161374542768,0.00412417474820666,-0.0151949962519127,0.000971768761057366,0.0846539585445727
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,28091,-0.0104209049090531,0.00605039650536263,-0.0222796820595638,0.00143787224145769,0.0850170136773074
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,28070,0.00915111510149088,0.00531543660135104,-0.00126714063715715,0.0195693708401389,0.0851509989383249
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,23738,0.00989402329043736,0.00575186217278336,-0.00137962656821802,0.0211676731490927,0.085419560564871
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,28036,-0.00651137350336296,0.00378675448638621,-0.0139334122966799,0.000910665289954015,0.0855320484003941
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,23795,-0.00874242327957246,0.00508859793335286,-0.0187160752289441,0.00123122866979914,0.0858020325562859
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,27682,-0.00877242168684637,0.00511311792167318,-0.0187941328133258,0.00124928943963305,0.0862337019528832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,27965,-0.0108548524884236,0.0063287858970265,-0.0232592728465955,0.00154956786974835,0.0863277888153886
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,27544,0.00947180643334573,0.00552698983604739,-0.00136109364530715,0.0203047065119986,0.0865883138158736
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,23795,0.00763664536566457,0.00445897298844052,-0.00110294169167884,0.016376232423008,0.0867905922605664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,23893,0.00249029179795263,0.001454103430974,-0.000359750926756408,0.00534033452266166,0.086799862042693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,23163,-0.0151342968249234,0.00884111362749446,-0.0324628795348126,0.00219428588496571,0.0869452892860114
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,23056,0.00505358843626289,0.00295675995082473,-0.000741661067353579,0.0108488379398794,0.0874339925672568
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,23725,0.00403579331659472,0.00236302987286754,-0.000595745234225663,0.0086673318674151,0.0876699842010665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,28091,0.00780061216381535,0.00457009373624074,-0.0011567715592165,0.0167579958868472,0.0878549862283649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,23725,-0.010005935393843,0.00586580695809209,-0.0215029170317035,0.00149104624401747,0.0880570899170423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,28320,-0.00309918971409336,0.00181877963706055,-0.00666399780273203,0.000465618374545308,0.0883931708621612
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23278,0.00558763626892407,0.00327984520237892,-0.000840860327738599,0.0120161328655867,0.0884639541419514
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,27562,-0.00468055180643332,0.00275030117651239,-0.0100711421123976,0.000710038499530972,0.0887980638543985
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",23795,-0.00783550837739463,0.0046073774942799,-0.0168659682661832,0.00119495151139398,0.0890229520769841
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,23337,0.00767993786956249,0.00452009989204769,-0.00117945791885098,0.016539333657976,0.0893205090200555
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,27702,-0.00330471234191754,0.00194569123077462,-0.0071182671542358,0.000508842470400718,0.0894289533556017
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,23738,0.00386931010671099,0.00228173668383608,-0.000602893793607727,0.00834151400702971,0.0899417789122343
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,23393,0.00334153714270715,0.0019705512259738,-0.000520743260201495,0.00720381754561579,0.0899489629456898
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,27682,0.00610678731867513,0.00360598034270955,-0.000960934153035583,0.0131745087903858,0.0903684474881277
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,23738,-0.00537456407381547,0.00318224365282548,-0.0116117616333534,0.00086263348572246,0.0912473536588379
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,23188,-0.00303490998114217,0.00179818733180411,-0.00655935715147822,0.000489537189193884,0.0914706233808128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,23188,-0.00335652232198497,0.00198947135684459,-0.00725588618140038,0.000542841537430435,0.0915893507847245
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,27702,0.00676836474749133,0.00401296299969354,-0.001097042731908,0.0146337722268907,0.0916866978792588
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,27544,-0.00623291239505134,0.00370325906331783,-0.0134913001591543,0.00102547536905161,0.0923693172000669
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,28411,0.00389224304174027,0.00231941216112671,-0.000653804794068088,0.00843829087754863,0.0933354273418591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,23188,-0.00557493685213573,0.0033257415576138,-0.0120933903050588,0.000943516600787313,0.093693152751125
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,28112,-0.00219939844576776,0.00131316627683055,-0.00477320434835565,0.000374407456820125,0.0939685311182862
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",28553,0.00563599407079765,0.00336604889161796,-0.000961461756773549,0.0122334498983688,0.0940698665609802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,28224,-0.00481083020294744,0.00287953307038264,-0.0104547150208974,0.00083305461500253,0.0947924328300247
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,23188,-0.0045117697430273,0.00270112111272387,-0.00980596712396609,0.000782427637911478,0.0948671476210055
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,27965,-0.00405279475966783,0.00243384932700502,-0.00882313944059768,0.000717549921262012,0.0958882589080205
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,28428,0.00648669789812554,0.00389568495399961,-0.0011488446117137,0.0141222404079648,0.0959041960243084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,23071,0.00956967365158522,0.0057595794630178,-0.00171910209592966,0.0208584493991001,0.0966220518307678
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,27544,-0.00953897465147516,0.00575060431038207,-0.020810159099824,0.00173220979687371,0.0971719709112267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,28307,0.00301771449146393,0.00181951067864058,-0.000548526438671597,0.00658395542159946,0.0972214619928739
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,23393,-0.00807634401429532,0.00487820181909269,-0.017637619579717,0.00148493155112635,0.0978165588333318
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,28195,0.00331061789468381,0.00200022348748176,-0.000609820140780446,0.00723105593014807,0.0979104831648091
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,27562,-0.00617079140500567,0.00373116199290104,-0.0134838689110917,0.00114228610108037,0.0981688893415305
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,23795,-0.0115797834034531,0.00703798720111213,-0.0253742383176328,0.00221467151072669,0.0999158145531051
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,23795,0.00243879038104468,0.00148252206451023,-0.000466952865395364,0.00534453362748472,0.0999772431197021
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,23188,-0.00237491153760317,0.00144750027197981,-0.00521201207068359,0.000462188995477262,0.100873585849476
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",23795,-0.00403840072481532,0.00246270435353334,-0.00886530125774066,0.000788499808110026,0.101055075653193
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,23071,-0.00783115784869635,0.00478784671807763,-0.0172153374161285,0.0015530217187358,0.101930167203712
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,28336,0.00660181457588228,0.00404073496711439,-0.00131802595966191,0.0145216551114265,0.102308755507873
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,23188,-0.0022381480029416,0.00137210011458714,-0.00492746422753238,0.000451168221649186,0.102865050568378
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,27562,-0.00557046510511046,0.00341617054104706,-0.0122661593655627,0.00112522915534177,0.102982632079899
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",27562,-0.00552113404924272,0.00338776245961557,-0.0121611484700892,0.0011188803716038,0.103170260731656
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,23056,0.00580465297647726,0.00356797337183094,-0.00118857483231138,0.0127978807852659,0.103776947368687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,28187,0.00870989492089384,0.00535565381457874,-0.00178718655568049,0.0192069763974682,0.103897229605296
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,23337,-0.0044049155628121,0.00270906102178996,-0.00971467516552043,0.00090484403989623,0.103964552403912
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,28521,0.00459840021889242,0.00282963950299593,-0.00094769320697961,0.0101444936447644,0.104155841560692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,23738,-0.00599359373221474,0.0036896446392147,-0.0132252972250755,0.00123810976064606,0.104295949071026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,27965,-0.00361060548883937,0.00222334106510932,-0.00796835397645363,0.000747142998774896,0.104396722676128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,23725,0.0031792218587227,0.00195815188275088,-0.00065875583146903,0.00701719954891444,0.104478156316529
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,28336,0.00507773949457084,0.0031388773800787,-0.0010744601703834,0.0112299391595251,0.10573994372453
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,23163,-0.00556104078863827,0.00343876964839099,-0.0123010292994846,0.00117894772220806,0.105857369448601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,23071,-0.00354709948152718,0.00219565867424298,-0.00785059048304342,0.00075639151998905,0.106214871729341
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,28307,0.00356618271845346,0.0022150800966123,-0.000775374270906659,0.00790773970781357,0.107418497357788
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,23795,0.00381948220250021,0.00237635110723073,-0.000838165967672015,0.00847713037267244,0.108004335097929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23149,-0.00388265117297025,0.00242473493716974,-0.00863513164982294,0.00086982930388244,0.109331161931869
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,28224,0.00292755107751639,0.00182958520632248,-0.000658435926875674,0.00651353808190845,0.109583745291663
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,28235,-0.00297201155683286,0.00185783593430845,-0.00661336998807743,0.0006693468744117,0.109672593243363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,28080,0.00368630022967178,0.00230761838437524,-0.000836631803703686,0.00820923226304724,0.110177151727816
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,23846,0.00828752031425676,0.0051908126143622,-0.00188647240989315,0.0184615130384067,0.110373791343603
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,28452,-0.00619272865328391,0.00387990783546229,-0.01379734801079,0.00141189070422217,0.110477133969336
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,28336,-0.00357616548950453,0.00224371977759414,-0.00797385625358905,0.000821525274579982,0.110979524079784
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,23862,-0.00430387372258446,0.00270327030920237,-0.0096022835286211,0.000994536083452178,0.111375734880869
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,27702,0.00399701316082457,0.00251160715977294,-0.000925736872330391,0.00891976319397954,0.111527281861952
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,23163,0.00597731210960259,0.00375752338153457,-0.00138743371820517,0.0133420579374104,0.111677599782207
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,27562,-0.00563738460732629,0.00354419736371706,-0.0125840114402117,0.00130924222555915,0.111712097955288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,23775,-0.0042956846230555,0.00270071408012827,-0.00958908422010691,0.000997714973995918,0.111718864377014
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,22978,0.00684023513524684,0.0043015581766734,-0.00159081889103303,0.0152712891615267,0.111808874910624
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,23775,-0.0115221887515104,0.00726114383988525,-0.0257540306776855,0.0027096531746647,0.112564837053356
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,28224,-0.00616235361326536,0.00388514829223785,-0.0137772442660515,0.00145253703952081,0.112720835327246
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,23725,-0.00528373602302886,0.00333148989815959,-0.0118134562234216,0.00124598417736393,0.112753118186399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,23071,-0.00513201333681506,0.00323610003398386,-0.0114747694034234,0.0012107427297933,0.112783961793352
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,27544,0.00554924873673728,0.00349980951231396,-0.00131037790739807,0.0124088753808726,0.112844754386754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,23846,-0.00525175553302272,0.00331310336293421,-0.0117454381243738,0.00124192705832832,0.112946229151081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,28307,-0.00269762291135168,0.00170227947826787,-0.00603409068875671,0.000638844866053347,0.113042934350659
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,23393,-0.00301041928104722,0.00190214944800815,-0.0067386321991432,0.000717793637048754,0.113516890397582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,23188,0.00449146392801474,0.00284542021489799,-0.00108555969318531,0.0100684875492148,0.114467008993675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,27544,0.0083924528290633,0.00531771584399135,-0.00203027022515975,0.0188151758832864,0.114529704884022
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,22978,-0.00446782484270715,0.00283569097269335,-0.0100257791491861,0.00109012946377181,0.115139098649676
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,23163,0.00381096137945302,0.00241894483692853,-0.000930170500926904,0.00855209325983294,0.115162963903011
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,23188,-0.00354313068329735,0.00225019843555598,-0.00795351961698708,0.000867258250392377,0.115365715067874
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,28176,-0.00900730048329101,0.00573141787547131,-0.0202408795192148,0.00222627855263276,0.116062510636144
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,28268,-0.0060659224073673,0.00386202664744189,-0.0136354946363534,0.00150364982161881,0.11627334639225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",23198,-0.0102194417568065,0.00651626498832276,-0.0229913211339191,0.00255243762030611,0.116825378510323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,23738,0.0108273722671281,0.00691452525545139,-0.00272509723355662,0.0243798417678128,0.117388172290104
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,22978,0.00591156534940752,0.00379318181089324,-0.00152307099994323,0.0133462016987583,0.119135324036583
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,23846,0.0075691287049508,0.00487353092028048,-0.00198299189879895,0.0171212493087005,0.120410180403107
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23163,0.0051619019023709,0.00332415624382506,-0.00135344433552623,0.011677248140268,0.120473659847993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,23056,-0.00398620447221758,0.00256966248978598,-0.0090227429521981,0.00105033400776294,0.120854069700395
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,22978,0.00382246785694054,0.00246746992925538,-0.00101377320440001,0.00865870891828109,0.121360730225488
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,28072,-0.00877301898274019,0.00567429641507289,-0.019894639956283,0.00234860199080267,0.122092152504768
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,23481,-0.00356216194180158,0.00230449230544901,-0.00807896686048164,0.000954642976878473,0.122179179194557
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,27702,-0.00503044037084704,0.00326631419297707,-0.0114324161890821,0.00137153544738801,0.123548162389321
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,22978,-0.00363968927961298,0.00236756730196526,-0.00828012119146489,0.00100074263223893,0.124230737389794
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,28496,-0.00531772650957707,0.00346055737270186,-0.0121004189600727,0.00146496594091857,0.124385829011071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,23071,-0.00380932029866662,0.00248094786363423,-0.00867197811138972,0.00105333751405648,0.124692106915246
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,27918,-0.00529094279297425,0.00344721299845027,-0.0120474802699368,0.00146559468398828,0.124832876100524
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,23393,-0.0077294706829704,0.00504784163216403,-0.0176232402820119,0.0021642989160711,0.125722949866459
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,28091,0.00609795289287383,0.00399667840689474,-0.00173553678463986,0.0139314425703875,0.127082103435315
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,23198,-0.00749866220534466,0.00491526721161269,-0.0171325859401055,0.00213526152941621,0.127126674116765
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,23636,0.00311407100864438,0.00204160842466761,-0.000887481503704136,0.00711562352099289,0.127196982073155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,23188,-0.00297247387901094,0.00195192217795215,-0.00679824134779714,0.000853293589775269,0.127811268117253
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,28033,-0.00229524429684665,0.00150774949067239,-0.00525043329856453,0.000659944704871234,0.127945670462604
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,28103,-0.00912355494011,0.00600143210419742,-0.0208863618643369,0.00263925198411694,0.128464527318832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,23725,0.00333221271606951,0.00219198001938486,-0.000964068121924817,0.00762849355406383,0.128478098701357
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,27544,-0.00749436815427315,0.00493287113031631,-0.0171627955696931,0.00217405926114682,0.128705774798804
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,22978,-0.00813694301929676,0.00535788565849972,-0.0186383989099562,0.00236451287136269,0.128855455958292
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,27562,-0.014180462692455,0.00933816479319795,-0.032483265687123,0.00412234030221297,0.128887481585252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,27562,0.00594288302876395,0.00392433422634155,-0.00174881205486549,0.0136345781123934,0.129944206460808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,23846,0.00745206366243966,0.00492110276850041,-0.00219329776382114,0.0170974250887005,0.129961085885768
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,28091,-0.00468146547913928,0.00309445710347917,-0.0107466014019584,0.00138367044367989,0.130327702504141
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,28187,0.00245022331582207,0.00162197585147012,-0.000728849353059358,0.0056292959847035,0.130891142566093
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,27544,-0.00332555359100874,0.00220294514051815,-0.00764332606642431,0.000992218884406828,0.131158434095811
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,23163,-0.00436727999403779,0.00291297502068569,-0.0100767110345817,0.00134215104650616,0.133822229550062
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,28187,-0.00237609484644545,0.0015851867132292,-0.00548306080437468,0.000730871111483776,0.133901208923271
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,23738,-0.00216247645316965,0.00144535153018297,-0.00499536545232827,0.000670412545988981,0.134625392524071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,28428,-0.00226792217052937,0.00152150239055426,-0.00525006685601572,0.000714222514956976,0.136082702477478
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,23188,-0.00487064382462493,0.00326950524032912,-0.01127887409567,0.00153758644642014,0.136311766068732
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23056,-0.00493542142445976,0.00332486475608603,-0.0114521563463884,0.00158131349746886,0.137717137257034
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,28320,-0.00922547703003177,0.00622514388196572,-0.0214267590386846,0.00297580497862105,0.138359385937561
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,23775,0.00280659930506027,0.0018956880125182,-0.000908949199475406,0.00652214780959595,0.138748448946795
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,27562,-0.0165201813125693,0.0111595742003698,-0.0383929467452941,0.00535258412015547,0.138788777050675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,23779,-0.00198386462118542,0.00134061979420278,-0.00461147941782287,0.00064375017545203,0.138936807794837
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",23071,-0.0039259452066763,0.00265379766667685,-0.00912738863336292,0.00127549822001032,0.139055462319065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,23393,0.00532106960697333,0.00360540204347136,-0.00174551839823054,0.0123876576121772,0.139994876581532
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,23276,0.00536787849282887,0.0036375912702115,-0.00176180039678568,0.0124975573824434,0.140046467774192
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,23056,-0.00615245490518361,0.00416998410749009,-0.0143256237558642,0.00202071394549698,0.140114810352992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,28239,-0.00463607242742182,0.00314386752037446,-0.0107980527673558,0.00152590791251211,0.140320540342768
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,23188,-0.00299085485427951,0.00202818686957935,-0.00696610111865503,0.000984391410096009,0.140321696884342
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,28428,-0.00456630802080713,0.00309783412944362,-0.0106380629145166,0.00150544687290237,0.140483933717844
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,27682,-0.00604073631012046,0.00410433007518023,-0.0140852232574737,0.00200375063723279,0.141087366055606
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",23775,-0.00543404799550476,0.00369959766922191,-0.0126852594271797,0.00181716343617018,0.141894493434261
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23163,-0.00470338261490374,0.00320495349951627,-0.0109850914739556,0.00157832624414816,0.142244061032035
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,27682,-0.00526828806423503,0.00359138988695071,-0.0123074122426584,0.00177083611418836,0.142408699358737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,27544,0.00321481816221082,0.00219296839846581,-0.00108339989878216,0.0075130362232038,0.142668840416684
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,27500,0.00604999529288851,0.00412852298591389,-0.00204190975950272,0.0141419003452797,0.142819444628056
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23163,-0.00411402644639819,0.00280865222674108,-0.0096189848108107,0.00139093191801432,0.142997558565587
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,23029,0.00339400633429798,0.00231909791495099,-0.00115142557900597,0.00793943824760192,0.143343499804841
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,27702,0.0053396842559427,0.00365166000300902,-0.00181756934995498,0.0124969378618404,0.143680732434257
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,27682,-0.00532791421876333,0.00364969598225724,-0.0124813183439875,0.00182548990646086,0.144349771927437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,23071,-0.00599384289967275,0.00410873164880378,-0.0140469569313282,0.00205927113198266,0.144632097973218
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,27562,-0.00832543022453848,0.00571238188860518,-0.0195216987262046,0.00287083827712768,0.145007502451079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,28452,0.00329994317979958,0.00226589425805441,-0.00114120956598706,0.00774109592558621,0.145305945215315
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,27702,-0.00382510230472939,0.0026313352793385,-0.00898251945223285,0.00133231484277407,0.146048189011667
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,23509,0.0107259525443948,0.00738655667060532,-0.00375169852999162,0.0252036036187812,0.146489654186216
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",23725,0.00503414016692326,0.00346832157817749,-0.00176377012630462,0.0118320504601511,0.146664230207356
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",28276,0.00842975867416586,0.00580969980005169,-0.00295725293393546,0.0198167702822672,0.146796506245672
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,23846,-0.00625719584393539,0.00433765567623266,-0.0147590009693514,0.00224460928148063,0.149166225440505
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,28521,-0.00262149618574105,0.0018214403722806,-0.00619151931541103,0.000948526943928924,0.150092529191259
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,23071,-0.00347399756476914,0.0024137615784091,-0.00820497025845098,0.0012569751289127,0.15009430977821
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,27544,0.00499377617263718,0.00347900846510587,-0.00182508041897032,0.0118126327642447,0.151183899367264
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,22978,-0.00515789070982957,0.00359359548547834,-0.0122013378613671,0.00188555644170798,0.151215000851085
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23188,-0.00341221915528215,0.00238906749478809,-0.00809479144506682,0.00127035313450251,0.153229355107006
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,26907,0.00270188262365554,0.00189219141623908,-0.00100681255217305,0.00641057779948413,0.153328832629595
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,23056,-0.00445580234367668,0.00312159626785831,-0.010574131028679,0.00166252634132561,0.153474875576157
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,23188,0.00553144414251291,0.00387859948141358,-0.00207061084105771,0.0131334991260835,0.153840045156499
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,28224,0.00378944242597189,0.0026705047295787,-0.00144474684400236,0.00902363169594614,0.155910477633143
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,27965,0.00375280000533614,0.00264583066432827,-0.00143302809674727,0.00893862810741955,0.156090260882301
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,27232,0.00343747228785612,0.00242412981531961,-0.00131382215017032,0.00818876672588255,0.156195443577511
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,23071,-0.00633126335559984,0.00447159481040763,-0.0150955891839988,0.00243306247279912,0.156822728578537
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,23163,-0.00361988744273368,0.00255708444143294,-0.00863177294794224,0.00139199806247489,0.156897087794712
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,23188,-0.00288788931331998,0.00204286744220275,-0.00689190950003738,0.00111613087339741,0.157479598751526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,28411,-0.00191089291556532,0.00135549400174374,-0.00456766115898305,0.000745875327852402,0.158627681832599
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,23198,0.00435388949726442,0.0030884445317381,-0.00169946178494225,0.0104072407794711,0.158631250541149
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,28428,-0.00271701290542752,0.00193023069625218,-0.00650026507008179,0.00106623925922675,0.159257389794872
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,23188,-0.00709678615075288,0.00504576741784403,-0.0169864902897272,0.00279291798822142,0.159594155099435
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,27481,0.0065999188964569,0.00469818740830071,-0.00260852842381249,0.0158083662167263,0.160098068018922
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,27544,-0.00676372310597936,0.00481663080577432,-0.016204319485297,0.00267687327333831,0.160257596233931
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23163,-0.00299640278164497,0.00213455887662587,-0.00718013817983168,0.00118733261654174,0.160404523033329
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",23795,-0.00445234177802122,0.00317249093432097,-0.0106704240092903,0.00176574045324789,0.160504261816105
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,23056,-0.00324486626523206,0.00231280985001188,-0.00777797357125535,0.00128824104079122,0.160631080825701
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23071,-0.00623162250246106,0.00445602576146314,-0.0149654329949288,0.00250218799000669,0.161985145125947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,23163,0.00422769557168718,0.00302601384465593,-0.00170329156383845,0.0101586827072128,0.16239176326158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,23862,0.00309514111536296,0.0022193872529623,-0.00125485790044314,0.00744514013116907,0.163151707656911
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23071,-0.00478697258070096,0.00343371152542113,-0.0115170471705264,0.00194310200912446,0.163297735422388
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,22829,0.0030762032348292,0.00220664895485517,-0.00124882871668693,0.00740123518634533,0.163312763121384
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,22978,-0.00519836035531361,0.00373374818799637,-0.0125165068037865,0.00211978609315927,0.163856179909596
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,23795,-0.0110501309313586,0.00795013748424658,-0.0266324004004819,0.00453213853776465,0.164563284685767
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,28428,0.00488243507578329,0.00351325603046625,-0.00200354674393057,0.0117684168954971,0.164625420753195
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,23198,-0.00450139719602032,0.00324006004717818,-0.0108519148884896,0.00184912049644892,0.164756596622737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,23393,-0.00566285256776575,0.00407764533480742,-0.0136550374239883,0.00232933228845679,0.164920327062275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,23775,0.00358148175568383,0.00258232667242005,-0.00147987852225947,0.00864284203362712,0.165479021298178
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,23725,-0.00379759548406721,0.0027399507956414,-0.00916789904352435,0.00157270807538992,0.165757298484652
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,23056,-0.00683422656407094,0.00493260851050709,-0.0165021392446648,0.00283368611652296,0.165907005062927
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,27985,-0.00461658814628712,0.00334094389117942,-0.0111648381729988,0.00193166188042454,0.167037547199057
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,22978,-0.00289950215550736,0.0020984239995752,-0.00701241319467475,0.00121340888366003,0.167061216090012
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,23188,-0.0112090816742616,0.00812408714299125,-0.0271322924745245,0.00471412912600121,0.167681780365632
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,22878,0.00406832039719492,0.00295741595762847,-0.00172821487975688,0.00986485567414671,0.168948612639894
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",23725,-0.00343351294804158,0.00249873222893936,-0.00833102811676272,0.00146400222067956,0.169423007742008
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23198,0.00193051576152387,0.00140763400278066,-0.00082844688392623,0.00468947840697396,0.170244427765025
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,27791,-0.0158556255667799,0.0115631454524816,-0.0385193906536438,0.00680813952008393,0.170317213209582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,27562,0.00403226576580509,0.00294672668361243,-0.00174331853407528,0.00980785006568546,0.171201782685414
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,23872,0.00553546875286357,0.00404574265614341,-0.00239418685317752,0.0134651243589047,0.17125589639213
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,28452,0.00238674845346702,0.00174620110739864,-0.00103580571703432,0.00580930262396836,0.171691485900059
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,23846,0.0025238607633787,0.00185032727266245,-0.00110278069103971,0.00615050221779711,0.172578004150443
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,23396,0.00230674868754249,0.00169146789655274,-0.00100852838970089,0.00562202576478586,0.172657650955895
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,22978,-0.00608318129642253,0.00446588395091565,-0.0148363138402172,0.00266995124737216,0.173165503590973
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,23738,0.00649275274761474,0.00476702584233999,-0.00285061790337165,0.0158361233986011,0.173206609838595
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,23725,-0.00511594472953921,0.00375645361498686,-0.0124785938149135,0.00224670435583504,0.173239817701479
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,23198,-0.0051641121534605,0.00379855508062568,-0.0126092801114868,0.00228105580456582,0.174003381918831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,23337,-0.00550148761565463,0.0040654340896713,-0.0134697384314104,0.00246676320010111,0.175993689522832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",23846,0.0027567109262326,0.00203744726358319,-0.00123668571039046,0.00675010756285565,0.176061443919649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,23664,-0.00423318978601285,0.00313188439826475,-0.0103716832066118,0.00190530363458606,0.176502458263174
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,23163,-0.00387613303868714,0.00286849723778261,-0.00949838762474105,0.00174612154736678,0.176620067744695
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,23757,-0.00217040440404168,0.00160879869332375,-0.00532364984295622,0.000982841034872865,0.177322886487938
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,23056,-0.00572810257685929,0.00425245569243459,-0.0140629157340311,0.0026067105803125,0.177990089797918
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,23738,-0.0126564129900338,0.0094050546971826,-0.0310903201965117,0.00577749421644413,0.178411087186019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,23071,-0.00502196190492879,0.00373292877907568,-0.0123385023119171,0.00229457850205955,0.178537036584689
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,23188,0.00757110986372581,0.00563028541420049,-0.00346424954810714,0.0186064692755588,0.178731561938521
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,27562,-0.00613041362166001,0.004559110713733,-0.0150662706205767,0.00280544337725667,0.178748976711461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,28187,0.00474584314455565,0.00353057037612802,-0.00217407479265527,0.0116657610817666,0.178889926307247
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,23071,-0.0046769389804183,0.00348748453515485,-0.0115124086693218,0.0021585307084852,0.17991297581014
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,28176,-0.00912169218811631,0.00680339279511069,-0.0224563420665333,0.00421295769030064,0.180010382282
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,22978,-0.00612750641037118,0.00457197804918619,-0.0150885833867761,0.00283357056603375,0.180183537342639
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,23071,-0.00327298750304964,0.00244252205224174,-0.00806033072544346,0.00151435571934417,0.18025749149291
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,28307,-0.00632326791763842,0.00472492232769166,-0.0155841156799141,0.00293757984463724,0.180816011813111
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,28496,0.00344353858060274,0.00257740986645941,-0.00160818475765771,0.00849526191886318,0.181544857281943
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,28134,-0.00610446368136884,0.00456947001569987,-0.0150606249121406,0.00285169754940292,0.181584996944872
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23198,-0.00361696314106974,0.00270871545239919,-0.00892604542777216,0.00169211914563267,0.181789428990885
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,22978,-0.00369885051748498,0.00277007995624146,-0.00912820723171824,0.00173050619674829,0.181795813430665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,23725,-0.00727260083513362,0.00546433482613459,-0.0179826970943574,0.00343749542409018,0.183227631595545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,27544,-0.00432124354541381,0.00324905937999351,-0.0106893999302011,0.00204691283937348,0.18352984029504
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,23725,-0.00497184674896371,0.00374656092255838,-0.0123151061571781,0.00237141265925073,0.184507298892909
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,23393,0.00473806299666542,0.00358679697280888,-0.00229205907003998,0.0117681850633708,0.186523199501133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,23862,-0.00277545209340808,0.00210967560719141,-0.00691041628350324,0.00135951209668708,0.188326892041248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,23056,-0.00859837030729486,0.00654151894043051,-0.0214197474305387,0.00422300681594894,0.188714543211657
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,23738,0.00609249982125104,0.00463777084141659,-0.00299753102792548,0.0151825306704276,0.188970027762255
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",28091,0.00294997906009648,0.00225006670067449,-0.00146015167322553,0.00736010979341849,0.189847223045928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,23056,-0.00292695857853076,0.00223991332561144,-0.00731718869672919,0.00146327153966767,0.191317977531084
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,27562,0.00540249433870917,0.00413586246267139,-0.00270379608812677,0.0135087847655451,0.191476488101612
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,27965,-0.00846314561509433,0.0064858756556281,-0.0211754619001254,0.00424917066993673,0.191952006403558
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,23337,-0.00752751056739189,0.0057699807952777,-0.0188366729261362,0.0037816517913524,0.192042337585866
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,23872,-0.00279820483860544,0.00214696559920103,-0.00700625741303946,0.00140984773582858,0.192474674367571
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,27562,0.00507763677882743,0.0038971074568569,-0.00256069383661209,0.0127159673942669,0.192611429789551
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,23600,-0.00262670747938202,0.00201702271806159,-0.00658007200678274,0.0013266570480187,0.192836937553755
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,23337,0.00728755696693846,0.00559786839185459,-0.00368426508109653,0.0182593790149735,0.192982235221445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,23071,-0.00351486097550217,0.00271197289109595,-0.00883032784205024,0.00180060589104589,0.194970151241532
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,23393,-0.00343673896109892,0.00265288189772171,-0.00863638748063348,0.00176290955843564,0.195169628877468
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,28428,-0.00529754401915885,0.00409036449655135,-0.0133146584323995,0.0027195703940818,0.195286732427433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,28187,-0.00249764984272996,0.00192864768369522,-0.00627779930277259,0.00128249961731267,0.195321703282014
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,28091,-0.00678290772700496,0.00523810157843643,-0.0170495868207404,0.00348377136673044,0.195359449144389
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,28411,0.00266115160359847,0.00205567420444483,-0.0013679698371134,0.00669027304431033,0.195489636220879
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,27910,0.00304187618273086,0.00235327710271312,-0.00157054693858685,0.00765429930404857,0.196155705000399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,23056,-0.00645535490532352,0.00500064282564826,-0.0162566148435941,0.00334590503294707,0.19674956742983
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,27702,-0.00516345190604828,0.00400125827419087,-0.0130059181234624,0.00267901431136583,0.196902794826041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,23198,-0.00796177356893424,0.00617721197966529,-0.0200691090490782,0.00414556191120972,0.197447681789028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,27544,-0.00340929425833555,0.00264688524545725,-0.00859718933943176,0.00177860082276066,0.197742840937961
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,28553,-0.00237696103374754,0.00184930188059606,-0.00600159271971581,0.00124767065222073,0.198687827814643
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,27942,0.00849392995988233,0.00660877840459712,-0.00445927571312802,0.0214471356328927,0.198715725720859
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,23725,0.0030125166021628,0.0023458120789447,-0.00158527507256882,0.00761030827689442,0.199080844955101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,23188,0.00499830018707778,0.0039023709442449,-0.00265034686364223,0.0126469472377978,0.200263824587431
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,23755,-0.00264199754568344,0.002063449420931,-0.00668635841070819,0.00140236331934131,0.200424344298805
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,23348,-0.0043716195785232,0.00341803995196692,-0.0110709778843784,0.00232773872733196,0.200915288907464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,27831,-0.00328035602066643,0.00256865425180724,-0.00831491835420862,0.00175420631287576,0.201587543896499
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,23862,0.00526143171793596,0.00412079600700487,-0.00281532845579359,0.0133381918916655,0.201685350997569
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,28307,-0.00538762862482212,0.00422087344225986,-0.0136605405716514,0.00288528332200721,0.201815780256737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,28187,0.00290158362407341,0.00227430899900357,-0.0015560620139736,0.00735922926212041,0.202033605123058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,23795,0.00306124768099102,0.00240064889679824,-0.00164402415673353,0.00776651951871558,0.202259732209722
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,28362,0.00705686621575085,0.00554129688467526,-0.00380407567821265,0.0179178081097144,0.202849538120167
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',23071,-0.00369847899836425,0.00290670308005622,-0.00939561703527444,0.00199865903854593,0.203245087165811
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,23198,-0.00872572586929079,0.00686474135453557,-0.0221806189241805,0.00472916718559893,0.203708256719372
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,27562,0.00835885275165439,0.00660375971174626,-0.00458451628336827,0.0213022217866771,0.205605502111541
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,28187,-0.00205601794716965,0.00162512064471319,-0.0052412544108075,0.00112921851646821,0.205828783867599
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",28121,0.00578302701361136,0.00457155673153881,-0.00317722418020471,0.0147432782074274,0.205881207970009
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,23163,-0.00538582546781544,0.00425807732011878,-0.0137316570152482,0.00296000607961736,0.205938142413417
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,28176,-0.00314182198410428,0.00249160780837692,-0.00802537328852305,0.00174172932031449,0.207333097349067
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,23725,-0.00824063043572811,0.0065455876941772,-0.0210699823163154,0.00458872144485921,0.208057320479584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,22978,-0.00401753629183614,0.00319175367870455,-0.0102733735020971,0.00223830091842477,0.208142910793173
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,23778,-0.00550750791036788,0.00438198218528193,-0.0140961929935205,0.0030811771727847,0.208819185915283
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,23163,-0.0035236067117353,0.00280847450502374,-0.00902821674158182,0.00198100331811122,0.209624437072201
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,27544,0.00326362349777295,0.00260131279835364,-0.0018349495870002,0.00836219658254609,0.209632356263082
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,28237,0.00420285339009924,0.00335869819986946,-0.00238019508164491,0.0107859018618434,0.210823002815073
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23071,-0.00513475957784753,0.00411422797088297,-0.0131986464007781,0.0029291272450831,0.212025656054841
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,23188,-0.00652809437024273,0.00523542043970226,-0.0167895184320592,0.0037333296915737,0.212443363101491
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,23846,0.00887456965187047,0.00712267001046616,-0.00508586356864319,0.0228350028723841,0.212790930446235
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,23738,-0.00488817685369576,0.00393702427397,-0.012604744430677,0.00282839072328543,0.21439950261865
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,28305,-0.00322359366692765,0.00259917046322472,-0.0083179677748481,0.0018707804409928,0.214897137975791
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,23393,-0.00598721983189319,0.00483653081740397,-0.015466820234005,0.00349238057021859,0.215759567512426
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,23862,-0.00330483330267159,0.00267467381071351,-0.00854719397167006,0.00193752736632688,0.216618574164597
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,23872,-0.00393187648691732,0.00318954766020208,-0.0101833899009134,0.00231963692707876,0.217685690040489
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,28182,-0.00374209694953204,0.00303811062770278,-0.00969679377982949,0.0022125998807654,0.218064553357442
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,23795,0.00487637798807148,0.00396205394888985,-0.00288924775175263,0.0126420037278956,0.218420991449077
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,28529,0.00280941498588676,0.00228818134634155,-0.00167542045294267,0.00729425042471619,0.21953449965387
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,23725,0.00361594322468481,0.00294626592269247,-0.00215873798379244,0.00939062443316205,0.21972318083161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,28176,-0.00691440350825515,0.00564878278101746,-0.0179860177590494,0.00415721074253908,0.220942875439262
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,22978,-0.00215529605215299,0.00176198961667357,-0.00560879570083319,0.00129820359652721,0.221260212760269
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,23337,-0.00176818299285579,0.00144711674036855,-0.00460453180397814,0.00106816581826657,0.221770588690056
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,22978,0.00549269331114102,0.00449821184663057,-0.0033238019082549,0.0143091885305369,0.222066854847036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,23188,-0.00420773116428971,0.00345419895585596,-0.0109779611177674,0.00256249878918798,0.223179520305451
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,27562,-0.00635497327646214,0.00522178492623526,-0.0165896717318832,0.00387972517895897,0.223610195452883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,23163,-0.00564716104885166,0.00464229599143511,-0.0147460611920645,0.00345173909436115,0.223822661941279
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,22978,-0.00337278955416712,0.00277939734496754,-0.00882040835030349,0.00207482924196926,0.224952449704936
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,23188,0.00448560076420974,0.00369905819050863,-0.00276455328918718,0.0117357548176067,0.22528245193992
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,23725,0.00286349394452693,0.00236324284763539,-0.00176846203683843,0.00749544992589229,0.225646996790133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,23393,-0.00339008802205688,0.00281197033457211,-0.00890154987781821,0.00212137383370446,0.227987172734462
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,27346,-0.00543674835804813,0.00451148654096692,-0.0142792619783433,0.00340576526224704,0.228178904296154
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,27544,0.00553084408849997,0.00459032141682628,-0.00346618588847954,0.0145278740654795,0.228255141446793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,23795,0.00503177513556848,0.00418316626745089,-0.00316723074863526,0.0132307810197722,0.229041388929853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,22978,-0.00210496010308386,0.00175514592898517,-0.0055450461238948,0.00133512591772707,0.230420679659923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",23071,-0.00414663555241233,0.00346476737302267,-0.0109375796035368,0.0026443084987121,0.231396602932049
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,23188,-0.00728770583627882,0.00609375663238814,-0.0192314688357596,0.00465605716320193,0.231736147455198
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,23393,-0.00286447236647879,0.00239595983637318,-0.00756055364577021,0.00183160891281264,0.231887177630976
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,28276,-0.0024147903216373,0.00202464643873174,-0.0063830973415515,0.0015535166982769,0.232997960414561
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,22936,0.00703145678340153,0.00590695444513726,-0.00454617392906749,0.0186090874958706,0.233913631221948
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,23393,-0.0035163785086896,0.00295429774095925,-0.00930680208096973,0.00227404506359052,0.233956824546719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,27562,0.0082936368105058,0.00696808774633536,-0.00536381517231151,0.0219510887933231,0.233965712923597
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,27702,0.00330251362039643,0.00278185679365933,-0.00214992569517586,0.00875495293596873,0.235174060982945
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,27965,0.00282996775324179,0.00239570408640164,-0.00186561225610544,0.00752554776258901,0.237506462189905
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,28091,-0.00242905204845075,0.0020564314134309,-0.00645965761877531,0.00160155352187381,0.237534201350184
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",23846,-0.00584649581361915,0.00495339822495335,-0.0155551563345277,0.00386216470728942,0.237892707484384
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,23747,0.00512049222864986,0.00433903221096656,-0.0033840109048446,0.0136249953621443,0.237972243615382
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,27702,-0.0112763574538705,0.00955932409725704,-0.0300126326844943,0.00745991777675326,0.238162037769038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,23198,-0.00197592789817831,0.00167724805865976,-0.00526333409315144,0.00131147829679481,0.238777874807869
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,22978,-0.00240655479347001,0.00204308468028347,-0.00641100076682561,0.0015978911798856,0.238847637782505
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,28278,-0.00223360997009415,0.00189751130291643,-0.00595273212381035,0.00148551218362206,0.239155114622464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,27489,-0.00275392370745516,0.00233995091543132,-0.00734022750170056,0.00183238008679023,0.239239566030888
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,23163,0.00548637852037222,0.00466448499495337,-0.00365601206973639,0.0146287691104808,0.239526094648987
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23393,-0.00393153033120984,0.00334272216425147,-0.0104832657731427,0.00262020511072304,0.239548391744673
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,23140,0.00460685333621495,0.00392334631806796,-0.00308290544719825,0.0122966121196282,0.240320884284436
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,23188,-0.0045206122384505,0.00385011369794495,-0.0120668350864226,0.0030256106095216,0.240346886075563
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",23790,0.00179777517116744,0.00153201199391575,-0.00120496833690743,0.0048005186792423,0.240617812678507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,28224,-0.0096313981078958,0.00820803213820678,-0.0257191410987811,0.00645634488298949,0.240640793171317
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,27682,0.00739474407766808,0.00630972886685565,-0.004972324501369,0.0197618126567052,0.241223574138075
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,28129,-0.00322314239872829,0.00275775558781701,-0.00862834335084963,0.00218205855339305,0.242512006877413
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,28061,-0.00329100183357431,0.00282693911576186,-0.00883180250046756,0.00224979883331894,0.244370170000271
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,28452,-0.00253241200216223,0.00217669195353214,-0.00679872823108522,0.00173390422676076,0.244667959657483
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,28184,-0.00264068806165248,0.00226979212125969,-0.00708948061932148,0.00180810449601652,0.244674976307216
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,23071,-0.00302295422384396,0.00259854177920723,-0.00811609611109013,0.00207018766340221,0.244708829696311
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,28195,0.0231455210585174,0.0199607693567008,-0.0159775868806161,0.0622686289976509,0.246241669023388
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,27562,-0.00588492859690166,0.00508348265655777,-0.0158485546037549,0.00407869740995158,0.247014130151242
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,23725,0.00265898343909891,0.00229878562733217,-0.00184663639047214,0.00716460326866995,0.247410495849607
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,27682,0.00379648644788284,0.0032882240118696,-0.00264843261538158,0.0102414055111473,0.248276323935641
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,23056,0.00659604330277568,0.00573221988884886,-0.00463910767936809,0.0178311942849195,0.249869206003771
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,28187,-0.00338319376743818,0.00295659430261188,-0.00917811860055746,0.0024117310656811,0.252514166292791
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,23393,-0.00294773636462096,0.00257773686258392,-0.00800010061528545,0.00210462788604352,0.252827589955345
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,27562,-0.00376593951984144,0.00329334659928758,-0.0102208988544451,0.00268901981476222,0.252841283250683
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,23393,-0.00644379846799849,0.00564119887824707,-0.0175005482693627,0.00461295133336576,0.253351573603719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,23872,-0.00170718110710988,0.00149559410794762,-0.00463854555868721,0.00122418334446745,0.253684371899062
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,23738,-0.00263293438414061,0.00230790393356286,-0.00715642609392382,0.00189055732564259,0.253950685808069
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,23198,-0.00589567520185661,0.00518366656040397,-0.0160556616602484,0.00426431125653518,0.255401172014777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23071,0.00311048810979313,0.00274124661186842,-0.00226235524946897,0.00848333146905523,0.256513509272007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,27562,-0.0030252869204533,0.00266808690970213,-0.00825473726346947,0.00220416342256287,0.256855299330369
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,28291,-0.00211761967684632,0.00186984849360781,-0.00578252272431762,0.00154728337062498,0.257430233920099
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,28320,0.00215413677865159,0.00190466635764649,-0.00157900928233553,0.0058872828396387,0.258073705567132
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,28159,-0.00975924575565222,0.00863879457235603,-0.02669128311747,0.0071727916061656,0.25861230804458
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,28452,0.00126456737725834,0.00111975460372538,-0.000930151646043413,0.00345928640056009,0.258770092489234
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,28224,0.00340898755639989,0.00303210084613385,-0.00253393010202245,0.00935190521482224,0.26089582396793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23071,-0.00303887960062294,0.00270317484047899,-0.00833710228796177,0.00225934308671588,0.260944530340743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,28233,-0.00802254845283493,0.00713880870155854,-0.0220146135078897,0.0059695166022198,0.261110102204563
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,23725,0.00204810861377157,0.00182320820288325,-0.00152537946387959,0.00562159669142273,0.261298461704257
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,28553,0.00336442190318846,0.00300238444676324,-0.00252025161246749,0.00924909541884441,0.262474701821408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",22978,-0.00432742067852239,0.00387088478999721,-0.0119143548669169,0.00325951350987215,0.263603902518354
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,28091,0.00336187193955023,0.00301325035124336,-0.00254409874888676,0.00926784262798722,0.264561750249867
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,23188,-0.00164404191672147,0.0014737571124931,-0.00453260585720794,0.001244522023765,0.264628647647691
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,23071,0.0038356658618381,0.00344465148651882,-0.00291585105173879,0.010587182775415,0.265499570404719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,23862,-0.00190592692681163,0.00171256843796684,-0.00526256106522664,0.00145070721160338,0.265760211926252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,23738,0.0129299338828274,0.0116281018892469,-0.0098611458200965,0.0357210135857512,0.266168476753464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,23071,-0.004668738539479,0.00420103965046629,-0.0129027762543929,0.00356529917543492,0.26643821138869
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,23663,0.00331174015663614,0.00298187884146729,-0.00253274237263975,0.00915622268591203,0.266742393299028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,22978,-0.002291278630339,0.00206632695479453,-0.00634127946173627,0.00175872220105827,0.267499830174487
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,23071,-0.00342569574883055,0.00309900927376725,-0.00949975392541436,0.00264836242775327,0.268990724643127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,27562,-0.00353661973439816,0.00320343335665308,-0.00981534911343819,0.00274210964464187,0.26959881202715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,23393,0.00367441024727465,0.00333569106504642,-0.00286354424021634,0.0102123647347656,0.270671336051815
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,27562,0.00539827198935551,0.00490615208306059,-0.00421778609344325,0.0150143300721543,0.271208130150019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,28176,-0.00280358053426116,0.002548923810304,-0.00779947120245699,0.00219231013393468,0.271381808288216
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,28521,-0.00344049877036123,0.00312843724759044,-0.00957223577563849,0.00269123823491604,0.271450362837549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,23198,0.00535221391728259,0.00487179830867303,-0.00419651076771655,0.0149009386022817,0.271948944015287
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,23163,-0.00269065579279965,0.00244931675025868,-0.00749131662330666,0.00211000503770737,0.271983149420215
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,28428,0.00346021003045075,0.00315103488032613,-0.00271581833498846,0.00963623839588997,0.272162006865154
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,27562,0.00329445883809986,0.00300225297419401,-0.00258995699132039,0.00917887466752011,0.272507250161244
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,23862,0.00649833719375577,0.0059243352950665,-0.00511335998457458,0.0181100343720861,0.272701069072299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,27965,-0.00315950847248306,0.00288210729845507,-0.00880843877745499,0.00248942183248887,0.272979079848004
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,23198,0.00308837582315153,0.00281790050776001,-0.00243470917205809,0.00861146081836115,0.273096857671208
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,23056,-0.00253828305385443,0.00232123051954989,-0.00708789487217221,0.00201132876446335,0.274182455897188
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,23775,0.0028214736363757,0.00258239783736141,-0.00224002612485266,0.00788297339760406,0.274589766156965
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,27544,0.00441213991914826,0.00404749292467709,-0.00352094621321883,0.0123452260515153,0.275682132669131
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,23056,-0.00551090496848272,0.00505935689881833,-0.0154272444901667,0.00440543455320121,0.276055006288086
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,27682,-0.00422530389587102,0.00388001037315188,-0.0118301242272487,0.00337951643550667,0.276166484919179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,23862,0.00166156633651691,0.00152983106160609,-0.00133690254423103,0.00466003521726486,0.277440866575439
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,23795,-0.0055947616501396,0.00515278923702941,-0.0156942285547172,0.00450470525443805,0.277590249704142
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,22978,-0.00424021004426726,0.00391057677181409,-0.0119049405170229,0.00342452042848834,0.278246401983066
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,28176,0.00283283017282058,0.00261840579070644,-0.00229924517696405,0.00796490552260521,0.279310141002196
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,27682,0.00354406653501228,0.00328359505714306,-0.00289177977698811,0.00997991284701267,0.280452240026339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,28091,0.00558321642163273,0.00517775407519358,-0.00456518156574668,0.0157316144090121,0.280905352290801
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,23735,0.00425042598966526,0.00394637064449998,-0.0034844604735547,0.0119853124528852,0.281470298409373
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,28307,0.00158401172968736,0.00147182723614182,-0.0013007696531506,0.00446879311252532,0.281837500538085
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,23647,0.00349883984971957,0.00325103522222974,-0.00287318918585071,0.00987086888528985,0.281838388667481
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,23653,-0.00203983943284105,0.0018970316639752,-0.00575802149423245,0.00167834262855034,0.282260545128876
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,27702,-0.00471291056577468,0.00439167264350521,-0.0133205889470449,0.00389476781549554,0.283214493916679
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,23687,0.00373917841802134,0.00348545330054282,-0.00309231005104258,0.0105706668870853,0.283373841468442
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,27544,-0.00566647009103621,0.00528314325204347,-0.0160214308650414,0.00468849068296899,0.283479513888364
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,28224,-0.00493205698613366,0.0046133913036869,-0.01397430394136,0.00411018996909266,0.285045445290665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,22978,0.00412973004839786,0.00387096450768675,-0.00345736038666818,0.0117168204834639,0.286051776031833
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,22978,-0.00241077361719833,0.00227022668336106,-0.006860417916586,0.00203887068218934,0.288288272200153
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,28521,-0.00451975905621622,0.00425718492216161,-0.012863841503653,0.00382432339122054,0.28839093942275
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,23872,0.00197219098553122,0.00186262605558336,-0.00167855608341217,0.00562293805447461,0.289691195440272
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,28521,-0.00247304284499938,0.00233729258702591,-0.00705413631557017,0.0021080506255714,0.290027877855664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,23163,0.00573593401945982,0.00542133331450494,-0.00488987927696987,0.0163617473158895,0.290052744141713
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,27562,-0.00221905994491471,0.00209926483596205,-0.00633361902340032,0.0018954991335709,0.29049107074888
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,23893,-0.00137008972572401,0.00130199932393477,-0.00392200840063617,0.00118182894918815,0.292674046340024
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,28068,-0.00256554880704301,0.0024393012341713,-0.00734657922601877,0.00221548161193275,0.292920739736155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,28404,0.00405329184832423,0.00386208106071215,-0.00351638703067158,0.01162297072732,0.29395248979632
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,28091,0.00606793414311207,0.00578310659247239,-0.00526695477813382,0.017402823064358,0.294071343180627
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,23393,-0.00441883146815649,0.00422909674420749,-0.0127078610868032,0.00387019815049018,0.296096575715525
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,23056,-0.00494511243790272,0.00474203820393922,-0.0142395073176236,0.00434928244181816,0.297040638164271
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,23862,-0.00233853778734264,0.00224679034110431,-0.00674224685590708,0.0020651712812218,0.297962733806301
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,23188,0.00312664155306439,0.00301048888387902,-0.0027739166593385,0.00902719976546727,0.299009709692356
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,23795,-0.00367972785131666,0.00355206968805087,-0.0106417844398964,0.00328232873726306,0.30024109176201
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,27965,-0.00391947910157684,0.0037836752294498,-0.0113354825512984,0.00349652434814476,0.300261467246226
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,28404,0.00360808601925284,0.00348387966075143,-0.00322031811581996,0.0104364901543256,0.300373467521538
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,23163,0.00342387813893858,0.00331561596847572,-0.00307472915927384,0.009922485437151,0.301777476385036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,27411,-0.00465604724101829,0.0045184935268909,-0.0135122945537244,0.00420020007168787,0.302811482297123
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,23393,-0.00199594270911187,0.00193838724965394,-0.00579518171843358,0.00180329630020985,0.303165054957268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,22978,-0.00440200748862946,0.00427943550867268,-0.0127897010856279,0.00398568610836899,0.303658725526645
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",27544,-0.00295117788621128,0.002869555215223,-0.00857550610804835,0.0026731503356258,0.303749884924727
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,28320,-0.00282423574254119,0.00274962931277582,-0.00821350919558179,0.0025650377104994,0.304366492255951
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,23393,0.00415886848993244,0.00405100410564743,-0.00378109955713653,0.0120988365370014,0.30460695478797
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,23056,-0.00427703297548207,0.00418384213176925,-0.0124773635537498,0.00392329760278566,0.30666197406165
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,23198,0.00594612698200495,0.00582519244184729,-0.00547125020401574,0.0173635041680256,0.307378522703266
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,28224,-0.00194777182047597,0.001912753807906,-0.00569676928397173,0.00180122564301978,0.308540510628845
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,23188,-0.00289232305017364,0.00284213658736657,-0.00846291076141212,0.00267826466106484,0.308851135089634
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,23738,0.00323029300649483,0.00317563835196334,-0.00299395816335331,0.00945454417634298,0.309063625837924
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,28176,-0.00384630143189163,0.00378148951123765,-0.0112580208739174,0.00356541801013417,0.30909592541007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23056,0.00408959787460946,0.00402217933635035,-0.00379387362463723,0.0119730693738562,0.309277484745266
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,23828,-0.00327539952950625,0.0032219434136356,-0.00959040862023202,0.00303960956121951,0.309358239359331
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,28143,0.0017693717558162,0.00174444799706191,-0.00164974631842515,0.00518848983005755,0.310454322457591
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,27918,0.0022995458771802,0.00226745801595793,-0.00214467183409734,0.00674376358845774,0.310519275299137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,23198,-0.00203877208755115,0.0020135689879992,-0.00598536730402958,0.00190782312892728,0.311301665700628
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,27910,-0.00330225552986522,0.00326372578048691,-0.00969915805961956,0.00309464699988913,0.311639859685197
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,28218,-0.00148373874610918,0.00146646241875121,-0.00435800508686156,0.00139052759464319,0.311651477816932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23056,0.00371968160506504,0.00368080979495067,-0.00349470559303827,0.0109340688031683,0.312237360322145
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,28206,-0.00262115243460385,0.002598736821245,-0.00771467660424406,0.00247237173503635,0.313162891134212
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,23071,0.00669694638878998,0.00664089719464364,-0.00631921211271156,0.0197131048902915,0.313253859235798
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,27562,0.00430099403557443,0.00427091020380993,-0.00406998996389305,0.0126719780350419,0.313922527182339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,28182,-0.00202643730698269,0.00201244958513506,-0.0059708384938474,0.00191796387988203,0.313967166278245
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,27682,-0.00908130969053449,0.00902921102644904,-0.0267785633023746,0.00861594392130562,0.314535011101916
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,27966,-0.0030819414618365,0.00307418496344221,-0.00910734399018323,0.00294346106651024,0.316099690469128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,23543,-0.00210137922170222,0.00209944810078674,-0.00621629749924423,0.00201353905583979,0.316875865332956
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,23795,0.00416219581068922,0.00416594894486591,-0.00400306412124797,0.0123274557426264,0.317756856363118
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,28521,0.00589386053047248,0.00590152250411472,-0.00567312357759237,0.0174608446385373,0.31794769613719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,23071,-0.00225252877958896,0.00225916303925171,-0.00668048833652231,0.0021754307773444,0.318744200782901
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,23188,-0.00442561237859265,0.0044411363691455,-0.0131302396621178,0.00427901490493253,0.319015486339067
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,23370,-0.00673650804232525,0.00677527973025794,-0.0200160563136308,0.0065430402289803,0.320098097876426
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,27562,0.00224017210112763,0.00226366079791039,-0.00219660306277673,0.00667694726503198,0.322366832399202
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,23261,-0.00560201454462936,0.00566472090569475,-0.0167048675197911,0.00550083843053236,0.322707502767363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,28307,-0.00633962167010012,0.00641905519773339,-0.0189209698576576,0.00624172651745732,0.323344609609575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,28176,-0.00450481329030324,0.00456185323281065,-0.0134460456266121,0.00443641904600564,0.32340786888447
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,23393,-0.00291880183763677,0.00295632426035135,-0.00871319738792543,0.00287559371265188,0.323502012809493
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,27702,0.0021984940182587,0.00222886646140387,-0.00217008424609289,0.00656707228261028,0.323958658155236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23056,-0.0043300334779511,0.00439788408246753,-0.0129498862795874,0.00428981932368525,0.324844692293211
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,23198,-0.0018484240961225,0.00187968485185946,-0.00553260640576704,0.00183575821352205,0.325436049520821
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,28191,0.00376694463626751,0.00383220280633222,-0.00374417286414364,0.0112780621366787,0.325630098867788
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,23775,0.00384917026590814,0.00391954992925478,-0.00383314759543124,0.0115314881272475,0.32608819923472
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,23337,0.00245068891223887,0.00249567796845345,-0.00244083990592989,0.00734221773040762,0.326123231240031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,23056,0.0036221305434609,0.00369605686973162,-0.00362214092121308,0.0108664020081349,0.327097100740089
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,23163,-0.00409991595878044,0.00418467257794793,-0.0123018742115584,0.00410204229399751,0.327221783094424
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,22978,-0.00573180183134599,0.00585174332864225,-0.0172012187554848,0.00573761509279282,0.327341683489907
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,23163,0.00196697973348099,0.00200825747672902,-0.00196920492090788,0.00590316438786987,0.32736989814374
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,28176,0.00537296258505387,0.00549214558310828,-0.00539164275783836,0.0161375679279461,0.327934683123102
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,28320,0.0019176286100709,0.00196111433069707,-0.00192615547809535,0.00576141269823716,0.32816873897243
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,23056,-0.00199636152536116,0.00204341803279413,-0.00600146086963767,0.00200873781891534,0.328593435193672
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,22978,-0.00419690084314473,0.00430868076812114,-0.0126419151486622,0.00424811346237271,0.330038477611313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,23725,0.00377943325939204,0.00388360102120741,-0.00383242474217449,0.0113912912609586,0.330475002825179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,28224,0.00709155386020464,0.00730043344827848,-0.00721729569842118,0.0214004034188305,0.331363402321857
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,28087,0.00228124070127023,0.00234873845673913,-0.00232228667393846,0.00688476807647892,0.331426133174777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23198,0.0027622376439237,0.00284515690404874,-0.00281426988801184,0.00833874517585924,0.331630121237585
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,22978,-0.00396376738791738,0.00408316001614666,-0.0119667610195648,0.00403922624373008,0.331678155717961
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,28391,-0.0018386792700161,0.00189802293297599,-0.00555880421864905,0.00188144567861684,0.332686200824957
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,23775,0.0017255402899546,0.00178411620064303,-0.00177132746330574,0.00522240804321493,0.333469846259301
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23198,0.00448860142349753,0.00465916405325578,-0.0046433601208838,0.0136205629678789,0.33536088247652
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,23872,-0.00149612304084923,0.00155346733389154,-0.00454091901527664,0.00154867293357818,0.33551399872142
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,28210,-0.00259664951113394,0.00269715013798219,-0.00788306378157903,0.00268976475931116,0.335687169679647
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,23071,-0.00718777340584382,0.00746750065481115,-0.0218240746892737,0.00744852787758604,0.335788156545762
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,23393,-0.00464641363379971,0.00483125792191725,-0.0141156791607575,0.00482285189315809,0.336190208144853
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,28176,-0.00237520590560509,0.00247425195608453,-0.00722473973953077,0.00247432792832059,0.337078910273512
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,23163,0.00594776644170171,0.0062020987948646,-0.0062083471962329,0.0181038800796363,0.337572521873882
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,23163,-0.00373406679861414,0.0039077409010732,-0.0113932389647176,0.00392510536748934,0.339306380161537
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,27544,-0.0030500865142765,0.00320353155064117,-0.0093290083535332,0.0032288353249802,0.341053974921649
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,23738,0.00344419096736864,0.00361959017638981,-0.00365020577835538,0.0105385877130927,0.341339157618032
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,27544,-0.0043514780286079,0.00459111732088277,-0.0133500679775381,0.00464711192032232,0.343237710983167
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,27544,0.00543201716007642,0.00573223972645413,-0.00580317270377367,0.0166672070239265,0.343328402155221
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,28176,0.00954541811146347,0.0100949836466462,-0.010240749835963,0.0293315860588899,0.344380895114461
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,27544,0.00325024281653159,0.00344242964632831,-0.00349691929027189,0.00999740492333507,0.345090472599607
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,23056,-0.00356627655032247,0.00379790257907421,-0.0110101656053079,0.00387761250466299,0.347734364742547
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,23056,-0.00279568964456566,0.00297764141533885,-0.00863186681862982,0.00304048752949849,0.347795014057253
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,27702,0.00273966507633426,0.00292351055891552,-0.00299041561914016,0.00846974577180869,0.34870767179983
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,28452,0.00339747829262167,0.00362651211928788,-0.00371048546118257,0.0105054420464259,0.348846455951587
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,23795,0.00478693692558962,0.00511415417565315,-0.00523680525869055,0.0148106791098698,0.349273770998448
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,23872,0.00154861555241705,0.0016550972712494,-0.00169537509923178,0.00479260620406588,0.349455489156227
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,27682,-0.00449768818480303,0.00481650016576691,-0.0139380285097062,0.00494265214010012,0.350410898599061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,23393,0.00709259715366763,0.00760688656730856,-0.00781690051825714,0.0220020948255924,0.351143811771464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,23725,0.00481935111372119,0.00517107019929708,-0.00531594647690109,0.0149546487043435,0.351354640884501
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,23846,0.00191226337908303,0.00205206564460608,-0.00210978528434488,0.00593431204251094,0.351411902189023
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,27702,-0.00180492770186475,0.00193693955007784,-0.00560132922001731,0.00199147381628782,0.35142468875595
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23056,-0.00206148975617369,0.00221829903925622,-0.00640935587311588,0.00228637636076851,0.352737657813273
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,22940,-0.00304950312413399,0.00328714818076729,-0.00949231355843788,0.0033933073101699,0.353570487687846
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,28439,0.00224687638756302,0.00242344685354505,-0.00250307944538527,0.00699683222051131,0.353861321224631
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,23056,0.00529520610408509,0.00572452209879315,-0.00592485720954949,0.0165152694177197,0.354973489813068
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,28176,0.00531888279907792,0.00575984482614143,-0.00597041306015927,0.0166081786583151,0.355784808770522
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",23775,0.00372868515435483,0.00404287813954412,-0.00419535599915163,0.0116527263078613,0.356389392214272
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23071,0.0020928408978575,0.00227097020232382,-0.00235826069869719,0.00654394249441219,0.356766486982593
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,27544,-0.00383954113936985,0.00417186672197285,-0.0120163999144366,0.00433731763569693,0.357402510320549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,27702,0.00392096541356034,0.00426154453713912,-0.00443166187923235,0.012273592706353,0.357538539642393
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",28176,0.00267704933639226,0.00291613042949712,-0.00303856630542209,0.00839266497820662,0.358619258973854
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,22978,0.00378808789564674,0.00412911128273222,-0.00430497021850842,0.0118811460098019,0.358937480154185
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,28091,0.0116841548208827,0.0127367315916447,-0.013279839098741,0.0366481487405063,0.358962451558923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,22978,0.00209091202882501,0.00228179414981423,-0.00238140450481089,0.0065632285624609,0.359495280898226
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,23725,0.00339670840495926,0.00372383627324341,-0.00390201069059781,0.0106954275005163,0.361697458496165
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,23393,-0.0045006005078296,0.00494974966931415,-0.0142021098596853,0.00520090884402613,0.363223219110865
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,23355,-0.00324734588552693,0.00357362925343707,-0.0102516592222636,0.00375696745120973,0.36351951419602
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,23071,0.00695263050302991,0.00765308858160267,-0.00804742311691132,0.0219526841229711,0.363637442738234
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,23163,0.00410371548592734,0.00451885165658205,-0.00475323376097348,0.0129606647328282,0.363817741283737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,28320,0.0026168323842701,0.00288271649601565,-0.00303329194792058,0.00826695671646078,0.364009527092236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",23675,0.00664247552853351,0.00734736788319695,-0.0077583655225325,0.0210433165795995,0.365971772403733
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,23775,-0.0082940012808964,0.00917506714837682,-0.026277132891715,0.00968913032992216,0.36601955892617
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23198,0.00381466821896706,0.0042199931217265,-0.00445651829961688,0.012085854737551,0.366030624022167
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,22978,-0.00194814099995428,0.0021559153173892,-0.00617373502203712,0.00227745302212856,0.366203261771665
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,27702,-0.00275404009721476,0.0030513375704773,-0.00873466173535026,0.00322658154092074,0.36676298988381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,27702,-0.00295358399858166,0.00327338415243357,-0.00936941693735146,0.00346224894018813,0.366903837013937
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,23188,-0.00194423779323314,0.00215901803438271,-0.00617591314062324,0.00228743755415697,0.367853222373985
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,23775,0.00650087582262147,0.007233451290674,-0.00767668870709957,0.0206784403523425,0.368808830623399
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,23056,-0.00250214336895744,0.00278970751292889,-0.00796997009429806,0.00296568335638319,0.36977118695223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,23188,0.00246315319057269,0.00274632275184505,-0.00291963940304362,0.00784594578418899,0.36978619957719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,28344,0.00197462081337979,0.00220307667115085,-0.00234340946207588,0.00629265108883546,0.370099401110347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,23795,0.00644300330561826,0.00719712713625493,-0.00766336588144141,0.0205493724926779,0.370679213369079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,23071,-0.00542521580524708,0.00606546333755757,-0.0173135239468599,0.00646309233636575,0.37109384681568
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,28390,0.00245449387273189,0.00274845687366847,-0.00293248159965832,0.00784146934512209,0.371840998088408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23056,0.00193926961140804,0.00217283106180937,-0.00231947926973834,0.00619801849255441,0.372129902404551
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,23188,0.00233757895119351,0.00262456521475339,-0.00280656886972314,0.00748172677211015,0.373124179842285
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,23056,-0.00287434624549571,0.00323151003042484,-0.00920810590512839,0.00345941341413698,0.37375732845043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,27702,-0.00178304041727977,0.00202490645988297,-0.00575185707865039,0.00218577624409086,0.378566658516296
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,22978,0.00474273613485612,0.00541192061500764,-0.00586462827055885,0.0153501005402711,0.380849007742579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,23795,0.0039414421254954,0.0044986583843049,-0.00487592830774221,0.012758812558733,0.380964281300913
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,23337,0.00404314525630925,0.00465610669915592,-0.00508282387403636,0.0131691143866549,0.385209929266358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23188,-0.00468979792875191,0.0054044075894354,-0.0152824368040453,0.00590284094654146,0.385527706574973
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,23795,0.00291979278183379,0.00336485310123257,-0.00367531929658205,0.00951490486024963,0.385549482435307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,28470,0.00161453520246828,0.00186313618894398,-0.00203721172786192,0.00526628213279848,0.386185765047489
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,23188,-0.00404483497989172,0.00466942875555722,-0.0131969153407839,0.00510724538100043,0.386368819956843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,27702,0.00274139240347906,0.00317662331969925,-0.00348478930313148,0.00896757411008959,0.388150743765133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,23071,0.00224038241327161,0.00259859172690061,-0.00285285737145359,0.0073336221979968,0.388612558350243
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,28091,0.00194858486834468,0.00226083783447532,-0.00248265728722694,0.00637982702391631,0.388757519538715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,23795,0.00159557798675436,0.00185237311419721,-0.00203507331707217,0.0052262292905809,0.389043169244331
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,23056,-0.00249161298427378,0.00290550879824945,-0.00818641022884269,0.00320318426029514,0.391151070501169
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",23331,0.00370176008036519,0.00431759129585874,-0.00476071885951793,0.0121642390202483,0.391250930570733
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,23738,0.00201142796243433,0.00234704438819192,-0.00258877903842184,0.0066116349632905,0.391450969526942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,23056,-0.00282523876158855,0.00331909699166302,-0.00933066886524806,0.00368019134207096,0.394663192508923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",23846,0.00288958639785738,0.00341247188662216,-0.00379885849992206,0.00957803129563682,0.39713059754981
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,22978,0.00419717588144667,0.00496706195220628,-0.00553826554487763,0.013932617307771,0.398118683495158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,27702,0.00320859986091608,0.00379775630005762,-0.00423500248719685,0.010652202209029,0.398192270679478
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,27544,-0.00272077693013099,0.00322120634144517,-0.00903434135936352,0.00359278749910155,0.398316225396221
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,22978,-0.00362785640220092,0.00429545768526962,-0.0120469534653294,0.00479124066092754,0.398354340594996
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",23795,-0.00439033341607657,0.00520887683571951,-0.0145997320140868,0.00581906518193368,0.399317426449503
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,23163,-0.00215274457452912,0.00255834252437002,-0.00716709592229436,0.00286160677323612,0.400098610378523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,23872,0.00148457500275747,0.00176731010665652,-0.00197935280628931,0.00494850281180425,0.400905854790934
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,23393,0.00392399891779657,0.00469300195758681,-0.00527428491907359,0.0131222827546667,0.40308562099993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,23188,0.00209706748493086,0.00251188397877613,-0.00282622511347035,0.00702036008333208,0.403806035758397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,28091,-0.00414405010346454,0.00496585433440909,-0.0138771245989064,0.00558902439197729,0.404001321541718
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23198,0.00196174142818649,0.00235101279974109,-0.00264624365930604,0.00656972651567902,0.404050713490753
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,23393,0.00247890130018366,0.00297473632975423,-0.00335158190613462,0.00830938450650195,0.404673925865304
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,27544,-0.00815954886896254,0.00980034389090671,-0.0273682228951397,0.0110491251572146,0.40509009946551
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",22978,0.00518841047250697,0.00625637329395295,-0.00707408118364081,0.0174509021286548,0.406943281815801
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,23795,0.0027032979364823,0.00326952469572788,-0.00370497046714436,0.00911156634010895,0.408349203805942
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",22940,-0.00144431434456701,0.00174799435221484,-0.00487038327490809,0.00198175458577407,0.408659853941542
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,23846,0.00409612701452268,0.00497178362724022,-0.00564856889486815,0.0138408229239135,0.410018971095047
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",23775,-0.00142233602419906,0.00172760031086772,-0.00480843263349979,0.00196376058510168,0.410344791805161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,27702,-0.00187400414332463,0.00227755351621126,-0.0063380090350987,0.00259000074844945,0.410620554463526
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,28176,-0.00622196552814243,0.00756181485156101,-0.021043122637202,0.00859919158091715,0.410620861084804
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,28176,0.00192404429717563,0.0023424824469609,-0.00266722129886772,0.00651530989321899,0.41144262344707
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,27832,0.0026091135423484,0.0031788340025457,-0.00362140110264117,0.00883962818733797,0.411780387762234
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,27702,-0.0028875178567198,0.00351993804112766,-0.00978659641733001,0.00401156070389042,0.412033923748719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,23393,-0.00373131910245453,0.00455328411588127,-0.0126557559695818,0.00519311776467275,0.412521734103679
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,23071,-0.00396572653796649,0.00484961487872991,-0.0134709717002771,0.00553951862434413,0.413513824489101
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,23846,0.00588927568189882,0.00722153002274494,-0.00826492316268125,0.0200434745264789,0.414784969474759
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,23188,-0.00316339048423671,0.00387911442969274,-0.0107664547664345,0.00443967379796106,0.414798577494188
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,28428,-0.00526034926119829,0.00645443046677224,-0.0179110329760719,0.00739033445367529,0.41508016700058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,27544,-0.00405267548364315,0.00497282474432636,-0.0137994119825228,0.00569406101523652,0.415099697768555
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,23198,0.000986977065371718,0.00121160770806135,-0.00138777404242853,0.00336172817317197,0.415309003598098
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,23337,0.00282753529100373,0.00347945307256383,-0.00399219273122137,0.00964726331322883,0.416434014100657
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,23846,0.00260997729138347,0.00321506405114259,-0.00369154824885601,0.00891150283162295,0.416916599445804
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,23725,0.00434551962614194,0.00535511481857763,-0.00615050541827022,0.0148415446705541,0.417103466302138
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,23393,0.00472774139115093,0.00583297542367552,-0.00670489043925309,0.016160373221555,0.417649807435369
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",28091,-0.00330449823575567,0.00407857865002118,-0.0112985123897972,0.00468951591828584,0.417827340209565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,27281,0.0046748246229915,0.00577204907445713,-0.00663839156294447,0.0159880408089275,0.418000529547137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,22978,-0.00269658452762948,0.00333189672652599,-0.00922710211162042,0.00383393305636146,0.418337096708267
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,23188,0.00465349706549119,0.0057573129244665,-0.00663083626646314,0.0159378303974455,0.418940091984361
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,23071,0.00338912322024539,0.00419737309786091,-0.004837728051562,0.0116159744920528,0.41942186835587
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,27562,0.00208256005181002,0.00258008527400211,-0.00297440708523411,0.00713952718885414,0.419577163439597
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,23163,0.00217488554913334,0.0027021982301889,-0.0031214229820369,0.00747119408030359,0.42090996055884
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,27965,0.00161234023267842,0.00200394772644801,-0.00231539731115968,0.00554007777651651,0.421067786642127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,23163,-0.00358137488870658,0.00445403732351143,-0.012311288042789,0.00514853826537581,0.421362589273869
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,27682,-0.00148830034324897,0.00185447246655615,-0.00512306637769903,0.00214646569120109,0.422243808638172
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,23393,-0.00224505932444956,0.00279956257385082,-0.00773220196919717,0.00324208332029805,0.422600339697755
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,23071,0.0025712431610729,0.00320847595839272,-0.00371736971737682,0.00885985603952262,0.422913689571718
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,23337,-0.00368977807354773,0.00462310332147023,-0.0127510605836294,0.00537150443653392,0.424810632818847
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,28176,-0.00480219472995891,0.00602166658005226,-0.0166046612268613,0.00700027176694352,0.425175560441676
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,23188,-0.00151894840010526,0.00191069465499004,-0.00526390992388574,0.00222601312367523,0.426638038374031
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,27638,0.00268119198903752,0.0033805485553051,-0.00394468317936048,0.00930706715743551,0.427712772750349
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,23644,0.00134284303062875,0.00170025822519534,-0.00198966309075411,0.00467534915201161,0.429659689334165
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,23725,0.00253645119627141,0.00321979197828352,-0.00377434108116429,0.00884724347370711,0.430839913562929
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,23738,0.00293911357264302,0.00373254002088236,-0.0043766648682864,0.0102548920135724,0.431038122576353
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,22978,-0.00231881687499053,0.00294691888254019,-0.00809477788476931,0.00345714413478825,0.431371094673521
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,22978,-0.00296059305662231,0.00376751744781713,-0.0103449272543439,0.00442374114109927,0.431980667578408
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,23795,0.00142821134731134,0.0018221760078934,-0.00214325362815972,0.0049996763227824,0.433168567648024
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,23056,0.00401578416685161,0.00513862263551684,-0.00605591619876139,0.0140874845324646,0.434522160725103
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,23337,-0.00303758493045483,0.00389369033083846,-0.0106692179788982,0.00459404811798856,0.435322232335376
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,28091,-0.00120330309886002,0.00154456251794709,-0.00423064563403632,0.00182403943631627,0.435952377588809
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,23188,0.00336767754343714,0.00433366225968311,-0.00512630048554175,0.011861655572416,0.437109257835376
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,23393,-0.00360694583283833,0.00464992520677066,-0.0127207992381088,0.00550690757243216,0.437934132310299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,23393,-0.00440648998620035,0.00568656074572763,-0.0155521490478265,0.00673916907542581,0.4384092844002
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",23795,0.00218137525784158,0.00282185105330271,-0.00334945280663173,0.00771220332231489,0.43951236442371
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,27562,0.00404942645644752,0.00524897581621945,-0.00623856614334261,0.0143374190562376,0.440435118370813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,23188,0.00140102196459543,0.00181802074355579,-0.00216229869277391,0.00496434262196477,0.440933921839378
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,27940,0.00245965404833757,0.00319932265559779,-0.0038110183566341,0.00873032645330925,0.442015805654651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,28129,-0.00149573866199942,0.00195129736384281,-0.00532028149513133,0.00232880417113249,0.443364184932879
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,28307,-0.00509975592773749,0.00665385187329518,-0.0181413055993961,0.00794179374392107,0.443422928103488
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,23738,0.0133403179294042,0.0174753173216923,-0.0209113040211126,0.0475919398799211,0.445244047275135
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,27682,-0.00550457927578699,0.00721864378562333,-0.0196531210956087,0.00864396254403474,0.445738111004321
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,22978,-0.00239701822262888,0.00314556000776847,-0.00856231583785507,0.00376827939259732,0.446048572752361
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,28195,-0.00119711966984356,0.00157250391310043,-0.00427922733952041,0.00188498799983328,0.446494736370571
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",28307,-0.00314330725314335,0.00413083454054457,-0.0112397429526107,0.00495312844632402,0.44670069055869
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,28187,0.00293356755457783,0.00385755133430289,-0.00462723306065583,0.0104943681698115,0.446977659580967
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,28224,0.00156021782977318,0.0020534332021072,-0.00246451124635692,0.00558494690590328,0.447374878377315
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23056,-0.00163808638911348,0.00215682397355462,-0.00586546137728054,0.00258928859905358,0.447567222098498
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,28320,-0.00107348830608023,0.00141959178163441,-0.00385588819808367,0.0017089115859232,0.449538541559127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,23071,-0.00249045771372468,0.00330595507404655,-0.00897012965885592,0.00398921423140656,0.451262493434664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,27544,-0.00240186005686641,0.00319141741048001,-0.00865703818140723,0.00385331806767442,0.451696881856517
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23163,0.00260618568776286,0.0034693636657368,-0.00419376709708126,0.00940613847260698,0.452539988205742
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,23188,0.00196019580466352,0.00261048879363371,-0.00315636223085855,0.00707675384018559,0.452725129110687
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",27910,0.00366770748973792,0.00491497250173078,-0.00596563861365442,0.0133010535931303,0.455533848039793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,23056,0.00221205492331568,0.0029675100477406,-0.00360426477025589,0.00802837461688725,0.456022694176623
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,23862,-0.00695740527372464,0.00933390723522016,-0.0252518634547562,0.0113370529073069,0.456043064223873
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,27682,-0.0016069803491247,0.00215651739593908,-0.0058337544451653,0.0026197937469159,0.456172964906608
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,23775,-0.00228301132145053,0.00306741275524757,-0.00829514032173577,0.0037291176788347,0.45671497993672
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,23795,0.0046776557244933,0.00629095595460249,-0.00765261794652758,0.0170079293955142,0.457154623800283
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,28553,-0.00350816727004786,0.00472585490606612,-0.0127708428859375,0.00575450834584173,0.457890530215793
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,28521,-0.00271831927450418,0.00366826278391824,-0.00990811433098393,0.00447147578197557,0.458676973886707
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,23188,-0.00145876596953977,0.00197433271435387,-0.00532845808967335,0.00241092615059381,0.459996266938396
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,23188,0.00202115442370217,0.00274138218236761,-0.00335195465373836,0.00739426350114269,0.460962180657575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,23163,-0.0026771649295721,0.00363379496721179,-0.00979940306530721,0.004445073206163,0.461287470127142
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,23731,-0.00185300943509331,0.0025155735071572,-0.00678353350912142,0.0030775146389348,0.461363734489613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,23284,-0.00555142432702691,0.00754040720867889,-0.0203306224560375,0.00922777380198372,0.461602167594904
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,23893,0.000960088354978011,0.0013089556352434,-0.00160546469009905,0.00352564140005507,0.463274983322856
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,23188,0.00272509438368181,0.00372413467127803,-0.00457420957202313,0.0100243983393868,0.464335319021813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,28336,-0.00277631451215574,0.00383507052039051,-0.0102930527321211,0.00474042370780965,0.469115985465349
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,23775,0.00366658188448487,0.00507223262861972,-0.00627499406760979,0.0136081578365795,0.469764801713308
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23071,-0.00231481510104709,0.00320536358561023,-0.00859732772884313,0.00396769752674895,0.470197734123161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",28050,-0.0051005505414419,0.00706746281765086,-0.0189527776640376,0.00875167658115379,0.47048821271341
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28520,-0.00133584460661833,0.0018560129415992,-0.00497362997215276,0.0023019407589161,0.471691706630738
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,27562,-0.00441764041169226,0.0061547196369266,-0.0164808909000684,0.00764561007668387,0.472908477025259
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,23163,-0.00204090945124424,0.00284456135707389,-0.00761624971110906,0.00353443080862058,0.473086606930833
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,23393,-0.00311395593842613,0.00434615353146673,-0.0116324168601009,0.00540450498324866,0.473698781374257
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,27682,-0.0022695079916601,0.00317384187634044,-0.00849023806928736,0.00395122208596716,0.474573988429356
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,28363,-0.00296867107510008,0.00415229459919466,-0.0111071684895216,0.00516982633932146,0.474647605202795
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,27652,0.00205319783070246,0.00287892713301256,-0.00358949935000217,0.00769589501140708,0.475739418228947
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,23056,0.00255820947116171,0.00360628037492228,-0.00451010006368597,0.00962651900600938,0.478098230233005
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,27615,-0.00425622957342617,0.0060112150807021,-0.0160382111316023,0.00752575198474995,0.478921350665625
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,23188,-0.00205851983594315,0.00291049137278621,-0.00776308292660411,0.00364604325471782,0.479402272832191
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,23725,-0.00512953446436161,0.00725265012953205,-0.0193447287182444,0.00908565978952121,0.479409715961702
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,23393,-0.00301482323395633,0.00426419961126805,-0.0113726544720417,0.00534300800412906,0.479568553626808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,23188,-0.00432817242390116,0.00612271862122371,-0.0163287009214996,0.0076723560736973,0.479633434642151
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,22978,0.00139611219593998,0.00197824331458026,-0.00248124470063733,0.00527346909251729,0.480361162965586
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,23071,-0.00584238748051589,0.00828622959314831,-0.0220833974830866,0.0103986225220548,0.480772627060466
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,28091,-0.00148912245981392,0.00211202376671438,-0.00562868904257411,0.00265044412294627,0.480773153525866
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,28195,0.00119396902950169,0.00169523875065258,-0.00212869892177738,0.00451663698078075,0.481247240243082
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,28428,-0.00360581004394463,0.00511996997889158,-0.0136409512025721,0.00642933111468288,0.481274212831752
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,23163,-0.00384294031200451,0.00546034989732236,-0.0145452261107563,0.00685934548674732,0.481570566029313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,23725,0.00189026835855281,0.0026867713650771,-0.00337580351699831,0.00715634023410393,0.481722200863464
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,23163,-0.00338818823988312,0.00481860122378977,-0.0128326466385111,0.00605627015874483,0.481970796222137
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,23872,-0.00127173203765978,0.00180909241244374,-0.00481755316604951,0.00227408909072995,0.48208325290641
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,27682,-0.00454807395111245,0.006470092565972,-0.0172294553804176,0.00813330747819267,0.482100300517364
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23071,-0.00277036944825313,0.00394160464222725,-0.0104959145470186,0.00495517565051228,0.482154333345997
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,23738,0.00279837934630401,0.00398756846206304,-0.00501725483933953,0.0106140135319476,0.482825830449479
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23136,-0.00182553619158446,0.00260430685498067,-0.00692997762734657,0.00327890524417766,0.483329938050333
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,23795,0.00271689826468549,0.00389301554838936,-0.00491341221015766,0.0103472087395286,0.485252547973678
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,28187,0.0013694171120376,0.00196342479166918,-0.00247889547963399,0.00521772970370919,0.485518534426161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,28091,0.00197126122891204,0.00283145111211896,-0.00357838295084112,0.0075209054086652,0.486308252764584
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,23163,-0.00353290841553027,0.00509794550522485,-0.013524881605771,0.00645906477471044,0.488312542446335
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,23725,-0.00184522605972587,0.0026689783861468,-0.00707642369657359,0.00338597157712186,0.489345829710645
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,27702,-0.00148626244494952,0.00215259972525,-0.00570535790643951,0.00273283301654048,0.489917040707682
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,27781,0.00103802503165376,0.00151293624236629,-0.00192733000338417,0.00400338006669169,0.492655998052474
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23188,0.00205496607440541,0.00299654818988483,-0.00381826837776885,0.00792820052657967,0.49286012958557
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,23056,-0.00160011288513958,0.00234334475742792,-0.0061930686096983,0.00299284283941913,0.494719305764299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,28176,-0.00312596758251908,0.00459582811695483,-0.0121337906917506,0.00588185552671239,0.496399224659053
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",26796,-0.00133541476342044,0.00196346110855986,-0.00518379853619778,0.00251296900935689,0.496426107613304
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23163,-0.00475613956962937,0.00699900196610874,-0.0184741834232025,0.00896190428394375,0.496799148274611
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,22479,-0.00229390687906935,0.00338161948080907,-0.00892188106145514,0.00433406730331643,0.497559545249592
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,23163,-0.00132338565229528,0.00196375955691867,-0.00517235438385587,0.00252558307926531,0.500379002586077
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,23163,0.0023669935544665,0.00352880706812277,-0.00454946829905412,0.00928345540798712,0.502378152500191
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,28176,-0.00211277190526296,0.00315548916303163,-0.00829753066480497,0.00407198685427904,0.503147329430437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,28224,-0.00109930818769462,0.00164267690960401,-0.00431895493051848,0.00212033855512923,0.503362200649309
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,23071,0.00206431757351773,0.00308775476440554,-0.00398768176471713,0.00811631691175259,0.503789450171251
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,23393,0.00197504841040738,0.00295509780979085,-0.00381694329678269,0.00776704011759746,0.503914904122533
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,28428,0.00124405864578618,0.00186148987468267,-0.00240446150859186,0.00489257880016422,0.503938983878425
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,23725,-0.00279855826504541,0.00419688664232595,-0.0110244560840043,0.00542733955391346,0.504895078835047
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,23163,0.00171173024349047,0.0025694081132156,-0.00332430965841211,0.00674777014539305,0.505292260088794
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,27562,0.00163897016260047,0.00246303072902783,-0.00318857006629408,0.00646651039149503,0.505782209076808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,23071,-0.00197340192413691,0.00298366936297437,-0.00782139387556666,0.00387459002729285,0.508361788751693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,28176,-0.00264526122681599,0.00400038238094223,-0.0104860106934628,0.00519548823983078,0.508456067684554
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,23188,-0.00206659759281869,0.00314594181231803,-0.00823264354496203,0.00409944835932465,0.511245933309558
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,23775,-0.00398759211599565,0.00607243255289541,-0.0158895599196707,0.00791437568767936,0.511398658474029
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,23188,-0.000750448278163248,0.00114362317425397,-0.00299194969970103,0.00149105314337453,0.511700416427028
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,23393,0.001980149129038,0.00302675279808581,-0.00395228635521018,0.00791258461328618,0.512979298436434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,23725,-0.00162241730888125,0.00248544969669894,-0.00649389871441117,0.00324906409664867,0.513913409162494
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,23337,0.00170767892325017,0.00261659229086713,-0.00342084196684939,0.00683619981334974,0.513998242217726
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,23163,0.00367518139781779,0.00564596293825148,-0.00739090596115512,0.0147412687567907,0.515091876475436
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,23862,0.0018968946876037,0.00291671123647338,-0.00381985933588413,0.00761364871109153,0.515469877715902
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,23287,-0.00134065965375776,0.00206295840020269,-0.00538405811815503,0.00270273881063951,0.515781084640462
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,23725,-0.00480887183148479,0.00740581555503962,-0.0193242703193624,0.00970652665639287,0.516126709897074
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,23337,0.00253616270370995,0.00391700346369439,-0.00514116408513106,0.010213489492551,0.517330795957669
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23071,-0.00301636366922916,0.00466645103947585,-0.0121626077066018,0.0061298803681435,0.518030975784664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23188,0.00122638983999562,0.00189875891305413,-0.00249517762959047,0.00494795730958172,0.518356839688351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,23738,-0.00333414266191,0.00516641235771329,-0.0134603108830281,0.00679202555920806,0.518706833346218
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,22978,-0.00271739652116323,0.00421608605262342,-0.0109809251843051,0.00554613214197868,0.519237852038175
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,28488,-0.00226679408262393,0.00353167230116283,-0.00918887179290307,0.00465528362765522,0.520977547224213
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,23071,0.00288090086070863,0.00449073544713377,-0.00592094061567356,0.0116827423370908,0.521190652309281
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,27489,0.00182875161818764,0.00285322707207008,-0.00376357344306971,0.00742107667944499,0.521566042328351
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,28082,-0.00197839598327543,0.00309641526862425,-0.00804736990977897,0.0040905779432281,0.522872975210683
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,23725,0.00194293465326526,0.00305990157714616,-0.00405447243794121,0.00794034174447172,0.525456463643854
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,23188,0.00145152952264594,0.00229513944203557,-0.00304694378374378,0.00595000282903565,0.527108052573552
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,28187,-0.00221617160200326,0.00351432253583804,-0.00910424377224581,0.00467190056823929,0.52829980519163
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,28253,-0.0015746253537673,0.00249784724973202,-0.00647040596324205,0.00332115525570746,0.528442608349392
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,22978,-0.00306828976148382,0.00488726414423414,-0.0126473274841827,0.00651074796121509,0.530132450803158
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,27544,-0.00354682886290788,0.0056865236714563,-0.0146924152589622,0.00759875753314647,0.532813151731712
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,28384,0.00206908336433764,0.00332228587779616,-0.00444259695614284,0.00858076368481813,0.53342814134012
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,28320,-0.00270453517676355,0.00436007619569973,-0.011250284520335,0.00584121416680793,0.535068321263517
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,28187,-0.00191198281982188,0.00309197388735872,-0.00797225163904496,0.00414828599940121,0.536336696344066
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,23846,-0.00134527211366884,0.00218183685130931,-0.00562167234223508,0.0029311281148974,0.537519146482252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,28336,-0.00114910297510231,0.00186854064591768,-0.00481144264110097,0.00251323669089634,0.538577164110803
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,23188,-0.00438069901980726,0.0071348550618187,-0.0183650149409719,0.00960361690135739,0.539230800097946
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,23862,-0.00368505470015341,0.00600318131073244,-0.015451290069189,0.00808118066888216,0.539320104439827
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,22978,-0.00184158779620834,0.00300089985697602,-0.00772335151588134,0.00404017592346466,0.539433860901252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,22978,-0.00167466327103711,0.00273403642469632,-0.00703337466344191,0.00368404812136768,0.540197106036743
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,23725,0.00215347755386182,0.00351873102717049,-0.00474323525939234,0.00905019036711598,0.540540962362774
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,27544,-0.00237112392443519,0.00387607291992955,-0.0099682268474971,0.00522597899862673,0.54071909912125
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,23071,0.00155364884650175,0.00254105179285646,-0.00342681266749691,0.00653411036050041,0.540927864493756
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,28184,-0.00163694529705048,0.0026776729306211,-0.00688518424106783,0.00361129364696687,0.540985200857099
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,23056,-0.0048767430125669,0.00798062284067494,-0.0205187637802898,0.010765277755156,0.541157292112633
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,23862,-0.00122723462011973,0.00200994729802927,-0.00516673132425709,0.00271226208401764,0.541483156091553
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,28174,0.00252186053900595,0.00413443879792871,-0.00558163950493432,0.0106253605829462,0.541890302838578
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,23163,0.00298031698854003,0.00489063905152572,-0.00660533555245038,0.0125659695295304,0.542270528452415
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,23846,0.00145400995300052,0.00238848448280659,-0.0032274196333004,0.00613543953930144,0.542690404306012
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,28428,0.00202656495246173,0.00333110135115877,-0.00450239369580945,0.00855552360073291,0.542942423728339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,28553,0.00143446206318227,0.0023658891947189,-0.00320268075846678,0.00607160488483131,0.54431380208719
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,28307,0.000990921607523378,0.00163517670299363,-0.00221402473034413,0.00419586794539089,0.544517776940755
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,22978,-0.00588107173659621,0.00970933809101763,-0.0249113743949908,0.0131492309217983,0.54471137501933
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,23163,-0.00246695698236739,0.00408700920771127,-0.0104774950294815,0.00554358106474669,0.546109307592952
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,23725,0.00115054668773069,0.00190733274661288,-0.00258782549563056,0.00488891887109194,0.546366221229874
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,23023,-0.0034668418907998,0.00575659181055986,-0.0147497618394971,0.00781607805789753,0.547021248258646
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,27562,0.00124101310927179,0.00206315352324617,-0.0028027677962907,0.00528479401483428,0.547503484957928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,23337,-0.00299704517712383,0.00498644291037973,-0.0127704732814681,0.00677638292722044,0.547820049822127
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,23795,-0.00276472830986436,0.00460979174271304,-0.0117999201255819,0.00627046350585319,0.5486777485228
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,23071,0.00203825260609203,0.00342508582748372,-0.00467491561577606,0.00875142082796012,0.551785585306292
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,28336,0.00171870717377946,0.00289314170519754,-0.00395185056840771,0.00738926491596663,0.552475014538746
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,22978,-0.00136725144472331,0.00230159967455458,-0.00587838680685029,0.00314388391740367,0.552488545455505
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,23393,0.00266327224842939,0.00448463743845998,-0.00612661713095218,0.011453161627811,0.552607703056677
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],27702,-0.00222147151286071,0.00375376710243545,-0.0095788550336342,0.00513591200791278,0.553990757093397
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,23725,0.00343740152528986,0.00581562666794888,-0.00796122674388995,0.0148360297944697,0.554483869266662
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,28091,0.000964508389202177,0.00163306208676003,-0.00223629330084749,0.00416531007925184,0.554784222683322
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,23795,0.00204408994531758,0.00346852389103958,-0.00475421688111999,0.00884239677175516,0.555648468966056
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,23163,-0.00146712788019206,0.00248954416880031,-0.00634663445104067,0.00341237869065656,0.555655153865926
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,23163,0.0019366075336959,0.003288104559801,-0.00450807740351405,0.00838129247090586,0.555884576695917
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,22978,0.00184754953507988,0.00314376769290242,-0.00431423514300885,0.00800933421316862,0.556748580670492
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,28091,-0.000755370057858812,0.00128594120653839,-0.00327581482267405,0.00176507470695643,0.556935539432653
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,23188,0.00102918347597777,0.00175208196805886,-0.00240489718141761,0.00446326413337314,0.556936782217896
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,28091,-0.0012576709387073,0.00214155655464629,-0.00545512178581402,0.00293977990839943,0.557027415467952
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,23393,-0.00163795173999702,0.00280178045139429,-0.00712944142472983,0.00385353794473579,0.558814934487195
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,23738,0.00101128717474772,0.0017312854589977,-0.00238203232488777,0.00440460667438321,0.559141748267973
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23071,0.00202498230780125,0.0034751659463604,-0.00478634294706514,0.00883630756266763,0.560100368812575
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,23163,-0.00268544584770321,0.00462794229945006,-0.0117562127546253,0.00638532105921892,0.561739693375296
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,28553,0.00135825537254491,0.00234584506652078,-0.00323960095783582,0.00595611170292565,0.562590556111225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,23163,0.00234896433842033,0.00407759064951406,-0.00564311333462723,0.0103410420114679,0.564575674162199
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,23163,0.00187747569349864,0.0032787470638952,-0.00454886855173595,0.00830381993873323,0.566907669212487
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,27786,-0.00163991062485218,0.00286911555756288,-0.00726337711767542,0.00398355586797105,0.567615530306796
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,23775,-0.00314868119525478,0.00553998529820426,-0.0140070523797351,0.00770968998922557,0.569798961460247
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",23795,0.00181550677285923,0.00319710188221489,-0.00445081291628195,0.00808182646200041,0.570135289916614
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,23725,-0.00196399194008326,0.00346120712873974,-0.00874795791241315,0.00481997403224663,0.570427605742436
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",22978,-0.00186466590789226,0.00328849710627599,-0.0083101202361932,0.00458078842040869,0.570701533122099
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,23071,-0.00180223502797906,0.00318487213840066,-0.00804458441924435,0.00444011436328623,0.571485223448559
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,28176,-0.00130050129577943,0.00231200882204536,-0.00583203858698833,0.00323103599542948,0.573780961169437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,23163,0.0012742630760848,0.00226558868342723,-0.00316629074343256,0.00571481689560216,0.573820102088841
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,23188,0.00292617080363066,0.00521066930108492,-0.00728674102649578,0.0131390826337571,0.574412461828086
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,27600,-0.00185220534702843,0.00329899677630933,-0.00831823902859472,0.00461382833453786,0.574498754169367
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,27562,0.0017931565562348,0.00320029612764451,-0.00447942385394845,0.00806573696641804,0.575272855364875
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,28414,0.00163555874863205,0.00292342370167024,-0.00409435170664162,0.00736546920390572,0.575847537942973
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23163,0.00293610100319629,0.00525046177231216,-0.00735480407053553,0.0132270060769281,0.576025082902982
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,28521,-0.000988278568217543,0.00177051958760609,-0.00445849695992548,0.00248193982349039,0.576722025082358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,23393,0.00201337017604941,0.00360789028919831,-0.00505809479077927,0.00908483514287809,0.576818045950578
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,28176,0.00333789980277503,0.00598525665400676,-0.00839320323907821,0.0150690028446283,0.577062571929638
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,23188,-0.00346406318733661,0.00622618486721745,-0.0156673855270828,0.0087392591524096,0.577963236834505
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,23393,0.00216395321724615,0.00391353577398218,-0.00550657689975892,0.00983448333425123,0.580309302368867
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,23056,0.0028508573358029,0.00517084225494818,-0.00728399348389553,0.0129857081555013,0.581410585999414
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,28390,0.00235443280247461,0.00429332560699893,-0.00606048538724329,0.0107693509921925,0.583425901588088
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,23795,-0.00124687631746828,0.00227725702352969,-0.00571030008358646,0.00321654744864992,0.584016854784162
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,23795,-0.00584305497704062,0.0106729188501449,-0.0267619759233247,0.0150758659692434,0.58406409615424
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,23188,-0.00276805387537904,0.00507397489987064,-0.0127130446791255,0.00717693692836741,0.585387752430347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,23056,0.00138716552039269,0.00254284281715078,-0.00359680640122284,0.00637113744200823,0.585402857158825
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,27702,0.00417449617596057,0.00766358179675335,-0.010846124145676,0.0191951164975971,0.585951400958366
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,23188,-0.00165594546071403,0.00304958940388862,-0.00763314069233573,0.00432124977090767,0.587130867413288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,23846,-0.00146719382446539,0.00270435355777061,-0.00676772679769578,0.003833339148765,0.587458293290035
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,23071,0.00255539350276627,0.0047367669231761,-0.00672866966665887,0.0118394566721914,0.589560541316846
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,23393,-0.00164826257741366,0.0030589442222974,-0.00764379325311657,0.00434726809828926,0.590006660995744
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23163,-0.00196976167821591,0.00368451235453878,-0.00919140589311193,0.00525188253668011,0.592927605929545
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,23071,-0.00144662376555454,0.0027173752768455,-0.00677267930817171,0.00387943177706263,0.594481338607961
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,23163,-0.00249231935744455,0.00469251029811405,-0.0116896395417481,0.00670500082685898,0.595335805950387
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,28187,-0.000950811732579044,0.00179212167918362,-0.00446337022377894,0.00256174675862085,0.595734224246965
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,23188,-0.0016551076854012,0.00313195899267397,-0.00779374731104218,0.00448353194023978,0.59718679495306
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,27544,0.00253965812606313,0.00480769134639617,-0.00688341691287336,0.0119627331649996,0.597330784882236
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,23188,-0.00365528048827923,0.00696958407384388,-0.0173156652730132,0.0100051042964548,0.599962410812808
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,27562,0.00113188996180971,0.0021596929258717,-0.00310110817289882,0.00536488809651825,0.600214847667531
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,22978,0.00271170650690646,0.00517611760481024,-0.0074334839985216,0.0128568970123345,0.600361415927459
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,27544,-0.00180611215315041,0.00344880778705526,-0.00856577541577871,0.0049535511094779,0.600497176692245
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,23163,0.00081218753233037,0.00155105323920365,-0.00222787681650878,0.00385225188116952,0.600536652111406
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,27562,-0.00125949708128827,0.00241114001361356,-0.00598533150797084,0.0034663373453943,0.601419863971993
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,23198,0.00283661837358365,0.00543746427115331,-0.00782081159787684,0.0134940483450441,0.60189787786852
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,27562,-0.00159788872401377,0.00310687966044367,-0.00768737285848336,0.00449159541045583,0.607041771628328
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23198,0.00113927220746285,0.00221536778122737,-0.00320284864374281,0.0054813930586685,0.607076017710538
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,23738,-0.00208120215535385,0.00404836443520247,-0.0100159964483507,0.00585359213764299,0.607197572699882
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,23725,-0.00386489249117369,0.00752503596575376,-0.0186139629840511,0.0108841780017037,0.60753330396622
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,23163,-0.00271816346615061,0.00529289252669545,-0.0130922328184737,0.00765590588617247,0.607571743053517
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,23056,-0.00331387426279269,0.00646636629366891,-0.0159879521983838,0.00936020367279838,0.608321014898499
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,23738,0.00154244525658316,0.00301184986402325,-0.00436078047690241,0.00744567099006872,0.60856791387179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,27544,0.00102880392811563,0.00201610849449519,-0.00292276872109494,0.00498037657732621,0.609851035234176
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,23775,0.00128316718682464,0.00251754817567397,-0.00365122723749634,0.00621756161114562,0.610273934383152
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,23163,0.000941722593758162,0.00184839838136375,-0.00268113823371479,0.00456458342123112,0.610420447888886
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,23198,0.0018234395074816,0.00358604780423801,-0.0052052141888249,0.0088520932037881,0.611120442394041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,23846,-0.00280368263255672,0.00551422742135034,-0.0136115683784034,0.00800420311328995,0.611145845886126
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,23188,0.00120421140003143,0.00236926825922788,-0.00343955438805521,0.00584797718811808,0.611273750307945
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,27562,-0.00254704402889612,0.00501301024735823,-0.0123725441137183,0.00727845605592601,0.611396582954417
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,22978,0.00168916669501443,0.00332598055061191,-0.00482975518418491,0.00820808857421378,0.611549191835703
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,23188,-0.0021304439276135,0.00419952098460801,-0.0103615050574452,0.00610061720221819,0.611944666963802
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,23056,-0.00119322354233869,0.00235329523096644,-0.00580568219503292,0.00341923511035554,0.612129002574002
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,23188,0.00162614802271687,0.00321094590379766,-0.00466730594872653,0.00791960199416028,0.612553365893106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,28187,0.00307222531684582,0.00606806253635221,-0.00882117725440451,0.0149656278880961,0.612654043846413
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,23056,-0.00370204924546397,0.00731264108675959,-0.0180348257755128,0.0106307272845848,0.612683631675193
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,23775,-0.00329069427234952,0.00650733494752698,-0.0160450707695024,0.00946368222480337,0.613078973641037
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,28091,0.000718409555514761,0.00142272019285188,-0.00207012202247492,0.00350694113350445,0.613594464903969
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,22978,0.00247382270983288,0.00490573729415599,-0.00714142238671287,0.0120890678063786,0.614075553871299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,28082,0.000886759653044544,0.00175949964586071,-0.00256185965284244,0.00433537895893153,0.614276582814858
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,23775,-0.00132911347416311,0.00263786721056179,-0.00649933320686422,0.00384110625853799,0.614365044772381
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,22882,-0.00117795141182448,0.00233903605373955,-0.005762462077154,0.00340655925350505,0.614543480735245
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,27196,0.00309825556567546,0.00618448587373288,-0.00902333674684099,0.0152198478781919,0.616394736516552
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,23056,0.00249001622344806,0.00497420060022525,-0.00725941695299344,0.0122394493998896,0.616667151111342
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,27544,0.00178679638474822,0.00357451961300838,-0.00521926205674821,0.00879285482624466,0.617170363220338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,23163,0.00213032061584504,0.00426591151521388,-0.00623086595397417,0.0104915071856642,0.617514846591656
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,22978,0.00124142845456809,0.00249018148429688,-0.00363932725465381,0.00612218416378998,0.618115791320582
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,27910,0.00373269015922475,0.00750791702273605,-0.0109828272053379,0.0184482075237874,0.619075060571664
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,28521,0.00122713744891257,0.00247218099230309,-0.00361833729600149,0.00607261219382664,0.619631230913043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,28553,-0.00106367450360438,0.00214587441963267,-0.0052695883660844,0.00314223935887565,0.62012155995385
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,23775,0.00315526356042504,0.00636602728029963,-0.00932214990896223,0.0156326770298123,0.620152367168048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,23795,-0.00240582682240833,0.00486662013095283,-0.0119444022790759,0.00713274863425921,0.621061675985831
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,22978,0.00262226000993837,0.00530814683144227,-0.00778170777968848,0.0130262277995652,0.621306184649539
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,28275,-0.000906272474493453,0.00183554564959189,-0.00450394194769356,0.00269139699870665,0.621497433342533
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,27562,-0.00223537358813462,0.00452980836955459,-0.0111137979924616,0.00664305081619237,0.621676816619323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,22978,-0.0013521948063637,0.00274142342855077,-0.0067253847263232,0.0040209951135958,0.621843839159445
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,23393,-0.00173214773113595,0.00352598730359238,-0.00864308284617701,0.00517878738390512,0.623252953124688
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",23188,-0.000956034397517745,0.00195900153389189,-0.00479567740394585,0.00288360860891036,0.625539399285518
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,23795,-0.00319557452209049,0.00657205371304825,-0.0160767997996651,0.00968565075548409,0.626803746386932
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,23393,-0.00550476928718494,0.0113712149304411,-0.0277923505508494,0.0167828119764796,0.628321673848577
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23188,0.00202167789071225,0.0041776904890188,-0.00616659546776461,0.0102099512491891,0.628445535196921
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,28238,0.00210401394614269,0.00439648628315758,-0.00651309916884616,0.0107211270611315,0.632250294006072
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,23163,0.00166462235470521,0.00348341872168894,-0.00516287833980512,0.00849212304921554,0.632747032628329
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,22936,-0.00256309695440073,0.00537391553897731,-0.0130959714107963,0.00796977750199479,0.633401221421911
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,28320,-0.00401938909065756,0.00843832713393467,-0.0205585102731695,0.0125197320918544,0.633846287564565
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,23845,-0.000901777915485197,0.00189763865780869,-0.00462114968479024,0.00281759385381984,0.634641261456026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,23725,0.00264898962470157,0.00559008161180062,-0.00830757033442765,0.0136055495838308,0.635594724848763
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,27562,-0.00208118927788471,0.00440642750418019,-0.0107177871860779,0.00655540863030846,0.636710974992454
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,28176,-0.0013057468188704,0.00278461189938819,-0.00676358614167126,0.00415209250393046,0.639133887757572
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,28142,-0.00126699654521595,0.00271417525197053,-0.0065867800390782,0.0040527869486463,0.64064144081981
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,28277,0.00222378007350924,0.00478073839553351,-0.00714646718173643,0.0115940273287549,0.641824688632347
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,27702,0.00153357303641088,0.00331650055065613,-0.00496676804287513,0.0080339141156969,0.643793121290966
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,28291,0.000567232575984466,0.00122797254477945,-0.00183959361178325,0.00297405876375218,0.644137865773086
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,23795,0.00209720520664099,0.00454257550564899,-0.00680624278443103,0.011000653197713,0.644316783582986
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,23795,0.00111127666641858,0.00241430746479371,-0.00362076596457709,0.00584331929741424,0.645313748008036
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,23056,-0.00152941126277283,0.0033368285038275,-0.00806959513027473,0.00501077260472908,0.646710514244359
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,23725,0.00157980296915856,0.00345210209935433,-0.00518631714557593,0.00834592308389306,0.64721884013977
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,27562,0.00250977522160991,0.00549881162775752,-0.00826789556879482,0.0132874460120146,0.648090588722549
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,27562,0.00181151132238958,0.00398551631872691,-0.00600010066231517,0.00962312330709432,0.649455573497211
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,22978,0.000812280071604802,0.0017879148424928,-0.00269203301968109,0.00431659316289069,0.649604990450348
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,28553,0.00204541388911672,0.00450983482357927,-0.00679386236509864,0.0108846901433321,0.650159659697018
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23198,0.00232757647560428,0.00515049599873197,-0.00776739568191038,0.0124225486331189,0.65133583373106
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,27682,-0.0018410506293613,0.00407531209838594,-0.00982866234219775,0.00614656108347515,0.65144761578682
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,28320,0.0010490690158946,0.00232457711858056,-0.0035071021365233,0.00560524016831251,0.651780719955313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,23188,0.00193654514006504,0.00429877600630555,-0.00648905583229384,0.0103621461124239,0.652363132135016
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,23163,-0.000949247906154565,0.00210786453977182,-0.00508066240410732,0.0031821665917982,0.652472189793964
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,23766,-0.000949328385289049,0.0021114847965449,-0.00508783858651706,0.00318918181593896,0.653001344226323
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,23188,-0.00159095043920657,0.00361863077167888,-0.00868346675169718,0.00550156587328405,0.660190833460941
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,23170,0.00166855702762159,0.00382172444175278,-0.00582202287821386,0.00915913693345703,0.662407025908883
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,28276,-0.00241005482049822,0.00553117970158953,-0.0132511670356137,0.00843105739461726,0.66304201381092
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,23707,0.00276659689651208,0.00635286184534316,-0.00968501232036052,0.0152182061133847,0.663212009178435
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,27702,-0.00141114764411077,0.00326575287967854,-0.00781202328828069,0.00498972800005916,0.665668577943532
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,23795,0.00139905010356598,0.0032460137472369,-0.00496313684101835,0.0077612370481503,0.666468204990725
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,23872,0.00200461117821174,0.00465656481319319,-0.00712225585564692,0.0111314782120704,0.666842098584612
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,23337,-0.000996577716435178,0.00231638475716091,-0.00553669184047056,0.0035435364076002,0.667032472625382
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,28151,0.00102246909245941,0.00238535302814935,-0.00365282284271332,0.00569776102763214,0.668185043059753
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,28091,0.00243994826901608,0.00569788417812263,-0.00872790472010426,0.0136078012581364,0.668494202157178
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,22978,-0.00136898969930104,0.00324298675698536,-0.00772524374299233,0.00498726434439026,0.67292784952033
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,23738,0.00121412349961554,0.00288575510554639,-0.00444195650725539,0.00687020350648648,0.673956125203789
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,27562,0.00259924612203534,0.00618028106699696,-0.00951410476927871,0.0147125970133494,0.674071756745604
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,27702,-0.0017742322678853,0.00422161486962118,-0.0100485974123428,0.00650013287657221,0.67428902980091
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",23071,-0.00112977195573324,0.00269397528280486,-0.00640996351003077,0.00415041959856428,0.674949776906409
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,28091,-0.00185883886743762,0.00443545017820677,-0.0105523212167229,0.00683464348184764,0.675155862827661
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,28232,0.00111438163049815,0.00267958142822527,-0.00413759796882337,0.00636636122981968,0.677501713424151
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,23725,0.00123521435301579,0.00297233960526111,-0.00459057127329599,0.00706099997932757,0.677728644609656
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23056,-0.0015909399599118,0.00382871498490161,-0.00909522133031896,0.00591334141049536,0.677758970345216
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,22978,-0.00224479948340749,0.00540373979208408,-0.0128361294758923,0.00834653050907731,0.677841342972811
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",23163,0.00109286798894957,0.00264288392962903,-0.00408718451312332,0.00627292049102246,0.67923431814866
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,28029,0.000726873938930133,0.00177232676391162,-0.00274688651833664,0.0042006343961969,0.681718042527837
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23163,-0.00136502851737703,0.00333104837911931,-0.00789388334045088,0.00516382630569682,0.681964190341155
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,27544,0.00184818235269344,0.00453522286971547,-0.00704085447194888,0.0107372191773358,0.68363116634043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,23738,0.00404242718629598,0.00994826826920378,-0.0154561786213434,0.0235410329939354,0.684492929768393
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,23056,-0.00148580773197916,0.00367285285208159,-0.00868459932205908,0.00571298385810076,0.685821058282984
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,22978,-0.00139364811309494,0.00345690054035634,-0.00816917317219336,0.00538187694600348,0.686841918118308
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,23056,-0.00209185489727931,0.00520237783760637,-0.0122885154589878,0.00810480566442918,0.68761716573605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,23684,0.00108181458674849,0.00269795810756979,-0.0042061833040883,0.00636981247758527,0.688441921767725
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,23188,0.00101895787207396,0.00254397108163331,-0.00396722544792732,0.00600514119207525,0.68876376646762
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,23725,-0.00164045893249811,0.004100904361595,-0.00967823148122431,0.00639731361622809,0.689142665050627
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,23071,-0.00107566889924217,0.00269637610047817,-0.00636056605617937,0.00420922825769503,0.689947499149498
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,28331,-0.000651413980477335,0.00163465068013511,-0.00385532931354215,0.00255250135258748,0.690262100084804
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,23163,-0.00277548795006699,0.00698533186492241,-0.0164667384053149,0.0109157625051809,0.691127153282105
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23188,0.00149853969903036,0.00377196141579994,-0.00589450467593752,0.00889158407399824,0.691161746676636
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,23163,0.00110475354478076,0.00279203879894393,-0.00436764250114935,0.00657714959071086,0.692344854991439
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,27682,0.00138900608221623,0.00351531067753496,-0.0055010028457523,0.00827901501018475,0.692749707317747
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,23071,-0.0012796915680323,0.00323932017589646,-0.00762875911278937,0.00506937597672477,0.692810067930459
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,23393,-0.00103012136217415,0.00261290911623945,-0.00615142323000348,0.00409118050565517,0.693405171640516
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,22594,-0.00184865463258096,0.00471385845468735,-0.0110878172037682,0.00739050793860625,0.694933056041074
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,28471,0.000947761274440839,0.00241930984660106,-0.00379408602489723,0.00568960857377891,0.695246901273264
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,27682,0.0020286158765021,0.00527933280400253,-0.00831887641934287,0.0123761081723471,0.700791589128002
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,27682,0.00115261916535393,0.00301997685566925,-0.00476653547175779,0.00707177380246565,0.70271286917467
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,27965,0.000980251629606452,0.00257414060435372,-0.00406506395492684,0.00602556721413975,0.703349108386656
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,23163,0.000889637884403332,0.00233647323934119,-0.0036898496647054,0.00546912543351206,0.703384095447315
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,27544,-0.000942741673795072,0.0025006157352247,-0.00584394851483548,0.00395846516724534,0.706173675098219
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,28521,0.00250175816461158,0.00664885469274144,-0.0105299970331616,0.0155335133623848,0.706719694519896
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,23163,-0.00149918224298842,0.00398867219942139,-0.00931697975385434,0.0063186152678775,0.707024440009991
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,23795,-0.000760008344365087,0.00202482044625382,-0.00472865641902258,0.00320863973029241,0.707406474448477
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,23393,-0.00143648658712816,0.00383336720748797,-0.00894988631380458,0.00607691313954825,0.707862951939427
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,27544,-0.00170553412354814,0.00455552212855252,-0.0106343574955111,0.0072232892484148,0.708118339952711
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,28452,0.000534049799443093,0.00143056410722871,-0.00226985585072518,0.00333795544961137,0.708917441520571
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,23872,0.00107555843103977,0.00289677567423962,-0.00460212189046989,0.00675323875254943,0.710421091096989
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,23188,-0.00108937474715837,0.00293700279651469,-0.00684590022832716,0.00466715073401042,0.710705157324925
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23188,-0.00110457390403717,0.00299120391540701,-0.00696733357823491,0.00475818577016058,0.711926859779037
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,27562,0.00307458913307015,0.00833383820408604,-0.0132597337469385,0.0194089120130788,0.712183970651091
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,23393,-0.00166427473310269,0.00453896439816696,-0.0105606449535099,0.00723209548730456,0.713872998999232
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,23163,-0.0020357191406748,0.005592040577441,-0.0129961186724592,0.00892468039110956,0.715832441099472
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,23163,-0.00102578604382575,0.00282669334445671,-0.0065661049989609,0.0045145329113094,0.716688442188338
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,22978,0.00170018940136717,0.00468589560277858,-0.00748416598007885,0.0108845447828132,0.716734278793096
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,27544,0.00155743208104467,0.0043055709137623,-0.00688148690992943,0.00999635107201878,0.717560416019865
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,27702,-0.0019338855354844,0.00536717014014964,-0.0124535390101777,0.0085857679392089,0.718612433332038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,23775,0.00166447128931844,0.00464244717944421,-0.0074347251823922,0.0107636677610291,0.719947537046475
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,23071,0.00143642164944766,0.00401194176573299,-0.006426984211389,0.00929982751028431,0.720319264728038
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,27965,-0.000713518247329756,0.00200460013061946,-0.00464253450334391,0.0032154980086844,0.721887857938128
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,27562,-0.000770749203366366,0.00217009934590563,-0.00502414392134141,0.00348264551460868,0.722466676653792
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,23738,0.000623554773172646,0.00176290508799329,-0.0028317391992942,0.00407884874563949,0.72356038490356
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,27965,0.000288770458710792,0.000820962784718869,-0.00132031659933819,0.00189785751675977,0.72503133502581
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",22978,-0.00121154106817162,0.00345806935547407,-0.00798935700490081,0.00556627486855756,0.726077855024515
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,23725,-0.00111953647733472,0.00321111148196308,-0.00741331498198236,0.00517424202731292,0.727359282679523
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,23071,-0.00153503905055288,0.00440682594828504,-0.0101724179091916,0.00710233980808581,0.727593950091417
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,27556,0.00184637011719888,0.0053061367903397,-0.00855365799186693,0.0122463982262647,0.727866264981083
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,23188,-0.00133651072303688,0.00387185841135058,-0.00892535320928402,0.00625233176321025,0.729957791386133
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,22978,-0.00124475628163565,0.00363973801543232,-0.008378642791883,0.00588913022861171,0.732361076492262
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,27965,-0.00216195462565159,0.00636904973573692,-0.0146452921076959,0.0103213828563928,0.734275591129057
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,23725,-0.000949487966623395,0.00283650314721762,-0.00650903413516993,0.00461005820192315,0.73782500935525
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,28091,0.000341067989476548,0.00101994529318512,-0.00165802478516629,0.00234016076411939,0.73808150694977
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",23846,-0.00198927831926723,0.00595544761166477,-0.0136619556381302,0.00968339899959572,0.738362374552174
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,23738,0.00119188556065859,0.00357167243199126,-0.00580859240604428,0.00819236352736146,0.738604996302016
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,28187,0.000561030178088225,0.00168468438092226,-0.0027409512085194,0.00386301156469585,0.739123194115466
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,23198,0.000908237074158573,0.0027288384250558,-0.00444028623895079,0.00625676038726794,0.739266234563394
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,23775,0.000504786990018108,0.00151756678931369,-0.00246964391703672,0.00347921789707294,0.739417151765365
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,28091,-0.00123544364181125,0.00371868784700724,-0.00852407182194545,0.00605318453832294,0.739721325431738
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,27702,-0.00205841611799191,0.00620629284846852,-0.0142227501009902,0.0101059178650064,0.7401440121692
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,28438,-0.000592635256428284,0.00179292625444946,-0.00410677071514922,0.00292150020229265,0.740993814950882
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,23056,-0.00133253510214374,0.00404277254011065,-0.00925636928076062,0.00659129907647314,0.741698251419726
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,23198,0.00583842454747328,0.0177549225144602,-0.0289612235808688,0.0406380726758153,0.742284032399134
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,23775,-0.000490296547177685,0.00149112964814374,-0.00341291065753941,0.00243231756318404,0.742303110498443
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,23393,0.000884790169842086,0.00269917059598629,-0.00440558419829103,0.00617516453797521,0.743065248769437
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,28187,-0.000746663868757463,0.0022869316205041,-0.0052290498449455,0.00373572210743057,0.744054900379078
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,23545,-0.000698450663508228,0.00214940473837028,-0.00491128395071398,0.00351438262369753,0.745221241603377
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,23738,0.00110527824001428,0.00341849917500791,-0.00559498014300122,0.00780553662302978,0.746453745798217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",27881,0.000879760343961311,0.00275168824000517,-0.00451354860644883,0.00627306929437145,0.749185589293557
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,23198,-0.00220406068624304,0.00689720543367808,-0.0157225833362521,0.011314461963766,0.749305910481904
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,22978,0.000896254581768407,0.00282084215847935,-0.00463259604885112,0.00642510521238793,0.750695760539041
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",23056,0.00180537500107781,0.00568793478928953,-0.00934297718592967,0.0129537271880853,0.750939715348361
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,23056,-0.000846824358365756,0.00271765342332062,-0.00617342506807416,0.00447977635134265,0.755346360050342
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,27544,-0.00137278665965378,0.00441095747346507,-0.0100182633076453,0.00727268998833777,0.75563427565429
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,23071,0.00105584302839256,0.00340717821438431,-0.00562222627180069,0.00773391232858581,0.756649066193166
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,28307,-0.000788420236065315,0.00255312777360547,-0.00579255067233204,0.00421571020020141,0.757471658283556
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,23071,-0.0013998427204271,0.00455418236676094,-0.0103260401592786,0.00752635471842435,0.758560577961023
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,22978,0.000914027072416013,0.00298896512921697,-0.00494434458084925,0.00677239872568128,0.759759309154724
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,23795,-0.00237645356832349,0.00778797941734281,-0.0176408932263154,0.0128879860896684,0.760259310290755
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,23188,-0.00134990124538112,0.0044239770841913,-0.0100208963303961,0.00732109383963384,0.760267625472339
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,23071,0.00102801401674651,0.00337103755120238,-0.00557921958361015,0.00763524761710317,0.760403345250141
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,23163,-0.00248782239868803,0.00816117362456957,-0.0184837227028444,0.0135080779054683,0.760493533668208
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,23071,0.00151236257832049,0.00497391566522449,-0.0082365121255195,0.0112612372821605,0.761085876652803
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,27373,0.00170868515867841,0.00567010747687725,-0.00940472549600099,0.0128220958133578,0.763150140121856
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",23775,0.000810576847819148,0.00269501719105393,-0.00447165684664656,0.00609281054228485,0.763593500498936
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,23071,-0.00239507120389543,0.00797254040850742,-0.01802125040457,0.0132311079967791,0.763863286285559
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,23163,0.00156489741125732,0.0052695922601577,-0.00876350341865178,0.0118932982411664,0.766494019200818
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,22978,-0.000723994468534297,0.00243856654252664,-0.0055035848918865,0.00405559595481791,0.766550531328282
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,28176,-0.000751883045859426,0.00253347324987808,-0.00571749061562046,0.0042137245239016,0.766637009423605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,23795,-0.000473631938384483,0.00160337851741067,-0.0036162538325094,0.00266898995574043,0.767693806555268
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,23393,-0.000607055549697809,0.00206341490850367,-0.004651348770365,0.00343723767096938,0.768608105904781
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,23071,0.0011208117688932,0.00383215790115013,-0.00639021771736105,0.00863184125514746,0.769925826808217
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,27562,-0.00167933606416926,0.00585399894549533,-0.0131531739973401,0.00979450186900159,0.77421409970562
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,23337,-0.00148638416267106,0.00521114680792349,-0.0117002319062011,0.00872746358085898,0.775469183047608
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,23738,0.00123343814386762,0.00435678562464875,-0.00730586168044392,0.00977273796817917,0.777096998083644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,28452,0.000554116058498166,0.00198896378295436,-0.00334425295609238,0.00445248507308871,0.780557408345777
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,23893,-0.000367879351511043,0.00133565471268701,-0.00298576258837759,0.0022500038853555,0.782988296513547
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,28521,-0.000165471998688169,0.000600843441953042,-0.00134312514491613,0.00101218114753979,0.783011304795754
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,22978,-0.000972254560220706,0.00359848413274179,-0.00802528346039462,0.00608077433995321,0.787020760795166
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,28521,0.000755947948572714,0.00281573353763468,-0.00476288978519126,0.00627478568233669,0.788337329405724
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,27544,0.000723966071911295,0.00269819823899698,-0.00456450247652279,0.00601243462034538,0.788459153446418
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,23188,-0.00164373718599616,0.00613230493456155,-0.0136630548577368,0.0103755804857445,0.788666625825055
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23056,0.000826319001378836,0.00308628524083572,-0.00522280007065917,0.00687543807341684,0.788902604905219
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,23393,-0.000415075594654075,0.00155486233735572,-0.00346260577587128,0.00263245458656313,0.789507490807261
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,23846,0.000955797212512099,0.00360997940429301,-0.00611976241990221,0.00803135684492641,0.791192573858057
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,28187,0.000562445195460394,0.00214390040796544,-0.00363959960415186,0.00476448999507265,0.793056079807833
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,23163,0.000554045166830226,0.00211681654089721,-0.00359491525332831,0.00470300558698876,0.793528014439315
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,23056,-0.0016108116786105,0.00616615400229687,-0.0136964735231124,0.0104748501658914,0.793914069064081
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23056,0.00101803042771035,0.00391982076487516,-0.00666481827144497,0.00870087912686567,0.795087087428843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,28428,0.000599916254164166,0.00233311661699084,-0.00397299231513789,0.00517282482346622,0.797079626549956
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,23188,-0.000813139994174905,0.00316673818174221,-0.00701994683038964,0.00539366684203983,0.797354555336423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,28091,-0.000558651415966998,0.00219908967080766,-0.00486886717075002,0.00375156433881602,0.799468386569306
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,28224,-0.000545168555211507,0.00215018432908175,-0.00475952984021173,0.00366919272978872,0.799848914598628
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,23188,-0.0010787558175829,0.00425914399987555,-0.00942667805733897,0.00726916642217318,0.800054128454599
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,28553,-0.000896803872728262,0.00354833833648261,-0.00785154701223417,0.00605793926677765,0.800471643717302
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,28091,-0.00174197514763784,0.00689342450338257,-0.0152530871742677,0.011769136878992,0.800501138190105
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,22978,0.000518661030358804,0.00206318024057579,-0.00352517224116974,0.00456249430188735,0.801515541074988
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23188,-0.000815091944653053,0.00327727514587504,-0.00723855123056813,0.00560836734126202,0.803587117927295
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,28307,-0.00133140185463126,0.00535462877598035,-0.0118264742555527,0.00916367054629023,0.803637174734724
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,23071,-0.00116167766611163,0.00467757032908082,-0.01032971551111,0.00800636017888677,0.803865319246077
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,28307,0.00152334311339337,0.00615321790789612,-0.010536963986083,0.0135836502128698,0.804470058570307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23056,-0.00123208171161353,0.00497936255987055,-0.0109916323289598,0.00852746890573275,0.804571753132322
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,23056,-0.00107533278741178,0.00437703478580305,-0.00965432096758576,0.0075036553927622,0.805935171337839
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,28176,-0.00119824154253757,0.00487868751481526,-0.0107604690715755,0.00836398598650034,0.805987983931011
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,23795,-0.000906880977933682,0.0037022394067078,-0.00816327021508098,0.00634950825921361,0.806493613341611
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,23071,-0.000796442742908265,0.00325969573450914,-0.00718544638254618,0.00559256089672965,0.80697711975601
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,23393,0.00108844050450094,0.00445529775860005,-0.00764394310235515,0.00982082411135703,0.806998669741962
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,28224,0.00111076271825071,0.00455909069414332,-0.00782505504227019,0.0100465804787716,0.807513819730389
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,22936,-0.000584823887023625,0.00240140961466802,-0.00529158673177294,0.00412193895772569,0.807594252152059
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,23795,-0.000429252759403142,0.00176470912346558,-0.00388808264139568,0.0030295771225894,0.807819423405583
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,27281,-0.000429988979885191,0.00177859889807976,-0.00391604282012151,0.00305606486035113,0.808970170461813
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,28320,-0.000663206616232752,0.0027471844996184,-0.00604768823548481,0.00472127500301931,0.809236627513589
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,23188,-0.000472050959024151,0.00198002761016478,-0.00435290507494712,0.00340880315689882,0.811568127695033
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,23393,0.00113059152403328,0.00475813784811126,-0.00819535865826479,0.0104565417063313,0.812183982125516
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",23795,0.00127907959146169,0.00538598525287608,-0.00927745150417543,0.0118356106870988,0.812284201444434
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,23775,0.000585756210949157,0.00248050155791414,-0.00427602684256255,0.00544753926446086,0.813322763893223
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,28320,0.00165790816062266,0.00702286430377329,-0.012106905874773,0.0154227221960183,0.813377786266943
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,27562,-0.000569577105303155,0.00241330470123053,-0.00529965431971499,0.00416050010910868,0.813422464876299
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,28440,-0.00129642038624361,0.00549972442409637,-0.0120758802574725,0.00948303948498527,0.813648071360026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23071,0.00104073366842674,0.00451015879015761,-0.00779917756028218,0.00988064489713565,0.817508571964999
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,23893,0.000393607992082696,0.00171437640079657,-0.00296656975347859,0.00375378573764398,0.8184103889724
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,23188,0.000940793966690246,0.00410002373615454,-0.00709525255617265,0.00897684048955314,0.818512953980927
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,27562,0.000547639446471242,0.00240200482514983,-0.00416029001082242,0.00525556890376491,0.819653646278148
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,27702,-0.000884036473427136,0.00391655596975903,-0.00856048617415483,0.00679241322730055,0.821422563755761
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,23198,0.00103850783064375,0.0046105126899123,-0.00799809704158437,0.0100751127028719,0.821788492641928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,28120,-0.000612565143535192,0.00275037186413624,-0.00600329399724222,0.00477816371017183,0.823754395883749
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,27434,-0.00105144981487972,0.00476263436594468,-0.0103862131721313,0.00828331354237185,0.825272672788342
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,27126,0.000467648365865676,0.0021244043178388,-0.00369618409709837,0.00463148082882972,0.825770379583568
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",27702,0.00175087108020239,0.00795689273634025,-0.0138446386830245,0.0173463808434293,0.825838061807785
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,23862,-0.000644725161633523,0.00295724492708759,-0.00644092521872521,0.00515147489545816,0.827418918365824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,28187,0.000588628074469105,0.00271442570821105,-0.00473164631362456,0.00590890246256277,0.82832541950501
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,27682,0.000450216263536202,0.00207867756967413,-0.0036239917730251,0.0045244243000975,0.828531167906132
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,23188,-0.000893333660497042,0.00412610671099634,-0.00898050281404987,0.00719383549305579,0.828593969835259
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,28553,0.000396618661447397,0.00183745713033188,-0.00320479731400309,0.00399803463689788,0.829104713374363
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23071,-0.000765508492015333,0.00354791233551944,-0.00771941666963344,0.00618839968560278,0.829174337121423
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,28091,-0.000383058993658583,0.0017912748861462,-0.00389395777050513,0.00312783978318797,0.830667823270651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",22978,0.000787543735525189,0.00369349977550003,-0.00645171582445486,0.00802680329550524,0.831153943808321
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,23738,-0.000952844649840377,0.00454955749107483,-0.00986997733234705,0.00796428803266629,0.83410908505904
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,23775,0.000381170357087204,0.00182075625870129,-0.00318751190996732,0.00394985262414173,0.834178945636882
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,23198,0.000430376612267177,0.00206807611665906,-0.00362305257638458,0.00448380580091894,0.835148950139774
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,27918,-0.000431298296418979,0.00207477098494969,-0.00449784942692038,0.00363525283408242,0.835326100639708
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23071,0.000633241538481167,0.00309055693710178,-0.00542425005823832,0.00669073313520065,0.837655496433616
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,28428,0.000779367363347424,0.00382581161548842,-0.00671922340300988,0.00827795812970472,0.838579282046231
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,23893,0.000568269180620682,0.00279219422671694,-0.00490443150374452,0.00604096986498588,0.838729842193336
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,27682,-0.000999445936524023,0.00491799228069847,-0.010638710806693,0.00863981893364498,0.838962740894637
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,23163,0.000566065938062729,0.0027954580057425,-0.00491303175319258,0.00604516362931804,0.839531638917016
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,28320,0.00038943289206768,0.00192948915625595,-0.00339236585419398,0.00417123163832934,0.840049418435814
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,23188,-0.000377016613612443,0.00188234691289674,-0.00406641656289005,0.00331238333566517,0.841254979442924
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,23163,-0.000493120888790831,0.00246653166808257,-0.00532752295823267,0.004341281180651,0.841541138340608
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,27562,-0.000698135949092644,0.0035461310012204,-0.00764855271148462,0.00625228081329933,0.843928706302528
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,28111,0.000357605296064637,0.00182437021072075,-0.00321816031694802,0.0039333709090773,0.844599255565796
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,23198,0.000916653200610726,0.00475278858898577,-0.00839881243380138,0.0102321188350228,0.847065293294421
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,23693,0.000755402929489886,0.0039642034778776,-0.00701443588715021,0.00852524174612998,0.848875065004043
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,27702,0.000901133383285992,0.00473435791585498,-0.00837820813178976,0.0101804748983617,0.849044818567861
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,28520,0.000301950301062812,0.00158875675922609,-0.00281201294702033,0.00341591354914595,0.849267811916876
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,23795,0.000474276564350508,0.00251239631250492,-0.00445002020815914,0.00539857333686016,0.850271104934119
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,23071,-0.000448918483159861,0.00238101247748886,-0.00511570293903803,0.00421786597271831,0.850454234580843
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,23188,-0.000458925223812736,0.00245926876235313,-0.00527909199802488,0.0043612415503994,0.851967714739239
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,23198,-0.000761973706921736,0.00411394292966669,-0.00882530184906845,0.00730135443522498,0.853060162447688
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,23393,0.00067090650984986,0.00363079987767381,-0.0064454612503908,0.00778727427009052,0.853401619323232
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,28320,0.000536061583978305,0.00290391552035058,-0.00515561283590883,0.00622773600386544,0.853544438242908
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23198,0.000586418429530102,0.00322641043618366,-0.00573734602538988,0.00691018288445008,0.855776054666161
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,27544,-0.000680015050135065,0.00375046654272001,-0.00803092947386629,0.00667089937359616,0.856121833206824
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,23393,0.000907911198887157,0.00501687671206875,-0.00892516715676759,0.0107409895545419,0.856391594060871
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,27682,0.000750453340523483,0.00415932170688361,-0.00740181720496839,0.00890272388601536,0.856818793326952
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,27544,-0.000566168599803175,0.00314488743886618,-0.00673014797998089,0.00559781078037454,0.857131710832035
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,28224,0.00038248348388972,0.00214690605267698,-0.00382545237935716,0.0045904193471366,0.858602003025179
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,27935,-0.00033579376384553,0.00191857119972513,-0.00409619331530679,0.00342460578761573,0.861062962620756
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,28182,-0.000454751482015052,0.00260562985294521,-0.00556178599378766,0.00465228302975756,0.861452953568675
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,23188,0.00027421035855004,0.0015836450895374,-0.00282973401694327,0.00337815473404335,0.862533938833243
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,27544,-0.000781661314378037,0.00453361768549517,-0.00966755197794857,0.0081042293491925,0.863112960352918
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,22978,-0.000429229285893604,0.00249754318855656,-0.00532441393546446,0.00446595536367725,0.863548631948225
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,23393,-0.000921805505228708,0.00538309148374371,-0.0114726648133664,0.00962905380290896,0.864035819939506
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,23393,0.00120768301812241,0.00711842730668272,-0.0127444345029757,0.0151598005392205,0.865282244912019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,23163,-0.000574800588184914,0.00339524608135731,-0.00722948290764523,0.00607988173127541,0.865565531250643
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,28428,-0.000721991087114276,0.00427017867710091,-0.00909154129423205,0.0076475591200035,0.865736894943433
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,23393,-0.000635263652829419,0.00377245905241269,-0.00802928339555829,0.00675875608989945,0.866273912410997
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,22978,0.00105016800287833,0.00632919311457037,-0.0113550505016796,0.0134553865074363,0.868217852092579
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,23188,0.00100340665673681,0.0060798728083532,-0.0109131440476355,0.0129199573611091,0.868915951077319
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,22978,0.000622312121792163,0.00380500450260122,-0.00683549670330623,0.00808012094689056,0.870086095836004
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,23071,-0.00071963208462399,0.00448790502783382,-0.00951592593917828,0.0080766617699303,0.872607390737332
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",23071,-0.000678654378172461,0.00423511559435848,-0.00897948094311508,0.00762217218677016,0.872689806221738
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,28187,-0.000474724274671732,0.00296582300460828,-0.00628773736370396,0.00533828881436049,0.872831068147499
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,28452,-0.000591751823751673,0.00374537761574333,-0.00793269195060859,0.00674918830310525,0.874461673751083
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,23846,-0.000368603699841767,0.00233645435571538,-0.00494805423704392,0.00421084683736038,0.874645683902058
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,27562,-0.000491975835962687,0.00311941952007459,-0.00660603809530888,0.00562208642338351,0.874683398406761
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,28276,-0.000870033648977448,0.00558348921453835,-0.0118136725094726,0.0100736052115177,0.876173991122021
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,28091,0.00143312421522327,0.00924454919681311,-0.0166861922105304,0.019552440640977,0.876803748139091
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,23198,0.000531508766001221,0.00344539541336722,-0.00622146624419852,0.00728448377620097,0.877401027497027
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,27702,-0.000678698136083943,0.00440039804870093,-0.00930347831153776,0.00794608203936987,0.877425078984065
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,22978,0.00060849498054342,0.00401996562634971,-0.00727063764710201,0.00848762760818885,0.879686598886613
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,27702,0.00055751697510299,0.00369710627050324,-0.00668881131508336,0.00780384526528934,0.880136003827897
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23056,-0.000578692251501804,0.00385992779502239,-0.00814415072974568,0.00698676622674207,0.880826616980185
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,23056,-0.000738335870376308,0.0049534866733334,-0.0104471697501098,0.00897049800935715,0.881512507783711
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,27702,0.000654843713095461,0.0045023274624286,-0.00816971811326459,0.00947940553945551,0.884360123610842
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,27682,-0.000264982697924543,0.00184093104899357,-0.00387320755395193,0.00334324215810285,0.885549290894273
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,23725,0.000430780836298839,0.00301638022574388,-0.00548132440615917,0.00634288607875685,0.886438421622025
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,23188,-0.000824548889377232,0.00584846674905814,-0.0122875437175312,0.0106384459387767,0.887882638796855
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,23163,0.000471302160546059,0.00339944173530426,-0.00619160364065029,0.00713420796174241,0.88973501185507
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,23163,-0.000555837299841805,0.00401181070318216,-0.00841898627807884,0.00730731167839523,0.889806778891474
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,23188,0.000843759077362307,0.0061000428978203,-0.0111123250023655,0.0127998431570901,0.889988573365119
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,23198,-0.00029591508676172,0.00215007488427471,-0.00451006185994016,0.00391823168641672,0.890533936683079
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,23846,-0.000425061571744143,0.00311007774585711,-0.00652081395362408,0.0056706908101358,0.891290956248387
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,22978,0.00106293479852395,0.00787545898319992,-0.0143729648085479,0.0164988344055958,0.892638372989177
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,23071,-0.000302623263596103,0.00226307429415057,-0.00473824888013121,0.00413300235293901,0.8936234202403
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,23071,-0.000386564532367885,0.00297836313048113,-0.0062241562681109,0.00545102720337513,0.896732968076904
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,23393,0.000684993470351656,0.00527775815503036,-0.00965941251350786,0.0110293994542112,0.896734704888421
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,27702,0.000572423701723874,0.00445375514871844,-0.00815693638976427,0.00930178379321201,0.897733592019105
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",27544,0.000466915792574909,0.00363748053925401,-0.00666254606436296,0.00759637764951277,0.897863109844061
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",27682,0.000375593880164928,0.00293780836471752,-0.0053825105146814,0.00613369827501126,0.898269934739304
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,23188,-0.000462566562211886,0.00368001444006845,-0.00767539486474605,0.00675026174032228,0.899972912856261
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,23163,-0.000306128645661279,0.00245829031643751,-0.0051243776658788,0.00451212037455624,0.900897453763174
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,28553,0.000264986014322495,0.00213092533701915,-0.00391162764623504,0.00444159967488003,0.901037011557455
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,28125,-0.000213881356583978,0.00172321061104925,-0.0035913741542405,0.00316361144107254,0.901222778890252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,23188,-0.000728028512627465,0.00588821844601181,-0.0122689366668106,0.0108128796415557,0.901600157325585
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,23370,0.000801921732895821,0.00666487658685786,-0.0122612363773456,0.0138650798431372,0.904230246948747
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,23862,0.000737737491493911,0.00615696704807474,-0.0113299179227326,0.0128053929057204,0.904625499696264
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,23056,-0.000735715526255051,0.00636082571486738,-0.0132029339273951,0.011731502874885,0.907920222648923
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",23071,0.000303776185096494,0.00264005036583848,-0.00487072253194693,0.00547827490213992,0.908394966869439
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,23337,-0.000509420171787923,0.0045328859753533,-0.00939387668348039,0.00837503633990455,0.910520552946518
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,27562,0.000825157028606125,0.00743493395061297,-0.0137473135145953,0.0153976275718075,0.911630022297183
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,22978,-0.00044322661916823,0.00399657958108592,-0.00827652259809664,0.00739006935976018,0.911695435463832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,23775,0.000338438956420594,0.00313288281555598,-0.00580201136206912,0.00647888927491031,0.913974420954168
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,23738,-0.000201586895507582,0.00190775964185435,-0.0039407957935421,0.00353762200252694,0.915847599745953
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,27682,0.000244188101030155,0.00233746233135602,-0.00433723806842764,0.00482561427048795,0.916799368537556
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23194,0.000270855287316924,0.00262615439511761,-0.00487640732711359,0.00541811790174744,0.91785464806646
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,23725,-0.000453766687455718,0.00449932773499836,-0.0092724490480525,0.00836491567314107,0.919668714031504
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,23893,0.000180361714561305,0.00179960348737703,-0.00334686112069767,0.00370758454982028,0.920168104027889
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,22978,-0.000404095242175518,0.00408784458625562,-0.00841627063123654,0.0076080801468855,0.92125593853358
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,27544,0.000252022675923843,0.00259107751997446,-0.00482648926322609,0.00533053461507378,0.922516192040965
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,27702,0.000354199850330438,0.00375475861831162,-0.00700512704156033,0.00771352674222121,0.924844852574211
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,23795,0.000281033527152679,0.00300040169128114,-0.00559975378775836,0.00616182084206371,0.925375824019803
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,28470,-0.000204339646312617,0.00220281361251404,-0.00452185432684013,0.0041131750342149,0.926092481960282
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,28224,0.000538825763638819,0.00584773982545419,-0.0109227442942514,0.012000395821529,0.926585422313213
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,23163,-0.000403292964346516,0.00442179170236999,-0.00907000470099169,0.00826341877229866,0.927329870908686
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,27562,-0.000182750518565426,0.00202440890389488,-0.00415059197019939,0.00378509093306854,0.928070518148518
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",23163,0.000507895439354396,0.00569875767130135,-0.0106616695963963,0.0116774604751051,0.928984224200746
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,28521,0.000204731681814507,0.00231247862303416,-0.00432772641933244,0.00473718978296146,0.929453331233605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,22978,0.000246043730608955,0.00280025415204263,-0.00524245440739461,0.00573454186861252,0.929984911505004
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",23287,0.000502926682631865,0.00577758022626567,-0.0108211305608488,0.0118269839261126,0.930634123917963
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,23725,0.00021783643165116,0.00251471529678091,-0.00471100555003943,0.00514667841334175,0.930970571771457
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,27562,-0.000254520461644982,0.00295729159712534,-0.00605081199201065,0.00554177106872069,0.931415059883404
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,22978,0.00035857152710047,0.00428069868310036,-0.00803159789177624,0.00874874094597718,0.933244228807564
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,23071,0.000554806801043325,0.00662510290855923,-0.0124303948997328,0.0135400085018194,0.933261398153995
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,23071,-0.000224271490490646,0.00269538363501737,-0.00550722341512469,0.00505868043414339,0.933688641351737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,23071,-0.000372444615456737,0.0045003713732404,-0.00919317250700792,0.00844828327609445,0.934044174963252
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,27956,-0.000707077149738421,0.00861272007615878,-0.0175880084990096,0.0161738541995328,0.934570289587605
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,23393,-0.000381056128189913,0.00469027418706632,-0.0095739935348399,0.00881188127846007,0.935248689767928
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,22936,-0.000222925203842438,0.0027610146180815,-0.00563451385528218,0.0051886634475973,0.935649175625685
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,23393,0.000187811613397317,0.00238098699548588,-0.00447892289775501,0.00485454612454964,0.93712896051292
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,23071,0.000245764819852423,0.00314674508298554,-0.00592185554279923,0.00641338518250407,0.937748166470307
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,27544,-0.000329121469975529,0.00427075599720506,-0.00869980322449745,0.00804156028454639,0.938573204736811
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,28091,0.000110306107903386,0.00146009537354302,-0.00275148082424094,0.00297209304004771,0.939779887947819
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,23775,-0.000182986815934657,0.00249172832373817,-0.00506677433046146,0.00470080069859215,0.941458430457092
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,28198,0.000312800904901489,0.00429854837042847,-0.00811235390113832,0.00873795571094129,0.941990486217114
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,23163,0.000322625578156486,0.00469862829949561,-0.00888668588885491,0.00953193704516788,0.945257842842019
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,23188,0.000187086235064445,0.00273908980125908,-0.00518152977540336,0.00555570224553225,0.945545552985175
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,28187,0.000196545844309379,0.00288238645787552,-0.00545293161312664,0.0058460233017454,0.945636000251199
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,28521,-0.00030517597079908,0.00454128913057974,-0.00920610266673536,0.0085957507251372,0.946422721285115
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,23795,0.000131124402688094,0.00199828670349803,-0.00378551753616805,0.00404776634154423,0.947682180634116
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,23071,-0.000239849005074224,0.00375611970815282,-0.00760184363305375,0.00712214562290531,0.949085817481226
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,27702,-0.000119798263632857,0.00195376591632163,-0.00394917945962326,0.00370958293235755,0.951107521324048
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,23188,-0.000168980057707275,0.00280926687772618,-0.00567514313805058,0.00533718302263603,0.952035933753393
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,23071,0.000240068272899483,0.00406579133699441,-0.00772888274760955,0.00820901929340852,0.952916067666908
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,23071,-0.000169504803069605,0.00308672852202814,-0.00621949270624477,0.00588048310010556,0.956207404291803
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,23056,-0.000173707189881022,0.00340319322604431,-0.00684396591292787,0.00649655153316583,0.95929216733071
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23071,0.000220543333479372,0.00446160546007273,-0.00852420336826317,0.00896529003522192,0.960575945940737
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,23393,0.000281562445572156,0.00579787923582444,-0.0110822808566438,0.0116454057477881,0.961267966724411
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,27702,-0.000268833790108562,0.0055440173407034,-0.0111351077778872,0.0105974401976701,0.961325452708696
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,23738,-8.38457423847915e-05,0.00200507862669258,-0.00401379985070225,0.00384610836593267,0.966645185421398
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,23163,9.88445024294758e-05,0.00238283020727337,-0.00457150270382633,0.00476919170868528,0.966912020319543
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,23393,0.000167851265682817,0.00436332467805982,-0.00838426510331444,0.00871996763468007,0.969314344910644
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,27562,-9.66066432777418e-05,0.00254588287937548,-0.00508653708685368,0.0048933238002982,0.969730832710954
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,23056,-0.00014565085007761,0.00428057605495454,-0.00853557991778851,0.00824427821763329,0.972856718158515
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,23071,8.14499030271201e-05,0.00243513953567318,-0.00469142358689231,0.00485432339294655,0.973317833060306
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,27702,-7.38943798633467e-05,0.00262871133360711,-0.00522616859373328,0.00507837983400659,0.97757422524715
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,27965,-0.000134686922321789,0.00527291975620898,-0.0104696096444914,0.0102002357998478,0.979621922092288
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,23056,0.000100891434980372,0.00433865134396369,-0.00840286519918847,0.00860464806914921,0.981447785548572
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,28422,-8.39928823786927e-05,0.00388089674256282,-0.00769055049780183,0.00752256473304444,0.982733165254313
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,23744,-0.000106960262080145,0.00500616646930892,-0.00991904654192563,0.00970512601776534,0.982954112612112
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,28187,3.9142565576552e-05,0.00185425275714439,-0.00359519283842646,0.00367347796957956,0.983158362819645
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,23337,-7.09346378328008e-05,0.00341841865181853,-0.00677103519539712,0.00662916591973152,0.983444688954651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,23188,3.951077608775e-05,0.00198435120123572,-0.00384981757833427,0.00392883913050977,0.984114397123871
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,23846,-3.79757781154e-05,0.00201141973960479,-0.00398035846774079,0.00390440691150999,0.984936923653335
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,22978,3.16232244326465e-05,0.0017090123168447,-0.00331804091658296,0.00338128736544826,0.985237105794241
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,28553,4.86512592672697e-05,0.00264970295579229,-0.00514476653408561,0.00524206905262015,0.985350973982651
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,23337,0.000142113275876079,0.00780749323427179,-0.0151605734632966,0.0154448000150488,0.985477731633248
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,23071,-5.63014362158179e-05,0.00340531563376094,-0.00673072007838725,0.00661811720595562,0.986809001606622
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,22978,-9.16044349928741e-05,0.00590990238629221,-0.0116750131121256,0.0114918042421399,0.987633291174203
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,23056,7.60715887247785e-05,0.00502760046572882,-0.00977802532410372,0.00993016850155327,0.987927964431417
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,23393,5.67460988337089e-05,0.00399381364533616,-0.00777112864602517,0.00788462084369258,0.988663760360738
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,27702,-2.74471289725496e-05,0.00212455004616363,-0.00419156521945327,0.00413667096150817,0.98969248403026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,23071,-7.95743588218273e-05,0.00668091256976384,-0.0131741629955589,0.0130150142779153,0.990496962495026
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,23775,-5.32742922403002e-05,0.0047785552930829,-0.00941924266668278,0.00931269408220218,0.991104966903394
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,22978,-2.95538533154381e-05,0.00276713090659969,-0.00545313043025083,0.00539402272361996,0.991478589540007
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,27531,-2.28411200265341e-05,0.00214190868763151,-0.00422098214778428,0.00417529990773122,0.991491669960473
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,28187,-3.42572414532432e-05,0.00344378915783383,-0.00678408399080755,0.00671556950790107,0.992063210185978
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,23188,2.5611482468466e-05,0.00276523675415093,-0.00539425255566735,0.00544547552060428,0.992610219074832
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,27682,-1.70062144658188e-05,0.00224880926563891,-0.00442467237511807,0.00439065994618643,0.993966253951456
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,28105,2.01337790459042e-05,0.00332859932915207,-0.00650392090609215,0.00654418846418395,0.995173888793693
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23198,9.22998374422696e-06,0.00176072020938863,-0.00344178162665748,0.00346024159414593,0.995817422698156
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,27702,-1.11451639664901e-05,0.00239540973865022,-0.00470614825172092,0.00468385792378793,0.996287715735602
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,23355,1.46989804393612e-05,0.00367913215707865,-0.0071964000474348,0.00722579800831352,0.996812310013899
NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,28428,-5.15258978450865e-06,0.00145797643871018,-0.00286278640965646,0.00285248123008745,0.99718025134145
